|
Main |
News |
Articles |
Papers|
About
|
COVID-19 Scientific Papers
updated April 27, 2022 16:00 EDT
Caveat 1: There are thousands of papers being published and this is not in any
way a representative sample.
Caveat 2: Research is happening at a very rapid pace, so keep in mind that
something published just a few months or weeks ago may have already been
superseded.
Earlier
03/25/2008 Modeling targeted layered containment of an influenza pandemic in the United States | PNAS
05/01/2007 Public health interventions and epidemic intensity during the 1918 influenza pandemic | PNAS
09/02/2014 Quantification of Shared Air: A Social and Environmental Determinant of Airborne Disease Transmission
03/02/2016 Pre-fusion structure of a human coronavirus spike protein | Nature
07/11/2017 Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen | PNAS
04/04/2018 Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin - PubMed
January 2020
01/27 Updated understanding of the outbreak of 2019 novel coronavirus (2019‐nCoV) in Wuhan, China - Wang - 2020 - Journal of Medical Virology - Wiley Online Library
01/30 Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany | NEJM
February 2020
02/09 Far-UVC light: A new tool to control the spread of airborne-mediated microbial diseases | Scientific Reports
March 2020
03/03 Fractal kinetics of COVID-19 pandemic | medRxiv
03/09 Temperature and Latitude Analysis to Predict Potential Spread and Seasonality for COVID-19 :: SSRN
03/16 Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand - Imperial College London [PDF]
03/17 The proximal origin of SARS-CoV-2 | Nature Medicine
03/17 Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1 | NEJM
03/27 Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma | JAMA | JAMA Network
April 2020
04/03 Respiratory virus shedding in exhaled breath and efficacy of face masks | Nature Medicine
04/06 Quantifying the effect of quarantine control in Covid-19 infectious spread using machine learning | medRxiv
04/07 Indoor transmission of SARS-CoV-2 | medRxiv
04/07 Early Release - High Contagiousness and Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2 - Volume 26, Number 7—July 2020 - Emerging Infectious Diseases journal - CDC
04/10 Association of Public Health Interventions With the Epidemiology of the COVID-19 Outbreak in Wuhan, China | Global Health | JAMA | JAMA Network
04/10 Early Release - Aerosol and Surface Distribution of Severe Acute Respiratory Syndrome Coronavirus 2 in Hospital Wards, Wuhan, China, 2020 - Volume 26, Number 7—July 2020 - Emerging Infectious Diseases journal - CDC
04/11 OSF | The Small World Network of College Classes: Implications for Epidemic Spread on a University Campus | Cornell
04/12 Face Masks Against COVID-19: An Evidence Review[v1] | Preprints
04/13 Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period | Science
04/13 Universal Screening for SARS-CoV-2 in Women Admitted for Delivery | NEJM
04/15 COVID-19: Hydroxychloroquine & Hypoxic Pneumonia / Timing of Viral Shedding & Transmission / Coinfection with Other Respiratory Pathogens
04/15 Fast spread of COVID-19 in Europe and the US and its implications: even modest public health goals require comprehensive intervention | medRxiv
04/18 Relative disease burdens of COVID-19 and seasonal influenza in New York City, February 1 - April 18, 2020. | medRxiv
04/20 Human monoclonal antibodies block the binding of SARS-CoV-2 spike protein to angiotensin converting enzyme 2 receptor | Nature
04/22 National Covid-19 Testing Action Plan - Rockefeller Foundation [PDF]
04/23 Modeling infectious disease dynamics | Science
04/23 Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19 | medRxiv
04/23 SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes | Nature Medicine
04/24 Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Randomized Clinical Trial | Infectious Diseases | JAMA Network Open | JAM
04/24 Aerosol Filtration Efficiency of Common Fabrics Used in Respiratory Cloth Masks | ACS Nano
04/24 Early Release - Asymptomatic SARS-CoV-2 Infection in Household Contacts of a Healthcare Provider, Wuhan, China - Volume 26, Number 8—August 2020 - Emerging Infectious Diseases journal - CDC
04/30 A rapid systematic review of the efficacy of face masks and respirators against coronaviruses and other respiratory transmissible viruses for the community, healthcare workers and sick patients
May 2020
05/05 Rapid development of an inactivated vaccine candidate for SARS-CoV-2 | Science
05/07 Hydroxychloroquine in patients with COVID-19: an open-label, randomized, controlled trial | medRxiv
05/08 Harnessing multiple models for outbreak management | Science discussed here: 05/07 Which COVID-19 models should we use to make policy decisions?
05/08 Impact of climate and public health interventions on the COVID-19 pandemic: a prospective cohort study | CMAJ
05/11 COVID-19 and Postinfection Immunity: Limited Evidence, Many Remaining Questions | Infectious Diseases | JAMA | JAMA Network
05/12 The airborne lifetime of small speech droplets and their potential importance in SARS-CoV-2 transmission | PNAS
05/12 Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: a population-based cohort study - The Lancet
05/13 An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study - The Lancet
05/13 An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study - The Lancet discussed here: 05/13 Kawasaki-like disease: emerging complication during the COVID-19 pandemic - The Lancet
05/14 Assessment of Deaths From COVID-19 and From Seasonal Influenza | Geriatrics | JAMA Internal Medicine | JAMA Network
05/14 Strong Social Distancing Measures In The United States Reduced The COVID-19 Growth Rate | Health Affairs
05/15 Early Release - Cluster of Coronavirus Disease Associated with Fitness Dance Classes, South Korea - Volume 26, Number 8—August 2020 - Emerging Infectious Diseases journal - CDC
05/20 Nasal ACE2 Levels and COVID-19 in Children | Infectious Diseases | JAMA | JAMA Network
05/25 Tail risk of contagious diseases | Nature Physics
05/29 Differential Effects of Intervention Timing on COVID-19 Spread in the United States | medRxiv
June 2020
06/01 Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis - The Lancet
06/03 Prevalence of Asymptomatic SARS-CoV-2 Infection: A Narrative Review: Annals of Internal Medicine: Vol 0, No 0
06/04 Serodiagnostics for Severe Acute Respiratory Syndrome–Related Coronavirus-2: A Narrative Review: Annals of Internal Medicine: Vol 0, No 0
06/05 False Negative Tests for SARS-CoV-2 Infection — Challenges and Implications | NEJM
06/08 The effect of large-scale anti-contagion policies on the COVID-19 pandemic | Nature discussed here: 06/08 Emergency COVID-19 measures prevented more than 500 million infections, study finds | Berkeley News
06/09 Rationing social contact during the COVID-19 pandemic: Transmission risk and social benefits of US locations | PNAS discussed here: 06/11 Which businesses should be open? | MIT News
06/10 A modelling framework to assess the likely effectiveness of facemasks in combination with ‘lock-down’ in managing the COVID-19 pandemic | Proceedings of the Royal Society A: Mathematical, Physical and Engineering Sciences
06/10 Identifying airborne transmission as the dominant route for the spread of COVID-19 | PNAS
06/11 Eurosurveillance | SARS-CoV-2 infection in farmed minks, the Netherlands, April and May 2020
06/11 Identifying airborne transmission as the dominant route for the spread of COVID-19 | PNAS
06/12 Ivermectin: a systematic review from antiviral effects to COVID-19 complementary regimen | The Journal of Antibiotics
06/16 Community Use Of Face Masks And COVID-19: Evidence From A Natural Experiment Of State Mandates In The US | Health Affairs
06/18 Cerebral Venous Thrombosis Associated with COVID-19 | American Journal of Neuroradiology
06/18 Economic Vulnerability of Households With Essential Workers | Health Disparities | JAMA | JAMA Network
06/22 Using influenza surveillance networks to estimate state-specific prevalence of SARS-CoV-2 in the United States | Science Translational Medicine
06/22 Early Release - Persistence of Severe Acute Respiratory Syndrome Coronavirus 2 in Aerosol Suspensions - Volume 26, Number 9—September 2020 - Emerging Infectious Diseases journal - CDC
06/29 Seroconversion of a city: Longitudinal monitoring of SARS-CoV-2 seroprevalence in New York City | medRxiv
06/29 Multisystem Inflammatory Syndrome in U.S. Children and Adolescents | NEJM
06/29 Multisystem Inflammatory Syndrome in Children in New York State | NEJM
July 2020
07/02 Eurosurveillance | Excess all-cause mortality during the COVID-19 pandemic in Europe – preliminary pooled estimates from the EuroMOMO network, March to April 2020
07/02 The implications of silent transmission for the control of COVID-19 outbreaks | PNAS
07/06 Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study - The Lancet
07/09 Persistent Symptoms in Patients After Acute COVID-19 | Critical Care Medicine | JAMA | JAMA Network
07/09 Socio-economic, environmental impacts of COVID-19 quantified
07/09 Air recirculation role in the infection with COVID-19, lessons learned from Diamond Princess cruise ship | medRxiv
07/10 Tracking the reach of COVID-19 kin loss with a bereavement multiplier applied to the United States | PNAS
07/11 Longitudinal evaluation and decline of antibody responses in SARS-CoV-2 infection | medRxiv
07/14 An Mrna Vaccine Against Sars Cov 2 — Preliminary Report articles: NEJM.org
07/15 Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19: Preliminary results from a multi-centre, randomized, controlled trial. | medRxiv
07/16 Reconstruction of the full transmission dynamics of COVID-19 in Wuhan | Nature
07/16 Impact of delays on effectiveness of contact tracing strategies for COVID-19: a modelling study - The Lancet Public Health
07/21 The Infectious Nature of Patient-Generated SARS-CoV-2 Aerosol | medRxiv
07/28 Social distancing responses to COVID-19 emergency declarations strongly differentiated by income | PNAS
07/29 Association Between Statewide School Closure and COVID-19 Incidence and Mortality in the US | Infectious Diseases | JAMA | JAMA Network
07/29 Characteristics and Quality of US Nursing Homes Reporting Cases of Coronavirus Disease 2019 (COVID-19) | Geriatrics | JAMA Network Open | JAMA Network
August 2020
08/01 Long-term patient-reported symptoms of COVID-19: an analysis of social media data | medRxiv
08/03 Use of facemasks during the COVID-19 pandemic - The Lancet Respiratory Medicine
08/04 Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling | Journal of Experimental Medicine | Rockefeller University Press
08/04 Viable SARS-CoV-2 in the air of a hospital room with COVID-19 patients | medRxiv
08/06 Clinical Course and Molecular Viral Shedding Among Asymptomatic and Symptomatic Patients With SARS-CoV-2 Infection in a Community Treatment Center in the Republic of Korea | Infectious Diseases | JAMA Internal Medicine | JAMA Network
08/07 Low-cost measurement of facemask efficacy for filtering expelled droplets during speech | Science Advances
08/07 Interferon responses in viral pneumonias | Science
08/07 Successful Elimination of Covid-19 Transmission in New Zealand | NEJM
08/10 Dental procedure aerosols and COVID-19 - The Lancet Infectious Diseases
08/11 Management of post-acute covid-19 in primary care | The BMJ
08/13 Transmission heterogeneities, kinetics, and controllability of SARS-CoV-2 | medRxiv
08/18 Variation in False-Negative Rate of Reverse Transcriptase Polymerase Chain Reaction–Based SARS-CoV-2 Tests by Time Since Exposure | Annals of Internal Medicine
08/19 Demographic perspectives on the mortality of COVID-19 and other epidemics | PNAS
08/19 Social and behavioral consequences of mask policies during the COVID-19 pandemic | PNAS
08/19 Characterizing superspreading events and age-specific infectiousness of SARS-CoV-2 transmission in Georgia, USA | PNAS
08/21 COVID-19 is, in the end, an endothelial disease | European Heart Journal | Oxford Academic
08/21 Efficacy of Remdesivir in COVID-19 | Infectious Diseases | JAMA | JAMA Network
08/21 Early Release - Asymptomatic Transmission of SARS-CoV-2 on Evacuation Flight - Volume 26, Number 11—November 2020 - Emerging Infectious Diseases journal - CDC
08/24 Full article: Exhaled respiratory particles during singing and talking
08/26 Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: a systematic review and meta-analysis - Clinical Microbiology and Infection
08/26 Population-scale longitudinal mapping of COVID-19 symptoms, behaviour and testing | Nature Human Behaviour
08/27 Misconceptions about weather and seasonality must not misguide COVID-19 response | Nature Communications
08/28 Salivary Detection of COVID-19 | Annals of Internal Medicine
08/28 Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2 | NEJM
September 2020
09/02 Reduced development of COVID-19 in children reveals molecular checkpoints gating pathogenesis illuminating potential therapeutics | PNAS
09/04 An alpaca nanobody neutralizes SARS-CoV-2 by blocking receptor interaction | Nature Communications
09/08 Comparison of Clinical Features of COVID-19 vs Seasonal Influenza A and B in US Children | Infectious Diseases | JAMA Network Open | JAMA Network
09/08 “When Will We Have a Vaccine?” — Understanding Questions and Answers about Covid-19 Vaccination | NEJM
09/08 Facial Masking for Covid-19 — Potential for “Variolation” as We Await a Vaccine | NEJM
09/08 Social and behavioral consequences of mask policies during the COVID-19 pandemic | PNAS
09/08 Demographic perspectives on the mortality of COVID-19 and other epidemics | PNAS
09/09 Clinical Outcomes in Young US Adults Hospitalized With COVID-19 | Critical Care Medicine | JAMA Internal Medicine | JAMA Network
09/09 Use of “normal” risk to improve understanding of dangers of covid-19 | The BMJ
09/09 Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score | The BMJ
09/09 Covid-19 Molecular Diagnostic Testing — Lessons Learned | NEJM
09/10 Trained Innate Immunity, Epigenetics, and Covid-19 | NEJM
09/10 Mapping global trends in vaccine confidence and investigating barriers to vaccine uptake: a large-scale retrospective temporal modelling study - The Lancet
09/11 COVID-19 and the Path to Immunity | Allergy and Clinical Immunology | JAMA | JAMA Network
09/11 Cardiovascular Magnetic Resonance Findings in Competitive Athletes Recovering From COVID-19 Infection | Infectious Diseases | JAMA Cardiology | JAMA Network
09/14 Seasonal coronavirus protective immunity is short-lasting | Nature Medicine
09/17 Patient-reported outcome measures after COVID-19: a prospective cohort study | European Respiratory Society
09/17 A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity | Nature Communications
09/17 Clustering and superspreading potential of SARS-CoV-2 infections in Hong Kong | Nature Medicine
09/18 Artificial intelligence in COVID-19 drug repurposing - The Lancet Digital Health
09/21 COVID-19 in children and young people | Science
09/21 Immune responses to SARS-CoV-2 infection in hospitalized pediatric and adult patients | Science Translational Medicine
09/22 Quantifying and contextualizing the impact of bioRxiv preprints through automated social media audience segmentation
09/22 Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and meta-analysis - PLOS
09/23 National Trends of Cases of COVID-19 in Children Based on US State Health Department Data | American Academy of Pediatrics
09/23 The rise of COVID-19 cases is associated with support for world leaders | PNAS
09/23 Physics of virus transmission by speaking droplets | PNAS
09/25 Susceptibility to SARS-CoV-2 Infection Among Children and Adolescents Compared With Adults: A Systematic Review and Meta-analysis | Adolescent Medicine | JAMA Pediatrics | JAMA Network
09/25 Speech can produce jet-like transport relevant to asymptomatic spreading of virus | PNAS
09/25 Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation | PNAS
09/25 Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study - The Lancet
09/28 Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity | Science
09/28 Effects of ventilation on the indoor spread of COVID-19 | Journal of Fluid Mechanics | Cambridge Core
09/28 Direct detection of SARS-CoV-2 using CRISPR-Cas13a and a mobile phone | medRxiv
09/29 Epidemiology and transmission dynamics of COVID-19 in two Indian states | Science
09/29 A Cytokine Circus with a Viral Ringleader: SARS-CoV-2-Associated Cytokine Storm Syndromes: Trends in Molecular Medicine - Cell
09/29 Genetic mechanisms of critical illness in Covid-19 | medRxiv
09/29 Low risk of SARS-CoV-2 transmission by fomites in real-life conditions - The Lancet Infectious Diseases
09/29 Early Release - Flight-Associated Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 Corroborated by Whole-Genome Sequencing - Volume 26, Number 12—December 2020 - Emerging Infectious Diseases journal - CDC
09/30 In-hospital cardiac arrest in critically ill patients with covid-19: multicenter cohort study | The BMJ
09/30 Spinal cord dysfunction after COVID-19 infection - Nature
October 2020
10/01 Seroprevalence of SARS-CoV-2 antibodies in people with an acute loss in their sense of smell and/or taste in a community-based population in London, UK: An observational cohort study - PLOS
10/01 COVID-19 Vaccine Predictions: Using Mathematical Modelling and Expert Opinions to Estimate Timelines and Probabilities of Success of COVID-19 Vaccines | Center For Global Development
10/01 Frontiers | Pandemic Dreams: Network Analysis of Dream Content During the COVID-19 Lockdown | Psychology
10/02 Airborne transmission of SARS-CoV-2 | Science
10/05 Long-term Health Consequences of COVID-19 | Cardiology | JAMA | JAMA Network
10/05 Follow-up of adults with non-critical COVID-19 two months after symptoms' onset - ScienceDirect
10/05 Neuropathology of patients with COVID-19 in Germany: a post-mortem case series - The Lancet Neurology
10/06 Children and Adolescents With SARS-CoV-2 Infection Epidemiology, Clinical Course and Viral Loads - The Pediatric Infectious Disease Journal
10/06 Symptoms and Transmission of SARS-CoV-2 among Children—Utah and Wisconsin, March–May 2020 | American Academy of Pediatrics
10/06 SARS-CoV-2-specific T-cells in unexposed humans: presence of cross-reactive memory cells does not equal protective immunity | Signal Transduction and Targeted Therapy
10/06 Cross-reactive memory T cells and herd immunity to SARS-CoV-2 | Nature Reviews Immunology
10/06 Characteristics of SARS-CoV-2 and COVID-19 | Nature Reviews Microbiology
10/06 Remdesivir targets a structurally analogous region of the Ebola virus and SARS-CoV-2 polymerases | PNAS
10/07 The effect of temperature on persistence of SARS-CoV-2 on common surfaces | Virology Journal | Full Text
10/07 Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19 | Nature Immunology
10/08 Characteristics of Hospitalized Children With SARS-CoV-2 in the New York City Metropolitan Area - PubMed
10/08 SARS-CoV-2 disrupts splicing, translation, and protein trafficking to suppress host defenses: Cell
10/08 Remdesivir for the Treatment of Covid-19 — Final Report | NEJM
10/08 Clinical impact of molecular point-of-care testing for suspected COVID-19 in hospital (COV-19POC): a prospective, interventional, non-randomised, controlled study - The Lancet Respiratory Medicine
10/09 Economic hardship and mental health complaints during COVID-19 | PNAS
10/10 Convalescent plasma for patients with severe COVID-19: a matched cohort study | Clinical Infectious Diseases | Oxford Academic
10/11 Global projections of potential lives saved from COVID-19 through universal mask use | medRxiv
10/12 Excess Deaths From COVID-19 and Other Causes, March-July 2020 | Cardiology | JAMA | JAMA Network
10/12 Outcomes of Neonates Born to Mothers With Severe Acute Respiratory Syndrome Coronavirus 2 Infection at a Large Medical Center in New York City | Infectious Diseases | JAMA Pediatrics | JAMA Network
10/12 SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies | Nature
10/12 The role of environmental factors on transmission rates of the COVID-19 outbreak: an initial assessment in two spatial scales | Scientific Reports - Nature
10/12 Seasonality and uncertainty in global COVID-19 growth rates | PNAS
10/12 Genomic evidence for reinfection with SARS-CoV-2: a case study - The Lancet Infectious Diseases
10/13 Sudden irreversible hearing loss post COVID-19 | BMJ Case Reports
10/13 Regeneron’s Antibodies Prevent and Treat SARS-CoV-2 Infection in Monkeys
10/13 SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates - The Lancet
10/13 COVID-19 in New Zealand and the impact of the national response: a descriptive epidemiological study - The Lancet Public Health
10/15 Synthesis and systematic review of reported neonatal SARS-CoV-2 infections | Nature Communications
10/16 Emergency Use Authorization of Covid Vaccines — Safety and Efficacy Follow-up Considerations | NEJM
10/19 Herd Immunity and Implications for SARS-CoV-2 Control | JAMA | JAMA Network
10/19 Asymptomatic and Presymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infection Rates in a Multistate Sample of Skilled Nursing Facilities | Geriatrics | JAMA Internal Medicine | JAMA Network
10/19 Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity | Science
10/19 Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate | Science
10/20 Numerical investigation of aerosol transport in a classroom with relevance to COVID-19: Physics of Fluids: Vol 32, No 10
10/20 Building Trust to Achieve Confidence in COVID-19 Vaccines | Infectious Diseases | JAMA Network Open | JAMA Network
10/20 Factors Associated With US Adults’ Likelihood of Accepting COVID-19 Vaccination | Infectious Diseases | JAMA Network Open | JAMA Network
10/20 Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study | The BMJ
10/20 Eurosurveillance | A large national outbreak of COVID-19 linked to air travel, Ireland, summer 2020 - Eurosurveillance
10/21 Early Release - Susceptibility of Raccoon Dogs for Experimental SARS-CoV-2 Infection - Volume 26, Number 12—December 2020 - Emerging Infectious Diseases journal - CDC
10/22 Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial) | The BMJ
10/23 Trends in COVID-19 Risk-Adjusted Mortality Rates | Journal of Hospital Medicine
10/24 Identification of required host factors for SARS-CoV-2 infection in human cells: Cell
10/26 Preventing the Spread of SARS-CoV-2 With Masks and Other “Low-tech” Interventions | Infectious Diseases | JAMA | JAMA Network
10/26 Return to Play for Athletes After Coronavirus Disease 2019 Infection—Making High-Stakes Recommendations as Data Evolve | Infectious Diseases | JAMA Cardiology | JAMA Network
10/26 Coronavirus Disease 2019 and the Athletic Heart: Emerging Perspectives on Pathology, Risks, and Return to Play | Infectious Diseases | JAMA Cardiology | JAMA Network
10/26 Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans | Nature Microbiology
10/27 Aerosol persistence in relation to possible transmission of SARS-CoV-2: Physics of Fluids: Vol 32, No 10
10/27 COVID-19 associated arterial ischaemic stroke and multisystem inflammatory syndrome in children: a case report - The Lancet Child & Adolescent Health
10/27 What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2 - The Lancet Infectious Diseases
10/28 Risk of hospital admission with coronavirus disease 2019 in healthcare workers and their households: nationwide linkage cohort study | The BMJ
10/28 Multi-omics resolves a sharp disease-state shift between mild and moderate COVID-19: Cell
10/28 SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19 | NEJM
10/29 Wearable sensor data and self-reported symptoms for COVID-19 detection | Nature Medicine
10/30 Association between SARS-CoV-2 infection, exposure risk and mental health among a cohort of essential retail workers in the USA | Occupational & Environmental Medicine
10/30 The Effects of Large Group Meetings on the Spread of COVID-19: The Case of Trump Rallies by B. Douglas Bernheim, Nina Buchmann, Zach Freitas-Groff, Sebastián Otero :: SSRN
10/30 SARS-CoV-2 direct cardiac damage through spike-mediated cardiomyocyte fusion | Research Square
November 2020
11/02 Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19 | Science Translational Medicine
11/02 Robust SARS-CoV-2-specific T-cell immunity is maintained at 6 months following primary infection | bioRxiv
11/03 Dispersion of evaporating cough droplets in tropical outdoor environment: Physics of Fluids: Vol 32, No 11
11/03 Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production: Cell
11/03 Revealing fine-scale spatiotemporal differences in SARS-CoV-2 introduction and spread | Nature Communications
11/03 Repeated cross-sectional sero-monitoring of SARS-CoV-2 in New York City | Nature
11/04 Lack of antibodies to SARS-CoV-2 in a large cohort of previously infected persons | Clinical Infectious Diseases | Oxford Academic
11/04 An ultrapotent synthetic nanobody neutralizes SARS-CoV-2 by stabilizing inactive Spike | Science
11/04 Case Study: Prolonged infectious SARS-CoV-2 shedding from an asymptomatic immunocompromised cancer patient.: Cell
11/04 High Prevalence of Pericardial Involvement in College Student-Athletes Recovering From COVID-19 | JACC: Cardiovascular Imaging
11/05 Differential effects of intervention timing on COVID-19 spread in the United States | Science Advances
11/05 Preexisting and de novo humoral immunity to SARS-CoV-2 in humans | Science
11/05 Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum | Nature Immunology
11/06 Acute Kidney Injury in a National Cohort of Hospitalized US Veterans with COVID-19 | American Society of Nephrology
11/06 Epidemiology and transmission dynamics of COVID-19 in two Indian states | Science
11/06 Cardiovascular impact of COVID-19 with a focus on children: A systematic review - NIH
11/09 Real-time, interactive website for US-county-level COVID-19 event risk assessment | Nature Human Behaviour
11/09 Rapid pathogen detection by metagenomic next-generation sequencing of infected body fluids | Nature Medicine
11/09 Characteristics and outcomes of neonatal SARS-CoV-2 infection in the UK: a prospective national cohort study using active surveillance - The Lancet Child & Adolescent Health
11/10 Speed, Evidence, and Safety Characteristics of Vaccine Approvals by the US Food and Drug Administration | Vaccination | JAMA Internal Medicine | JAMA Network
11/10 Mobility network models of COVID-19 explain inequities and inform reopening | Nature
11/11 Sixty-Day Outcomes Among Patients Hospitalized With COVID-19 | Annals of Internal Medicine
11/11 Structure and drug binding of the SARS-CoV-2 envelope protein transmembrane domain in lipid bilayers | Nature Structural & Molecular Biology
11/12 The emerging role of neutrophil extracellular traps in severe acute respiratory syndrome coronavirus 2 (COVID-19) | Scientific Reports
11/13 Enhancing host cell infection by SARS-CoV-2 | Science
11/13 Real-time Conformational Dynamics of SARS-CoV-2 Spikes on Virus Particles: Cell Host & Microbe
11/13 SARS-CoV-2 Cell Entry Factors ACE2 and TMPRSS2 are Expressed in the Microvasculature and Ducts of Human Pancreas but are Not Enriched in β Cells: Cell Metabolism
11/14 Staying sane in our new COVID-19 world - The Lancet
11/16 Trends in Outpatient Care Delivery and Telemedicine During the COVID-19 Pandemic in the US | Infectious Diseases | JAMA Internal Medicine | JAMA Network
11/16 Diaphragm Pathology in Critically Ill Patients With COVID-19 and Postmortem Findings From 3 Medical Centers | Critical Care Medicine | JAMA Internal Medicine | JAMA Network
11/16 COVID-19-associated Non-Occlusive Fibrin Microthrombi in the Heart | Circulation
11/16 Immunological memory to SARS-CoV-2 assessed for greater than six months after infection | bioRxiv
11/16 Ranking the effectiveness of worldwide COVID-19 government interventions | Nature Human Behaviour
11/17 Ensuring vaccine safety | Science
11/17 Expecting the unexpected with COVID-19 vaccines - The Lancet Infectious Diseases
11/18 The known unknowns of T cell immunity to COVID-19 | Science Immunology
11/18 Effectiveness of Adding a Mask Recommendation to Other Public Health Measures to Prevent SARS-CoV-2 Infection in Danish Mask Wearers: A Randomized Controlled Trial: Annals of Internal Medicine: Vol 0, No 0 - ACP Journals
11/18 COVID-19-associated olfactory dysfunction reveals SARS-CoV-2 neuroinvasion and persistence in the olfactory system | bioRxiv
11/18 Antibodies to SARS-CoV-2 are associated with protection against reinfection | medRxiv
11/18 Pre-symptomatic detection of COVID-19 from smartwatch data | Nature Biomedical Engineering
11/18 Macrophage expression and prognostic significance of the long pentraxin PTX3 in COVID-19 | Nature Immunology
11/18 Event-specific interventions to minimize COVID-19 transmission | PNAS
11/18 Age and frailty in COVID-19 vaccine development - The Lancet
11/19 Ct values and infectivity of SARS-CoV-2 on surfaces - The Lancet Infectious Diseases
11/19 SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis - The Lancet Microbe
11/20 Test sensitivity is secondary to frequency and turnaround time for COVID-19 screening | Science Advances
11/20 Air-Filtering Masks for Respiratory Protection from PM2.5 and Pandemic Pathogens: One Earth
11/23 Transmission heterogeneities, kinetics, and controllability of SARS-CoV-2 | Science
11/23 Functional SARS-CoV-2-specific immune memory persists after mild COVID-19: Cell
11/24 Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020 | Infectious Diseases | JAMA Internal Medicine | JAMA Network
11/24 Antibodies, Immunity, and COVID-19 | Infectious Diseases | JAMA Internal Medicine | JAMA Network
11/24 SARS-CoV-2 receptors and entry genes are expressed in the human olfactory neuroepithelium and brain: iScience
11/24 A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of Covid-19 | NEJM
11/24 A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia | NEJM
11/24 Cholesterol 25-hydroxylase suppresses SARS-CoV-2 replication by blocking membrane fusion | PNAS
11/26 Nucleic Acid-Based Technologies Targeting Coronaviruses: Trends in Biochemical Sciences
11/26 Rethinking Covid-19 Test Sensitivity — A Strategy for Containment | NEJM
11/27 Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate | Science
11/27 SARS-CoV-2 and the risk of Parkinson's disease: facts and fantasy - The Lancet Neurology
11/28 The effectiveness of population-wide, rapid antigen test based screening in reducing SARS-CoV-2 infection prevalence in Slovakia | CMMID Repository
11/28 A tribute to some of the doctors who died from COVID-19 - The Lancet
11/30 Frontiers | Mucosal Immunity in COVID-19: A Neglected but Critical Aspect of SARS-CoV-2 Infection | Immunology
11/30 COVID-19 in a case previously infected with MERS-CoV: No cross immunity - Journal of Infection
11/30 Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19 | Nature Neuroscience
December 2020
12/01 Post-infectious inflammatory disease in MIS-C features elevated cytotoxicity signatures and autoreactivity that correlates with severity | medRxiv
12/01 Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer | NEJM
12/02 Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results - PubMed
12/02 Reversible Myocardial Injury Associated With SARS-CoV-2 in an Infant | JACC: Case Reports
12/02 Placebo-Controlled Trials of Covid-19 Vaccines — Why We Still Need Them | NEJM
12/03 Case report and systematic review suggest that children may experience similar long-term effects to adults after clinical COVID-19 - PubMed
12/03 Fast detection of SARS-CoV-2 RNA via the integration of plasmonic thermocycling and fluorescence detection in a portable device | Nature Biomedical Engineering
12/03 Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host | NEJM
12/03 Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination | NEJM
12/03 Cytokine Storm | NEJM
12/04 Amplification-free detection of SARS-CoV-2 with CRISPR-Cas13a and mobile phone microscopy: Cell
12/04 Correlates of protection against SARS-CoV-2 in rhesus macaques | Nature
12/04 Untuned antiviral immunity in COVID-19 revealed by temporal type I/III interferon patterns and flu comparison | Nature Immunology
12/07 IgA dominates the early neutralizing antibody response to SARS-CoV-2 | Science Translational Medicine
12/07 Enhanced SARS-CoV-2 neutralization by dimeric IgA | Science Translational Medicine
12/07 Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis | The BMJ
12/07 Model-informed COVID-19 vaccine prioritization strategies by age and serostatus | medRxiv
12/07 Effect of internationally imported cases on internal spread of COVID-19: a mathematical modelling study - The Lancet Public Health
12/08 iGenomics: Comprehensive DNA sequence analysis on your Smartphone | GigaScience | Oxford Academic
12/08 Effect of sneezing on the flow around a face shield: Physics of Fluids: Vol 32, No 12
12/08 Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic | Science
12/08 Simultaneous COVID-19 in Homozygous Twins | Annals of Internal Medicine
12/08 Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Randomized Trial: Annals of Internal Medicine: Vol 0, No 0
12/08 Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK - The Lancet
12/08 SARS-CoV-2 infection and transmission in educational settings: a prospective, cross-sectional analysis of infection clusters and outbreaks in England - The Lancet Infectious Diseases
12/09 Occupation and risk of severe COVID-19: prospective cohort study of 120 075 UK Biobank participants | Occupational & Environmental Medicine
12/09 Genomic epidemiology of superspreading events in Austria reveals mutational dynamics and transmission properties of SARS-CoV-2 | Science Translational Medicine
12/10 Evaluation of Cloth Masks and Modified Procedure Masks as Personal Protective Equipment for the Public During the COVID-19 Pandemic | Infectious Diseases | JAMA Internal Medicine | JAMA Network
12/10 Using Cardiovascular Cells from Human Pluripotent Stem Cells for COVID-19 Research: Why the Heart Fails: Stem Cell Reports
12/11 The kinetics of humoral response and its relationship with the disease severity in COVID-19 | Communications Biology
12/11 Targeting transcriptional regulation of SARS-CoV-2 entry factors ACE2 and TMPRSS2 | PNAS
12/12 Is my cough COVID-19? - The Lancet
12/13 SARS-CoV-2 RNA reverse-transcribed and integrated into the human genome | bioRxiv
12/14 Household Transmission of SARS-CoV-2: A Systematic Review and Meta-analysis | Global Health | JAMA Network Open | JAMA Network
12/15 Effects of mask-wearing on the inhalability and deposition of airborne SARS-CoV-2 aerosols in human upper airway: Physics of Fluids: Vol 32, No 12
12/15 Effects of space sizes on the dispersion of cough-generated droplets from a walking person: Physics of Fluids: Vol 32, No 12
12/15 COVID-19 neutralizing antibodies predict disease severity and survival: Cell
12/15 Nursing home staff networks and COVID-19 | PNAS
12/15 Neuroimaging manifestations in children with SARS-CoV-2 infection: a multinational, multicentre collaborative study - The Lancet Child & Adolescent Health
12/15 SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study - The Lancet Infectious Diseases
12/16 All-Cause Excess Mortality and COVID-19–Related Mortality Among US Adults Aged 25-44 Years, March-July 2020 | Infectious Diseases | JAMA | JAMA Network
12/16 The S1 protein of SARS-CoV-2 crosses the blood–brain barrier in mice | Nature Neuroscience
12/16 Emergence of a Highly Fit SARS-CoV-2 Variant | NEJM
12/17 COVID-19 Myocardial Pathology Evaluation in AthleTEs with Cardiac Magnetic Resonance (COMPETE CMR) | Circulation
12/17 A Crisp(r) New Perspective on SARS-CoV-2 Biology: Cell
12/17 Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses | Nature Medicine
12/17 T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial | Nature Medicine
12/17 Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, population-based retrospective cohort study - The Lancet Respiratory Medicine
12/18 Kinetics of antibody responses dictate COVID-19 outcome | medRxiv
12/18 Infectivity of asymptomatic versus symptomatic COVID-19 - The Lancet
12/20 Preliminary genomic characterisation of an emergent SARS-CoV-2 lineage in the UK defined by a novel set of spike mutations - nCoV-2019 Genomic Epidemiology - Virological
12/20 Threat Assessment Brief: Rapid increase of a SARS-CoV-2 variant with multiple spike protein mutations observed in the United Kingdom - ECDC
12/21 Excess Mortality in California During the Coronavirus Disease 2019 Pandemic, March to August 2020 | Infectious Diseases | JAMA Internal Medicine | JAMA Network
12/21 Multiplex assays for the identification of serological signatures of SARS-CoV-2 infection: an antibody-based diagnostic and machine learning study - The Lancet Microbe
12/22 Variation in US Hospital Mortality Rates for Patients Admitted With COVID-19 During the First 6 Months of the Pandemic | Infectious Diseases | JAMA Internal Medicine | JAMA Network
12/22 Neurological Manifestations of COVID-19 Feature T Cell Exhaustion and Dedifferentiated Monocytes in Cerebrospinal Fluid: Immunity
12/22 COVID-19 and the Swedish enigma - The Lancet
12/23 Assessment of Air Contamination by SARS-CoV-2 in Hospital Settings | Infectious Diseases | JAMA Network Open | JAMA Network
12/23 SARS-CoV-2 mutations among minks show reduced lethality and infectivity to humans | bioRxiv
12/23 Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers | NEJM
12/24 Characterizing Long COVID in an International Cohort: 7 Months of Symptoms and Their Impact | medRxiv
12/25 Reverse Engineering the source code of the BioNTech/Pfizer SARS-CoV-2 Vaccine - Articles
12/25 SalivaDirect: A simplified and flexible platform to enhance SARS-CoV-2 testing capacity: Med
12/28 One Year Later, How Does COVID-19 Affect Children? | Infectious Diseases | JAMA Pediatrics | JAMA Network
12/28 Superspreading in early transmissions of COVID-19 in Indonesia | Scientific Reports
12/29 Assessment of Neutrophil Extracellular Traps in Coronary Thrombus of a Case Series of Patients With COVID-19 and Myocardial Infarction | Acute Coronary Syndromes | JAMA Cardiology | JAMA Network
12/29 Update Alert 4: Masks for Prevention of Respiratory Virus Infections, Including SARS-CoV-2, in Health Care and Community Settings | Annals of Internal Medicine
12/29 Masks and Face Coverings for the Lay Public: A Narrative Update: Annals of Internal Medicine: Vol 0, No 0
12/30 Fluid dynamics of COVID-19 airborne infection suggests urgent data for a scientific design of social distancing | Scientific Reports
12/30 Microvascular Injury in the Brains of Patients with Covid-19 | NEJM
12/30 Neutralizing Antibody LY-CoV555 for Outpatient Covid-19 | NEJM
12/30 Maintaining Safety with SARS-CoV-2 Vaccines | NEJM
January 2021
01/01 Airflows inside passenger cars and implications for airborne disease transmission | Science Advances
01/02 Mutations arising in SARS-CoV-2 spike on sustained human-to-human transmission and human-to-animal passage - SARS-CoV-2 coronavirus - Virological
01/02 Mutations arising in SARS-CoV-2 spike on sustained human-to-human transmission and human-to-animal passage - #12 by rfgarry - SARS-CoV-2 coronavirus - Virological
01/04 Risk Factors Associated With All-Cause 30-Day Mortality in Nursing Home Residents With COVID-19 | Dementia and Cognitive Impairment | JAMA Internal Medicine | JAMA Network
01/05 Endemic SARS-CoV-2 will maintain post-pandemic immunity | Nature Reviews Immunology
01/05 Early Release - Genomic Evidence of In-Flight Transmission of SARS-CoV-2 Despite Predeparture Testing - Volume 27, Number 3—March 2021 - Emerging Infectious Diseases journal - CDC
01/06 Genetic Variants of SARS-CoV-2—What Do They Mean? | Infectious Diseases | JAMA | JAMA Network
01/06 Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection | Science
01/07 The value of decreasing the duration of the infectious period of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection - PLOS
01/07 COVID-19 vasculitis and novel vasculitis mimics - The Lancet Rheumatology
01/08 A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis | Science
01/08 Establishment and lineage dynamics of the SARS-CoV-2 epidemic in the UK | Science
01/08 Findings from Cardiovascular Evaluation of NCAA Division I Collegiate Student-Athletes after Asymptomatic or Mildly Symptomatic SARS-CoV-2 Infection | medRxiv
01/11 Immunological characteristics govern the transition of COVID-19 to endemicity | Science
01/11 Mosaic nanoparticles elicit cross-reactive immune responses to zoonotic coronaviruses in mice | Science
01/11 A novel ACE2 isoform is expressed in human respiratory epithelia and is upregulated in response to interferons and RNA respiratory virus infection | Nature Genetics
01/11 The distribution of cellular turnover in the human body | Nature Medicine
01/11 Microbiome connections with host metabolism and habitual diet from 1,098 deeply phenotyped individuals | Nature Medicine
01/11 A trimeric human angiotensin-converting enzyme 2 as an anti-SARS-CoV-2 agent | Nature Structural & Molecular Biology
01/11 Retail store customer flow and COVID-19 transmission | PNAS
01/12 MuSK Antibody–Associated Myasthenia Gravis With SARS-CoV-2 Infection: A Case Report | Annals of Internal Medicine
01/12 The Sensitivity and Costs of Testing for SARS-CoV-2 Infection With Saliva Versus Nasopharyngeal Swabs: A Systematic Review and Meta-analysis: Annals of Internal Medicine: Vol 0, No 0 - ACP Journals
01/12 Adaptive immunity to SARS-CoV-2 and COVID-19: Cell
01/12 First detection of SARS-CoV-2 spike protein N501 mutation in Italy in August, 2020 - The Lancet Infectious Diseases
01/13 Messenger RNA vaccines against SARS-CoV-2: Cell
01/13 Immune determinants of COVID-19 disease presentation and severity | Nature Medicine
01/13 Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19 | NEJM
01/13 Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine | NEJM
01/13 SARS-CoV-2 Cross-Reactivity in Prepandemic Serum from Rural Malaria-Infected Persons, Cambodia - Volume 28, Number 2—February 2022 - Emerging Infectious Diseases journal - CDC
01/14 Evaluation for Myocarditis in Competitive Student Athletes Recovering From Coronavirus Disease 2019 With Cardiac Magnetic Resonance Imaging | Cardiology | JAMA Cardiology | JAMA Network
01/14 SARS-CoV-2 antibody testing for estimating COVID-19 prevalence in the population: Cell Reports Medicine
01/14 Long COVID in the skin: a registry analysis of COVID-19 dermatological duration - The Lancet Infectious Diseases
01/14 Public health surveillance of infectious diseases: beyond point mutations - The Lancet Microbe
01/15 Comparison of Saliva and Nasopharyngeal Swab Nucleic Acid Amplification Testing for Detection of SARS-CoV-2: A Systematic Review and Meta-analysis | Infectious Diseases | JAMA Internal Medicine | JAMA Network
01/15 Isolation of SARS-CoV-2 from the air in a car driven by a COVID patient with mild illness | medRxiv
01/15 Characterisation of the first 250 000 hospital admissions for COVID-19 in Brazil: a retrospective analysis of nationwide data - The Lancet Respiratory Medicine
01/18 Case report and systematic review suggest that children may experience similar long-term effects to adults after clinical COVID-19 - PubMed
01/18 Sociodemographic disparities in energy insecurity among low-income households before and during the COVID-19 pandemic | Nature Energy
01/18 Household transmission of SARS-CoV-2 and risk factors for susceptibility and infectivity in Wuhan: a retrospective observational study - The Lancet Infectious Diseases
01/19 mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants | bioRxiv
01/19 Vaccinology in the post−COVID-19 era | PNAS
01/19 Mask-wearing and control of SARS-CoV-2 transmission in the USA: a cross-sectional study - The Lancet Digital Health
01/21 Severely ill COVID-19 patients display impaired exhaustion features in SARS-CoV-2-reactive CD8+ T cells | Science Immunology
01/21 Model-informed COVID-19 vaccine prioritization strategies by age and serostatus | Science
01/21 Optimizing age-specific vaccination | Science
01/22 Sex differences in immune responses | Science
01/22 Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody | Science
01/22 The Proportion of SARS-CoV-2 Infections That Are Asymptomatic: A Systematic Review: Annals of Internal Medicine: Vol 0, No 0
01/23 B cell memory: understanding COVID-19: Immunity
01/25 Global absence and targeting of protective immune states in severe COVID-19 | Nature
01/25 Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis | Nature
01/25 Early warnings of COVID-19 outbreaks across Europe from social media | Scientific Reports
01/26 A novel SARS-CoV-2 related coronavirus in bats from Cambodia | bioRxiv
01/26 Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases: Cell Reports Medicine
01/26 Antibodies, epicenter of SARS-CoV-2 immunology | Cell Death & Differentiation
01/26 An evidence review of face masks against COVID-19 | PNAS
01/27 The case against delaying SARS-CoV-2 mRNA vaccine boosting doses | Clinical Infectious Diseases | Oxford Academic
01/27 Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K, and N501Y variants by BNT162b2 vaccine-elicited sera | bioRxiv
01/27 Duration of Culturable SARS-CoV-2 in Hospitalized Patients with Covid-19 | NEJM
01/27 Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence - The Lancet
01/28 Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine–elicited human sera | Science
01/28 Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity: Cell
01/28 SARS-CoV-2 testing for public health use: core principles and considerations for defined use settings - The Lancet Global Health
01/29 Translating viral vaccines into immunity | Science
01/29 Insights from SARS-CoV-2 sequences | Science
01/29 Genomic monitoring of SARS-CoV-2 uncovers an Nsp1 deletion variant that modulates type I interferon response: Cell Host & Microbe
01/29 Public health actions to control new SARS-CoV-2 variants: Cell
01/29 Leveraging the antiviral type-I interferon system as a first line defense against SARS-CoV-2 pathogenicity: Immunity
01/29 Robust spike antibody responses and increased reactogenicity in seropositive individuals after a single dose of SARS-CoV-2 mRNA vaccine | medRxiv
01/30 SARS-CoV-2 persistence is associated with antigen-specific CD8 T-cell responses - EBioMedicine
February 2021
02/01 Age groups that sustain resurging COVID-19 epidemics in the United States | Science
02/02 Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape | Science
02/02 Naive human B cells can neutralize SARS-CoV-2 through recognition of its receptor binding domain | bioRxiv
02/02 Outcome of SARS-CoV-2 infection is linked to MAIT cell activation and cytotoxicity | Nature Immunology
02/02 Sixteen novel lineages of SARS-CoV-2 in South Africa | Nature Medicine
02/02 Timing matters when correcting fake news | PNAS
02/02 Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia - The Lancet
02/02 Transmission of COVID-19 in 282 clusters in Catalonia, Spain: a cohort study - The Lancet Infectious Diseases
02/02 Understanding the drivers of transmission of SARS-CoV-2 - The Lancet Infectious Diseases
02/03 Treatment of influenza and SARS-CoV-2 infections via mRNA-encoded Cas13a in rodents | Nature Biotechnology
02/03 SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas | Nature Metabolism
02/04 Povidone Iodine Mouthwash, Gargle, and Nasal Spray to Reduce Nasopharyngeal Viral Load in Patients With COVID-19: A Randomized Clinical Trial | Infectious Diseases | JAMA Otolaryngology–Head & Neck Surgery | JAMA Network
02/04 Comparative cost-effectiveness of SARS-CoV-2 testing strategies in the USA: a modelling study - The Lancet Public Health
02/05 Cardiac arrest occurrence during successive waves of the COVID-19 pandemic: direct and indirect consequences | European Heart Journal | Oxford Academic
02/05 Antibodies elicited by SARS-CoV-2 infection and boosted by vaccination neutralize an emerging variant and SARS-CoV-1 | medRxiv
02/05 SARS-CoV-2 evolution during treatment of chronic infection | Nature
02/05 COVID-19 vaccine hesitancy in a representative working-age population in France: a survey experiment based on vaccine characteristics - The Lancet Public Health
02/05 Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial - The Lancet Respiratory Medicine
02/07 Genomic epidemiology identifies emergence and rapid transmission of SARS-CoV-2 B.1.1.7 in the United States | medRxiv
02/08 Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies: Cell Host & Microbe
02/08 SARS-CoV-2 transmission among children and staff in daycare centres during a nationwide lockdown in France: a cross-sectional, multicentre, seroprevalence study - The Lancet Child & Adolescent Health
02/09 Simulation-based study of COVID-19 outbreak associated with air-conditioning in a restaurant: Physics of Fluids: Vol 33, No 2
02/09 Prevalence and Outcomes of SARS-CoV-2 Infection Among Migrant Workers in Singapore | Global Health | JAMA | JAMA Network
02/09 Public Health Interventions, Epidemic Growth, and Regional Variation of the 1918 Influenza Pandemic Outbreak in a Swiss Canton and Its Greater Regions | Annals of Internal Medicine
02/09 A SARS-CoV-2 Cluster in an Acute Care Hospital | Annals of Internal Medicine
02/09 Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection: Cell
02/09 COVID-19 immune signatures reveal stable antiviral T cell function despite declining humoral responses: Immunity
02/09 Poor antigen-specific responses to the second BNT162b2 mRNA vaccine dose in SARS-CoV-2-experienced individuals | medRxiv
02/09 COVID-19 Modeling and the Path to Herd Immunity - Medscape
02/09 The hygiene hypothesis, the COVID pandemic, and consequences for the human microbiome | PNAS
02/10 Severe reinfection with South African SARS-CoV-2 variant 501Y.V2: A case report | Clinical Infectious Diseases | Oxford Academic
02/10 Effectiveness of Mask Wearing to Control Community Spread of SARS-CoV-2 | Infectious Diseases | JAMA | JAMA Network
02/10 Safety and efficacy of the ChAdOx1 nCoV-19 (AZD1222) Covid-19 vaccine against the B.1.351 variant in South Africa | medRxiv
02/10 Public policy and health in the Trump era - The Lancet
02/10 Effect of the new SARS-CoV-2 variant B.1.1.7 on children and young people - The Lancet Child & Adolescent Health
02/11 The Spike D614G mutation increases SARS-CoV-2 infection of multiple human cell types | eLife
02/11 Emergence of a Novel SARS-CoV-2 Variant in Southern California | Public Health | JAMA | JAMA Network
02/11 The role of children in the spread of COVID-19: Using household data from Bnei Brak, Israel, to estimate the relative susceptibility and infectivity of children - PLOS
02/11 Multi-clonal SARS-CoV-2 neutralization by antibodies isolated from severe COVID-19 convalescent donors - PLOS
02/11 Early initiation of prophylactic anticoagulation for prevention of coronavirus disease 2019 mortality in patients admitted to hospital in the United States: cohort study | The BMJ
02/11 Hydrating the respiratory tract: an alternative explanation why masks lower severity of COVID-19: Biophysical Journal
02/12 Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US—December 14, 2020-January 18, 2021 | Allergy and Clinical Immunology | JAMA | JAMA Network
02/12 Assessing Brain Capillaries in Coronavirus Disease 2019 | Infectious Diseases | JAMA Neurology | JAMA Network
02/12 Single-domain antibodies make a difference | Science
02/12 Mosaic nanoparticles elicit cross-reactive immune responses to zoonotic coronaviruses in mice | Science
02/12 A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection | bioRxiv
02/12 Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection: Cell
02/15 Viral load of SARS-CoV-2 in adults during the first and second wave of COVID-19 pandemic in Houston, TX: the potential of the super-spreader | The Journal of Infectious Diseases | Oxford Academic
02/15 OSF Preprints | Superspreaders drive the largest outbreaks of hospital onset COVID-19 infection
02/15 Diagnostics for SARS-CoV-2 infections | Nature Materials
02/15 Interleukin-6 Receptor Inhibition in Covid-19 — Cooling the Inflammatory Soup | NEJM
02/16 Densely sampled viral trajectories suggest longer duration of acute infection with B.1.1.7 variant relative to non-B.1.1.7 SARS-CoV-2 - Harvard
02/16 Ocular MRI Findings in Patients with Severe COVID-19: A Retrospective Multicenter Observational Study | Radiology
02/16 COVID-19 and the human innate immune system: Cell
02/17 Predictors of hospital discharge and mortality in patients with diabetes and COVID-19: updated results from the nationwide CORONADO study | SpringerLink
02/17 Intranasal fusion inhibitory lipopeptide prevents direct-contact SARS-CoV-2 transmission in ferrets | Science
02/17 Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine | NEJM
02/17 Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine — Preliminary Report | NEJM
02/18 Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera: Cell
02/18 Circulating SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity | medRxiv
02/18 Could mutations of SARS-CoV-2 suppress diagnostic detection? | Nature Biotechnology
02/19 Immunogenicity of clinically relevant SARS-CoV-2 vaccines in non-human primates and humans | Science Advances
02/19 SARS-CoV-2 Positivity on or After 9 Days Among Quarantined Student Contacts of Confirmed Cases | Infectious Diseases | JAMA | JAMA Network
02/19 Sequelae in Adults at 6 Months After COVID-19 Infection | Infectious Diseases | JAMA Network Open | JAMA Network
02/19 Severe clinical relapse in an immunocompromised host with persistent SARS-CoV-2 infection | Leukemia | Nature
02/19 Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials - The Lancet
02/19 Delayed-onset myocarditis following COVID-19 - The Lancet Respiratory Medicine
02/23 Relationship between human exhalation diffusion and posture in face-to-face scenario with utterance: Physics of Fluids: Vol 33, No 2
02/23 Viral load and contact heterogeneity predict SARS-CoV-2 transmission and super-spreading events | eLife
02/23 Prolonged evolution of the human B cell response to SARS-CoV-2 infection | Science Immunology
02/23 SARS-CoV-2 lineage B.1.526 emerging in the New York region detected by software utility created to query the spike mutational landscape | bioRxiv
02/23 Extremely potent human monoclonal antibodies from COVID-19 convalescent patients: Cell
02/23 Mechanistic transmission modeling of COVID-19 on the Diamond Princess cruise ship demonstrates the importance of aerosol transmission | PNAS
02/23 Modeling SARS-CoV-2 viral kinetics and association with mortality in hospitalized patients from the French COVID cohort | PNAS
02/23 Pandemic precarity: COVID-19 is exposing and exacerbating inequalities in the American heartland | PNAS
02/23 Exhaled aerosol increases with COVID-19 infection, age, and obesity | PNAS
02/24 Single-dose BNT162b2 vaccine protects against asymptomatic SARS-CoV-2 infection - Authorea
02/24 BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting | NEJM
02/25 Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals - The Lancet
02/25 Effect of previous SARS-CoV-2 infection on humoral and T-cell responses to single-dose BNT162b2 vaccine - The Lancet
02/26 SARS-CoV-2 Infects Human Engineered Heart Tissues and Models COVID-19 Myocarditis | JACC: Basic to Translational Science
02/26 SARS-CoV-2 spike D614G change enhances replication and transmission | Nature
March 2021
03/01 Binding and Neutralization Antibody Titers After a Single Vaccine Dose in Health Care Workers Previously Infected With SARS-CoV-2 | Vaccination | JAMA | JAMA Network
03/01 COVID-19 -- exploring the implications of long-term condition type and extent of multimorbidity on years of life lost: a modelling study | Wellcome Open Research
03/01 Negligible impact of SARS-CoV-2 variants on CD4+ and CD8+ T cell reactivity in COVID-19 exposed donors and vaccinees | bioRxiv
03/02 Deep immune profiling of MIS-C demonstrates marked but transient immune activation compared to adult and pediatric COVID-19 | Science Immunology
03/02 High-Throughput Wastewater SARS-CoV-2 Detection Enables Forecasting of Community Infection Dynamics in San Diego County | mSystems
03/02 Increased Resistance of SARS-CoV-2 Variant P.1 to Antibody Neutralization | bioRxiv
03/02 ‘nAb’ the self-reactive activity in the COVID-19 combat | Signal Transduction and Targeted Therapy
03/02 The prevalence of antibodies to SARS-CoV-2 among blood donors in China | Nature Communications
03/02 Single-cell meta-analysis of SARS-CoV-2 entry genes across tissues and demographics | Nature Medicine
03/02 SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma | Nature Medicine
03/02 Quantifying asymptomatic infection and transmission of COVID-19 in New York City using observed cases, serology, and testing capacity | PNAS
03/02 The effects of school closures on SARS-CoV-2 among parents and teachers | PNAS
03/02 The effect of the D614G substitution on the structure of the spike glycoprotein of SARS-CoV-2 | PNAS
03/02 A genomic region associated with protection against severe COVID-19 is inherited from Neandertals | PNAS
03/02 An interactive website tracking COVID-19 vaccine development - The Lancet Global Health
03/03 Filtering Facepiece Respirator (N95 Respirator) Reprocessing: A Systematic Review | Infectious Diseases | JAMA | JAMA Network
03/03 Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England | Science
03/03 Broad neutralization of H1 and H3 viruses by adjuvanted influenza HA stem vaccines in nonhuman primates | Science Translational Medicine
03/03 SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral Spike vaccines: Cell Host & Microbe
03/03 Preliminary Efficacy of the NVX-CoV2373 Covid-19 Vaccine Against the B.1.351 Variant | medRxiv
03/03 Delayed Large Local Reactions to mRNA-1273 Vaccine against SARS-CoV-2 | NEJM
03/03 Multisystem inflammatory syndrome in a neonate, temporally associated with prenatal exposure to SARS-CoV-2: a case report - The Lancet Child & Adolescent Health
03/04 Prevalence of Inflammatory Heart Disease Among Professional Athletes With Prior COVID-19 Infection Who Received Systematic Return-to-Play Cardiac Screening | Cardiology | JAMA Cardiology | JAMA Network
03/04 SARS-CoV-2 on Ocular Surfaces in a Cohort of Patients With COVID-19 From the Lombardy Region, Italy | Infectious Diseases | JAMA Ophthalmology | JAMA Network
03/04 Tocilizumab plus standard care versus standard care in patients in India with moderate to severe COVID-19-associated cytokine release syndrome (COVINTOC): an open-label, multicentre, randomised, controlled, phase 3 trial - The Lancet Respiratory Medicine
03/04 Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial - The Lancet Respiratory Medicine
03/04 IL-6 blockade for COVID-19: a global scientific call to arms - The Lancet Respiratory Medicine
03/05 An early warning approach to monitor COVID-19 activity with multiple digital traces in near real time | Science Advances
03/05 Longitudinal antibody repertoire in "mild" versus "severe" COVID-19 patients reveals immune markers associated with disease severity and resolution | Science Advances
03/06 The impact of Spike mutations on SARS-CoV-2 neutralization: Cell Reports
03/06 Longitudinal Analysis Reveals Distinct Antibody and Memory B Cell Responses in SARS-CoV2 Naïve and Recovered Individuals Following mRNA Vaccination | medRxiv
03/08 Acute Allergic Reactions to mRNA COVID-19 Vaccines | Allergy and Clinical Immunology | JAMA | JAMA Network
03/08 Higher COVID-19 vaccination rates are linked to decreased county-level COVID-19 incidence across USA | medRxiv
03/08 Long-term clinical, virological and immunological outcomes in patients hospitalized for COVID-19: antibody response predicts long COVID. | medRxiv
03/08 Genome-wide CRISPR screening identifies TMEM106B as a proviral host factor for SARS-CoV-2 | Nature Genetics
03/08 Neutralizing Activity of BNT162b2-Elicited Serum | NEJM
03/08 Clinical Characteristics, Activity Levels and Mental Health Problems in Children with Long COVID: A Survey of 510 Children[v1] | Preprints
03/08 18Fluorodeoxyglucose PET/CT findings in a systemic inflammatory response syndrome after COVID-19 vaccine - The Lancet
03/08 Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysis - The Lancet Global Health
03/09 Epidemiological and evolutionary considerations of SARS-CoV-2 vaccine dosing regimes | Science
03/09 SARS-CoV-2 within-host diversity and transmission | Science
03/09 The cytosolic DNA sensor cGAS recognizes neutrophil extracellular traps | Science Signaling
03/09 Clinical and Economic Effects of Widespread Rapid Testing to Decrease SARS-CoV-2 Transmission | Annals of Internal Medicine
03/09 The plasmablast response to SARS-CoV-2 mRNA vaccination is dominated by non-neutralizing antibodies that target both the NTD and the RBD | medRxiv
03/09 Emergence of a SARS-CoV-2 variant of concern with mutations in spike glycoprotein | Nature
03/10 Impact of the COVID-19 Vaccine on Asymptomatic Infection Among Patients Undergoing Pre-Procedural COVID-19 Molecular Screening | Clinical Infectious Diseases | Oxford Academic
03/10 Effectiveness of three versus six feet of physical distancing for controlling spread of COVID-19 among primary and secondary students and staff: A retrospective, state-wide cohort study | Clinical Infectious Diseases | Oxford Academic
03/10 Infodemics: Do healthcare professionals detect corona-related false news stories better than students? - PLOS
03/10 Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization - PubMed
03/10 Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study | The BMJ
03/10 Virus vaccines: proteins prefer prolines: Cell Host & Microbe
03/10 The great escape? SARS-CoV-2 variants evading neutralizing responses: Cell Host & Microbe
03/10 Long-Haul Post–COVID-19 Symptoms Presenting as a Variant of Postural Orthostatic Tachycardia Syndrome: The Swedish Experience | JACC: Case Reports
03/10 Case fatality risk of the SARS-CoV-2 variant of concern B.1.1.7 in England | medRxiv
03/10 Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial | medRxiv
03/10 Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine | NEJM
03/10 Children and young people remain at low risk of COVID-19 mortality - The Lancet Child & Adolescent Health
03/10 Surveillance of SARS-CoV-2 in Zimbabwe shows dominance of variants of concern - The Lancet Microbe
03/11 Transmission of SARS-CoV-2 from asymptomatic and presymptomatic individuals in healthcare settings despite medical masks and eye protection | Clinical Infectious Diseases | Oxford Academic
03/11 What level of neutralising antibody protects from COVID-19? | medRxiv
03/11 Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies | Nature
03/12 Immunity to SARS-CoV-2 variants of concern | Science
03/12 T cell and antibody kinetics delineate SARS-CoV-2 peptides mediating long-term immune responses in COVID-19 convalescent individuals | Science Translational Medicine
03/12 Potent SARS-CoV-2 Neutralizing Antibodies Directed Against Spike N-Terminal Domain Target a Single Supersite: Cell Host & Microbe
03/12 Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity: Cell
03/12 Are vaccines safe in patients with Long COVID? A prospective observational study. | medRxiv
03/12 Perfect as the enemy of good: tracing transmissions with low-sensitivity tests to mitigate SARS-CoV-2 outbreaks - The Lancet Microbe
03/12 Could a good night's sleep improve COVID-19 vaccine efficacy? - The Lancet Respiratory Medicine
03/13 Probable airborne transmission of SARS-CoV-2 in a poorly ventilated restaurant - ScienceDirect
03/15 Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients | Surgery | JAMA | JAMA Network
03/15 Association of Clinical, Biological, and Brain Magnetic Resonance Imaging Findings With Electroencephalographic Findings for Patients With COVID-19 | Neurology | JAMA Network Open | JAMA Network
03/15 SARS-CoV-2 infection of human iPSC-derived cardiac cells reflects cytopathic features in hearts of patients with COVID-19 | Science Translational Medicine
03/15 The first 12 months of COVID-19: a timeline of immunological insights | Nature Reviews Immunology - Nature
03/15 Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7 | Nature
03/15 Common pitfalls and recommendations for using machine learning to detect and prognosticate for COVID-19 using chest radiographs and CT scans | Nature Machine Intelligence
03/16 Structural impact on SARS-CoV-2 spike protein by D614G substitution | Science
03/16 SARS-CoV-2 evolution in an immunocompromised host reveals shared neutralization escape mechanisms: Cell
03/16 N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2: Cell
03/16 Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein: Cell
03/16 Spread of a Variant SARS-CoV-2 in Long-Term Care Facilities in England | NEJM
03/16 Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant | NEJM
03/16 Vaccinating the oldest against COVID-19 saves both the most lives and most years of life | PNAS
03/16 SARS-CoV-2 infection and transmission in primary schools in England in June–December, 2020 (sKIDs): an active, prospective surveillance study - The Lancet Child & Adolescent Health
03/16 Arthritis after SARS-CoV-2 infection - The Lancet Rheumatology
03/17 SARS-CoV-2 Epidemiology on a Public University Campus in Washington State | medRxiv
03/17 An integrated analysis of contact tracing and genomics to assess the efficacy of travel restrictions on SARS-CoV-2 introduction and transmission in England from June to September, 2020 | medRxiv
03/17 Associations of the BNT162b2 COVID-19 vaccine effectiveness with patient age and comorbidities | medRxiv
03/17 Factors associated with myocardial SARS-CoV-2 infection, myocarditis, and cardiac inflammation in patients with COVID-19 | Modern Pathology
03/17 Shifting attention to accuracy can reduce misinformation online | Nature
03/17 Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant | NEJM
03/17 Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study - The Lancet
03/18 Myocarditis in naturally infected pets with the British variant of COVID-19 | bioRxiv
03/18 Association between living with children and outcomes from covid-19: OpenSAFELY cohort study of 12 million adults in England | The BMJ
03/18 Antivirals with common targets against highly pathogenic viruses: Cell
03/18 Case fatality risk of the SARS-CoV-2 variant of concern B.1.1.7 in England, 16 November to 5 February - Eurosurveillance
03/18 Early Release - Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 during Border Quarantine and Air Travel, New Zealand (Aotearoa) - Volume 27, Number 5—May 2021 - Emerging Infectious Diseases journal - CDC
03/19 Neutralizing Antibodies Against SARS-CoV-2 Variants After Infection and Vaccination | Infectious Diseases | JAMA | JAMA Network
03/19 Combining initial chest CT with clinical variables in differentiating coronavirus disease 2019 (COVID-19) pneumonia from influenza pneumonia | Scientific Reports
03/20 Acute myocarditis after administration of the BNT162b2 vaccine against COVID-19 - PubMed
03/20 Infection and vaccine-induced antibody binding and neutralization of the B.1.351 SARS-CoV-2 variant: Cell Host & Microbe
03/20 SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies: Cell
03/20 Seroprevalence and humoral immune durability of anti-SARS-CoV-2 antibodies in Wuhan, China: a longitudinal, population-level, cross-sectional study - The Lancet
03/22 Association of Age With SARS-CoV-2 Antibody Response | Adolescent Medicine | JAMA Network Open | JAMA Network
03/22 COVID-19 Survivors’ Reports of the Timing, Duration, and Health Impacts of Post-Acute Sequelae of SARS-CoV-2 (PASC) Infection | medRxiv
03/23 Convalescent COVID-19 patients are susceptible to endothelial dysfunction due to persistent immune activation | eLife
03/23 Trends in Health Care Worker Intentions to Receive a COVID-19 Vaccine and Reasons for Hesitancy | Health Care Workforce | JAMA Network Open | JAMA Network
03/23 Persistent neurologic symptoms and cognitive dysfunction in non‐hospitalized Covid‐19 “long haulers” - Graham - - Annals of Clinical and Translational Neurology - Wiley Online Library
03/23 The impact of population-wide rapid antigen testing on SARS-CoV-2 prevalence in Slovakia | Science
03/23 Emergence of the E484K Mutation in SARS-CoV-2 Lineage B.1.1.220 in Upstate New York | medRxiv
03/23 Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol. | medRxiv
03/23 SARS-CoV-2 Infection after Vaccination in Health Care Workers in California | NEJM
03/23 BNT162b2 mRNA Covid-19 Vaccine Effectiveness among Health Care Workers | NEJM
03/23 Antibody Responses after a Single Dose of SARS-CoV-2 mRNA Vaccine | NEJM
03/23 Early Evidence of the Effect of SARS-CoV-2 Vaccine at One Medical Center | NEJM
03/23 Higher airborne pollen concentrations correlated with increased SARS-CoV-2 infection rates, as evidenced from 31 countries across the globe | PNAS
03/23 Using artificial intelligence to improve COVID-19 rapid diagnostic test result interpretation | PNAS
03/23 Impacts of introducing and lifting nonpharmaceutical interventions on COVID-19 daily growth rate and compliance in the United States | PNAS
03/23 Rapid identification and tracking of SARS-CoV-2 variants of concern - The Lancet
03/23 Dynamics of SARS-CoV-2 neutralising antibody responses and duration of immunity: a longitudinal study - The Lancet Microbe
03/24 B.1.526 SARS-CoV-2 variants identified in New York City are neutralized by vaccine-elicited and therapeutic monoclonal antibodies | bioRxiv
03/24 Quadrivalent influenza nanoparticle vaccines induce broad protection | Nature
03/24 New SARS-CoV-2 Variants — Clinical, Public Health, and Vaccine Implications | NEJM
03/24 Serologic Screening of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Cats and Dogs during First Coronavirus Disease Wave, the Netherlands - Volume 27, Number 5—May 2021 - Emerging Infectious Diseases journal - CDC
03/25 Emergence of porcine delta-coronavirus pathogenic infections among children in Haiti through independent zoonoses and convergent evolution | medRxiv
03/25 Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England | Nature
03/25 SARS-CoV-2 infection of the oral cavity and saliva | Nature Medicine
03/25 Performance and operational feasibility of antigen and antibody rapid diagnostic tests for COVID-19 in symptomatic and asymptomatic patients in Cameroon: a clinical, prospective, diagnostic accuracy study - The Lancet Infectious Diseases
03/26 Case Study: Longitudinal immune profiling of a SARS-CoV-2 reinfection in a solid organ transplant recipient | medRxiv
03/26 Dramatic drop of new SARS-CoV-2 infections among health care workers after the first dose of the BNT162b2 mRNA Covid-19 Vaccine | medRxiv
03/26 First manifestation of adult-onset Still's disease after COVID-19 - The Lancet Rheumatology
03/28 Emergence of a SARS-CoV-2 E484K variant of interest in Arizona | medRxiv
03/29 SARS-CoV2 Nsp16 activation mechanism and a cryptic pocket with pan-coronavirus antiviral potential: Biophysical Journal
03/29 Clinical performance evaluation of SARS-CoV-2 rapid antigen testing in point of care usage in comparison to RT-qPCR | medRxiv
03/29 Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma | Nature
03/29 The spatial landscape of lung pathology during COVID-19 progression | Nature
03/29 Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine | Nature Medicine
03/29 Early Release - Epidemiologic Evidence for Airborne Transmission of SARS-CoV-2 during Church Singing, Australia, 2020 - Volume 27, Number 6—June 2021 - Emerging Infectious Diseases journal - CDC
03/30 Emergence and rapid transmission of SARS-CoV-2 B.1.1.7 in the United States: Cell
03/30 Antibody evasion by the P.1 strain of SARS-CoV-2: Cell
03/30 mRNA vaccines take on immune tolerance | Nature Biotechnology
03/30 Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial - The Lancet
03/30 Pandemic moves and countermoves: vaccines and viral variants - The Lancet
03/31 Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study | The BMJ
03/31 Alterations in T and B cell function persist in convalescent COVID-19 patients: Med - Cell
April 2021
04/01 Quantitative Microbial Risk Assessment for Airborne Transmission of SARS-CoV-2 via Breathing, Speaking, Singing, Coughing, and Sneezing | Environmental Health Perspectives | Vol. 129, No. 4
04/01 Computational epitope map of SARS-CoV-2 spike protein - PLOS
04/01 Systems serology detects functionally distinct coronavirus antibody features in children and elderly | Nature Communications - Nature
04/01 Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2 | Nature Medicine
04/01 Early Release - Genetic Evidence and Host Immune Response in Persons Reinfected with SARS-CoV-2, Brazil - Volume 27, Number 5—May 2021 - Emerging Infectious Diseases journal - CDC
04/02 X-ray screening identifies active site and allosteric inhibitors of SARS-CoV-2 main protease | Science
04/02 Qualitatively distinct modes of Sputnik V vaccine-neutralization escape by SARS-CoV-2 Spike variants | medRxiv
04/03 Early introductions and transmission of SARS-CoV-2 variant B.1.1.7 in the United States - ScienceDirect
04/05 Vaccination with prefusion-stabilized respiratory syncytial virus fusion protein induces genetically and antigenically diverse antibody responses: Immunity
04/05 SARS-CoV-2 infectivity by viral load, S gene variants and demographic factors and the utility of lateral flow devices to prevent transmission | medRxiv
04/06 Trends in Geographic and Temporal Distribution of US Children With Multisystem Inflammatory Syndrome During the COVID-19 Pandemic | Pediatrics | JAMA Pediatrics | JAMA Network
04/06 Administration of a Second Dose of the Moderna COVID-19 Vaccine After an Immediate Hypersensitivity Reaction With the First Dose: Two Case Reports | Annals of Internal Medicine
04/06 Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19 | Nature Reviews Immunology
04/06 Susceptibility of Circulating SARS-CoV-2 Variants to Neutralization | NEJM
04/06 Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19 | NEJM
04/06 Overdispersion in COVID-19 increases the effectiveness of limiting nonrepetitive contacts for transmission control | PNAS
04/06 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records - The Lancet Psychiatry
04/07 Reactive Infectious Mucocutaneous Eruption Associated With SARS-CoV-2 Infection | Dermatology | JAMA Dermatology | JAMA Network
04/07 Effectiveness of CoronaVac in the setting of high SARS-CoV-2 P.1 variant transmission in Brazil: A test-negative case-control study | medRxiv
04/07 Drugs that inhibit TMEM16 proteins block SARS-CoV-2 Spike-induced syncytia | Nature
04/07 Neutralization of SARS-CoV-2 Variants B.1.429 and B.1.351 | NEJM
04/07 Cross-Reactive Neutralizing Antibody Responses Elicited by SARS-CoV-2 501Y.V2 (B.1.351) | NEJM
04/07 SARS-CoV-2 spike E484K mutation reduces antibody neutralisation - ScienceDirect
04/07 Comparison of seven commercial SARS-CoV-2 rapid point-of-care antigen tests: a single-centre laboratory evaluation study - The Lancet Microbe
04/08 Early T cell and binding antibody responses are associated with Covid-19 RNA vaccine efficacy onset: Med
04/09 Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2 mRNA vaccinated individuals | medRxiv
04/09 Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination | NEJM
04/09 Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination | NEJM
04/09 SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN) - ScienceDirect
04/09 Correlates of protection from SARS-CoV-2 infection - The Lancet
04/09 Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial - The Lancet Respiratory Medicine
04/12 Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV | Nature
04/12 Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort study - The Lancet Infectious Diseases
04/12 Lack of detail in population-level data impedes analysis of SARS-CoV-2 variants of concern and clinical outcomes - The Lancet Infectious Diseases
04/12 Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study - The Lancet Public Health
04/12 Epidemiology of Confirmed COVID-19 Deaths in Adults, England, March–December 2020 - Volume 27, Number 5—May 2021 - Emerging Infectious Diseases journal - CDC
04/13 T-Cell and Antibody Responses to First BNT162b2 Vaccine Dose in Previously SARS-CoV-2-Infected and Infection-Naive UK Healthcare Workers: A Multicentre, Prospective, Observational Cohort Study by Adrienn Angyal, Stephanie Longet, Shona Moore, Rebecca P. P
04/13 Immune dysregulation and autoreactivity correlate with disease severity in SARS-CoV-2-associated multisystem inflammatory syndrome in children: Immunity
04/13 Is IL-6 a key cytokine target for therapy in COVID-19? | Nature Reviews Immunology
04/13 Ranking the risk of animal-to-human spillover for newly discovered viruses | PNAS
04/13 Serum sample neutralisation of BBIBP-CorV and ZF2001 vaccines to SARS-CoV-2 501Y.V2 - The Lancet Microbe
04/13 Suicide trends in the early months of the COVID-19 pandemic: an interrupted time-series analysis of preliminary data from 21 countries - The Lancet Psychiatry
04/13 Introduction of ORF3a-Q57H SARS-CoV-2 Variant Causing Fourth Epidemic Wave of COVID-19, Hong Kong, China - Volume 27, Number 5—May 2021 - Emerging Infectious Diseases journal - CDC
04/14 Spatiotemporal pattern of COVID-19 spread in Brazil | Science
04/14 Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil | Science
04/14 SARS-CoV-2 Antibody Response in Persons with Past Natural Infection | NEJM
04/14 Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination | NEJM
04/14 Pulmonary embolism and thrombocytopenia following ChAdOx1 vaccination - The Lancet
04/14 Bilateral superior ophthalmic vein thrombosis, ischaemic stroke, and immune thrombocytopenia after ChAdOx1 nCoV-19 vaccination - The Lancet
04/14 Longevity of Middle East Respiratory Syndrome Coronavirus Antibody Responses in Humans, Saudi Arabia - Volume 27, Number 5—May 2021 - Emerging Infectious Diseases journal - CDC
04/15 COVID-19 neuropathology at Columbia University Irving Medical Center/New York Presbyterian Hospital | Brain | Oxford Academic
04/15 Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals following mRNA vaccination | Science Immunology
04/15 A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection: Cell Host & Microbe
04/15 SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study - The Lancet Respiratory Medicine
04/16 The SARS-CoV-2 Spike variant D614G favors an open conformational state | Science Advances
04/16 # AstraZeneca vaccine disinformation on Twitter | medRxiv
04/16 Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination — Response from the Manufacturer | NEJM
04/16 SARS-CoV-2 Vaccine–Induced Immune Thrombotic Thrombocytopenia | NEJM
04/16 Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination | NEJM
04/17 BNT162b2 Vaccination Effectively Prevents the Rapid Rise of SARS-CoV-2 Variant B.1.1.7 in high risk populations in Israel: Cell Reports Medicine
04/19 A Trial Studying the SARS-CoV-2 mRNA Vaccine CVnCoV to Learn About the Immune Response, the Safety, and the Degree of Typical Vaccination Reactions When CVnCoV is Given at the Same Time as a Flu Vaccine Compared to When the Vaccines Are Separately Given i
04/19 A systematic review and meta-analysis of psychological interventions to improve mental wellbeing | Nature Human Behaviour
04/19 Statistical mechanics meets single-cell biology | Nature Reviews Genetics
04/19 COVID-19 dynamics after a national immunization program in Israel | Nature Medicine
04/19 Response to first vaccination against SARS-CoV-2 in patients with multiple myeloma - The Lancet Haematology
04/20 How accurately can we assess zoonotic risk? - PLOS
04/20 Serious adverse reactions associated with ivermectin: A systematic pharmacovigilance study in sub-Saharan Africa and in the rest of the World - PLoS
04/20 SARS-CoV-2 Reinfection in a Liver Transplant Recipient | Annals of Internal Medicine
04/20 Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies.: Cell Reports Medicine
04/20 Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant: Cell
04/20 Single-cell multi-omics analysis of the immune response in COVID-19 | Nature Medicine
04/20 Suicide in England in the COVID-19 pandemic: Early observational data from real time surveillance - The Lancet Regional Health – Europe
04/21 Delayed Large Local Reactions to mRNA Vaccines | NEJM
04/21 Vaccine Breakthrough Infections with SARS-CoV-2 Variants | NEJM
04/22 SARS-CoV-2 can recruit a haem metabolite to evade antibody immunity | Science Advances
04/22 Detection of SARS‐CoV‐2 in respiratory samples from cats in the UK associated with human‐to‐cat transmission - Hosie - 2021 - Veterinary Record - Wiley Online Library
04/22 SARS-CoV-2 Transmission Risk Among National Basketball Association Players, Staff, and Vendors Exposed to Individuals With Positive Test Results After COVID-19 Recovery During the 2020 Regular and Postseason | Infectious Diseases | JAMA Internal Medicine
04/22 Acute Ischemic Stroke During the Convalescent Phase of Asymptomatic COVID-2019 Infection in Men | Cerebrovascular Disease | JAMA Network Open | JAMA Network
04/22 Rapid induction of antigen-specific CD4+ T cells guides coordinated humoral and cellular immune responses to SARS-CoV-2 mRNA vaccination | bioRxiv
04/22 High-dimensional characterization of post-acute sequalae of COVID-19 | Nature
04/23 Resurgence of SARS-CoV-2: detection by community viral surveillance | Science
04/23 Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees | bioRxiv
04/23 B cell genomics behind cross-neutralization of SARS-CoV-2 variants and SARS-CoV: Cell
04/23 Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study - The Lancet
04/23 Hospital admissions due to COVID-19 in Scotland after one dose of vaccine - The Lancet
04/23 COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study - The Lancet
04/24 Protection of previous SARS-CoV-2 infection is similar to that of BNT162b2 vaccine protection: A three-month nationwide experience from Israel | medRxiv
04/26 The SARS-CoV-2 RNA interactome: Molecular Cell
04/27 Interrupting vaccination policies can greatly spread SARS-CoV-2 and enhance mortality from COVID-19 disease: The AstraZeneca case for France and Italy: Chaos: An Interdisciplinary Journal of Nonlinear Science: Vol 31, No 4
04/27 Socioeconomic status determines COVID-19 incidence and related mortality in Santiago, Chile | Science
04/27 Performance Evaluation of Serial SARS-CoV-2 Rapid Antigen Testing During a Nursing Home Outbreak | Annals of Internal Medicine
04/27 Divergent and self-reactive immune responses in the CNS of COVID-19 patients with neurological symptoms: Cell Reports Medicine
04/27 Single‐cell analyses reveal SARS‐CoV‐2 interference with intrinsic immune response in the human gut | Molecular Systems Biology
04/27 A guideline to limit indoor airborne transmission of COVID-19 | PNAS
04/27 COVID-19-associated coagulopathy and antithrombotic agents—lessons after 1 year - The Lancet Haematology
04/27 Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study - The Lancet Infectious Diseases
04/27 Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study - The Lancet Oncology
04/28 Dynamic changes and prevalence of SARS-CoV-2 IgG/IgM antibodies: Analysis of multiple factors - International Journal of Infectious Diseases
04/28 Associations between body-mass index and COVID-19 severity in 6·9 million people in England: a prospective, community-based, cohort study - The Lancet Diabetes & Endocrinology
04/29 Complications of COVID-19 Nasopharyngeal Swab Test | Coronavirus (COVID-19) | JAMA Otolaryngology–Head & Neck Surgery | JAMA Network
04/29 Household COVID-19 risk and in-person schooling | Science
04/29 Previously infected vaccinees broadly neutralize SARS-CoV-2 variants | medRxiv
04/29 A molecular single-cell lung atlas of lethal COVID-19 | Nature
04/29 COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets | Nature
04/30 US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021 | Coagulation Disorders | JAMA | JAMA Network
04/30 COVID-19 Outbreak Associated with a SARS-CoV-2 R.1 Lineage Variant in a Skilled Nursing Facility After Vaccination Program - Kentucky, March 2021 - PubMed
04/30 Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose | Science
04/30 Estimating the early impact of immunization against COVID-19 on deaths among elderly people in Brazil: analyses of secondary data on vaccine coverage and mortality | medRxiv
May 2021
05/01 Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial - The Lancet
05/03 Viral genomes reveal patterns of the SARS-CoV-2 outbreak in Washington State | Science Translational Medicine
05/03 COVID-19-related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters | Science Translational Medicine
05/03 A human-airway-on-a-chip for the rapid identification of candidate antiviral therapeutics and prophylactics | Nature Biomedical Engineering
05/04 evolutionary portrait of the progenitor SARS-CoV-2 and its dominant offshoots in COVID-19 pandemic | Molecular Biology and Evolution | Oxford Academic
05/04 Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes | Science
05/04 Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to eight months post-symptom onset: Cell Reports Medicine
05/04 Testing at scale during the COVID-19 pandemic | Nature Reviews Genetics
05/04 SARS-CoV-2 related Paediatric Acute-onset Neuropsychiatric Syndrome - The Lancet Child & Adolescent Health
05/05 SARS CoV-2 variant B.1.617.1 is highly pathogenic in hamsters than B.1 variant | bioRxiv
05/05 Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study | The BMJ
05/05 Delayed production of neutralizing antibodies correlates with fatal COVID-19 | Nature Medicine
05/05 Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants | NEJM
05/05 Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant | NEJM
05/05 Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data - The Lancet
05/06 Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers | Health Care Workforce | JAMA | JAMA Network
05/06 Asymptomatic and Symptomatic SARS-CoV-2 Infections After BNT162b2 Vaccination in a Routinely Screened Workforce | Infectious Diseases | JAMA | JAMA Network
05/06 Profiling B cell immunodominance after SARS-CoV-2 infection reveals antibody evolution to non-neutralizing viral targets: Immunity
05/06 Aerosol generating procedures: are they of relevance for transmission of SARS-CoV-2? - The Lancet Respiratory Medicine
05/06 The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity - The Lancet Respiratory Medicine
05/07 Rapid antigen testing in COVID-19 responses | Science
05/07 Vaccination boosts naturally enhanced neutralizing breadth to SARS-CoV-2 one year after infection | bioRxiv
05/07 Detection of persistent SARS-CoV-2 IgG antibodies in oral mucosal fluid and upper respiratory tract specimens following COVID-19 mRNA vaccination | medRxiv
05/07 TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines | Nature Immunology
05/07 Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study - The Lancet Rheumatology
05/08 Association Between Myocarditis and Mortality in SARS-CoV-2 Patients in a Large Registry by Frank Annie, Haytham Alkhaimy, Aravinda Nanjundappa, Ahmad Elashery :: SSRN
05/08 Prospective Case-Control Study of Cardiovascular Abnormalities 6 Months Following Mild COVID-19 in Healthcare Workers - ScienceDirect
05/10 Real-World Effectiveness of Ad26.COV2.S Adenoviral Vector Vaccine for COVID-19 by Juan Corchado-Garcia, David Puyraimond-Zemmour, Travis Hughes, Tudor Cristea-Platon, Patrick Lenehan, Colin Pawlowski, Sairam Bade, John C. O'Horo, Gregory J. Gores, Amy W.
05/10 A global database of COVID-19 vaccinations | Nature Human Behaviour
05/10 Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses | Nature
05/11 Global Incidence of Neurological Manifestations Among Patients Hospitalized With COVID-19—A Report for the GCS-NeuroCOVID Consortium and the ENERGY Consortium | Neurology | JAMA Network Open | JAMA Network
05/11 Towards psychological herd immunity: Cross-cultural evidence for two prebunking interventions against COVID-19 misinformation - Melisa Basol, Jon Roozenbeek, Manon Berriche, Fatih Uenal, William P. McClanahan, Sander van der Linden, 2021
05/11 Catch me if you can: Superspreading of SARS-CoV-2: Trends in Microbiology
05/11 JCI - A randomized double-blind controlled trial of convalescent plasma in adults with severe COVID-19 - JCI
05/11 Cerebral venous thrombosis and portal vein thrombosis: a retrospective cohort study of 537,913 COVID-19 cases | medRxiv
05/11 SARS-CoV-2 gene content and COVID-19 mutation impact by comparing 44 Sarbecovirus genomes | Nature Communications
05/11 Reversed-engineered human alveolar lung-on-a-chip model | PNAS
05/11 Automated, multiparametric monitoring of respiratory biomarkers and vital signs in clinical and home settings for COVID-19 patients | PNAS
05/11 Impact of COVID-19 on diagnoses, monitoring, and mortality in people with type 2 diabetes in the UK - The Lancet Diabetes & Endocrinology
05/12 Delayed Localized Hypersensitivity Reactions to the Moderna COVID-19 Vaccine: A Case Series | Dermatology | JAMA Dermatology | JAMA Network
05/12 mRNA vaccine-induced SARS-CoV-2-specific T cells recognize B.1.1.7 and B.1.351 variants but differ in longevity and homing properties depending on prior infection status | bioRxiv
05/12 The epidemiological impact of the NHS COVID-19 App | Nature
05/12 Structural basis for broad coronavirus neutralization | Nature Structural & Molecular Biology
05/12 BNT162b2-Elicited Neutralization against New SARS-CoV-2 Spike Variants | NEJM
05/12 A preliminary report of a randomized controlled phase 2 trial of the safety and immunogenicity of mRNA-1273 SARS-CoV-2 vaccine - ScienceDirect
05/12 Data discrepancies and substandard reporting of interim data of Sputnik V phase 3 trial – Authors' reply - The Lancet
05/12 Data discrepancies and substandard reporting of interim data of Sputnik V phase 3 trial - The Lancet
05/12 Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data - The Lancet
05/13 Infections, Hospitalizations, and Deaths Averted Via Direct Effects of the Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine in a Nationwide Vaccination Campaign, Israel by Eric J. Haas, John M. McLaughlin, Farid Khan, Frederick J. Angulo, Emilia Anis, Marc
05/13 Structural basis of ribosomal frameshifting during translation of the SARS-CoV-2 RNA genome | Science
05/14 Archival influenza virus genomes from Europe reveal genomic and phenotypic variability during the 1918 pandemic | bioRxiv
05/14 Innate immune and inflammatory responses to SARS-CoV-2: Implications for COVID-19: Cell Host & Microbe
05/14 Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial - The Lancet
05/15 Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease | NEJM
05/16 Identification of SARS-CoV-2 P.1-related lineages in Brazil provides new insights about the mechanisms of emergence of Variants of Concern - nCoV-2019 Genomic Epidemiology - Virological
05/16 Durability of mRNA-1273-induced antibodies against SARS-CoV-2 variants | bioRxiv
05/16 The Spike Proteins of SARS-CoV-2 B.1.617 and B.1.618 Variants Identified in India Provide Partial Resistance to Vaccine-elicited and Therapeutic Monoclonal Antibodies | bioRxiv
05/16 Longitudinal analysis reveals that delayed bystander CD8+ T cell activation and early immune pathology distinguish severe COVID-19 from mild disease.: Immunity
05/17 High Seroprevalence of SARS-CoV-2 Eight Months After Introduction in Nairobi, Kenya by Isaac A. Ngere, Jeanette Dawa, Elizabeth Hunsperger, Nancy Otieno, Moses Masika, Patrick Amoth, Lyndah Makayotto, Carolyne Nasimiyu, Bronwyn Mei Gunn, Bryan Nyawanda, O
05/17 Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection | Nature Medicine
05/17 Genome-wide bioinformatic analyses predict key host and viral factors in SARS-CoV-2 pathogenesis | Communications Biology
05/18 Fast SARS-CoV-2 virus detection using disposable cartridge strips and a semiconductor-based biosensor platform: Journal of Vacuum Science & Technology B: Vol 39, No 3
05/18 Seropositivity in blood donors and pregnant women during the first year of SARS‐CoV‐2 transmission in Stockholm, Sweden - Castro Dopico - - Journal of Internal Medicine - Wiley Online Library
05/18 Clonal analysis of immunodominance and cross-reactivity of the CD4 T cell response to SARS-CoV-2 | Science
05/18 SARS-CoV-2 infects human pancreatic β-cells and elicits β-cell impairment: Cell Metabolism
05/18 SARS-CoV-2 variants: Subversion of antibody response and predicted impact on T cell recognition: Cell Reports Medicine
05/19 Characteristics Associated With Multisystem Inflammatory Syndrome Among Adults With SARS-CoV-2 Infection | Infectious Diseases | JAMA Network Open | JAMA Network
05/19 Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study | The BMJ
05/19 Diverse Functional Autoantibodies in Patients with COVID-19 | Nature
05/19 Incident SARS-CoV-2 Infection among mRNA-Vaccinated and Unvaccinated Nursing Home Residents | NEJM
05/19 SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity - The Lancet Infectious Diseases
05/20 Novel Canine Coronavirus Isolated from a Hospitalized Pneumonia Patient, East Malaysia | Clinical Infectious Diseases | Oxford Academic
05/20 Preliminary Analysis of Association Between COVID-19 Vaccination and Sudden Hearing Loss Using US Centers for Disease Control and Prevention Vaccine Adverse Events Reporting System Data | Vaccination | JAMA Otolaryngology–Head & Neck Surgery | JAMA Networ
05/20 Dispersal dynamics of SARS-CoV-2 lineages during the first epidemic wave in New York City - PLOS
05/20 Face masks effectively limit the probability of SARS-CoV-2 transmission | Science
05/20 Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants | Science
05/21 Nonreplicable publications are cited more than replicable ones | Science Advances
05/21 SARS-CoV-2 Human T cell Epitopes: adaptive immune response against COVID-19.: Cell Host & Microbe
05/21 SARS-CoV-2 infection of BNT162b2(mRNA)-vaccinated individuals is not restricted to variants of concern or high-risk exposure environments | medRxiv
05/21 Single-dose SARS-CoV-2 vaccine in a prospective cohort of COVID-19 patients | medRxiv
05/22 Patient care and clinical outcomes for patients with COVID-19 infection admitted to African high-care or intensive care units (ACCCOS): a multicentre, prospective, observational cohort study - The Lancet
05/24 Public Trust and Willingness to Vaccinate Against COVID-19 in the US From October 14, 2020, to March 29, 2021 | Infectious Diseases | JAMA | JAMA Network
05/24 An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies: Cell
05/24 Effectiveness of COVID-19 vaccines against the B.1.617.2 variant | medRxiv
05/24 Rapid single-molecule detection of COVID-19 and MERS antigens via nanobody-functionalized organic electrochemical transistors | Nature Biomedical Engineering
05/24 SARS-CoV-2 simulations go exascale to predict dramatic spike opening and cryptic pockets across the proteome | Nature Chemistry
05/24 SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans | Nature
05/24 6-month multidisciplinary follow-up and outcomes of patients with paediatric inflammatory multisystem syndrome (PIMS-TS) at a UK tertiary paediatric hospital: a retrospective cohort study - The Lancet Child & Adolescent Health
05/25 Complement control for COVID-19 | Science Immunology
05/25 SARS-CoV-2 variants of concern partially escape humoral but not T-cell responses in COVID-19 convalescent donors and vaccinees | Science Immunology
05/25 Association Between Bitter Taste Receptor Phenotype and Clinical Outcomes Among Patients With COVID-19 | Infectious Diseases | JAMA Network Open | JAMA Network
05/25 Estimating infectiousness throughout SARS-CoV-2 infection course | Science
05/25 Absence of Humoral Response After Two-Dose SARS-CoV-2 Messenger RNA Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: A Case Series | Annals of Internal Medicine
05/25 Symptoms After COVID-19 Vaccination in Patients With Persistent Symptoms After Acute Infection: A Case Series | Annals of Internal Medicine
05/25 Variants of concern are overrepresented among post-vaccination breakthrough infections of SARS-CoV-2 in Washington State | medRxiv
05/25 Impacts of social distancing policies on mobility and COVID-19 case growth in the US | Nature Communications
05/25 Immune response to SARS-CoV-2 variants of concern in vaccinated individuals | Nature Communications
05/25 COVID-19 in Amazonas, Brazil, was driven by the persistence of endemic lineages and P.1 emergence | Nature Medicine
05/25 Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection | Nature Metabolism
05/25 Just 2% of SARS-CoV-2−positive individuals carry 90% of the virus circulating in communities | PNAS
05/25 Reverse-transcribed SARS-CoV-2 RNA can integrate into the genome of cultured human cells and can be expressed in patient-derived tissues | PNAS
05/26 Inhalable Nanobody (PiN-21) prevents and treats SARS-CoV-2 infections in Syrian hamsters at ultra-low doses | Science Advances
05/26 Assessment of the Frequency and Variety of Persistent Symptoms Among Patients With COVID-19: A Systematic Review | Infectious Diseases | JAMA Network Open | JAMA Network
05/26 Mask Use in Community Settings in the Context of COVID-19: A Systematic Review of Ecological Data by Nathan Ford, Haley K. Holmer, Roger Chou, Paul Villeneuve, April Baller, Maria Van Kerkhove, Benedetta Allegranzi :: SSRN
05/26 Social media use in China before and during COVID-19: Preliminary results from an online retrospective survey - PubMed
05/26 Reduced sensitivity of infectious SARS-CoV-2 variant B.1.617.2 to monoclonal antibodies and sera from convalescent and vaccinated individuals | bioRxiv
05/26 Emergence of a new SARS-CoV-2 variant from GR clade with a novel S glycoprotein mutation V1230L in West Bengal, India | medRxiv
05/26 Cytokine release syndrome in a patient with colorectal cancer after vaccination with BNT162b2 | Nature Medicine
05/26 “Vaccine-Induced Covid-19 Mimicry” Syndrome:Splice reactions within the SARS-CoV-2 Spike open reading frame result in Spike protein variants that may cause thromboembolic events in patients immunized with vector-based vaccines | Research Square
05/27 Prevalence of Clinical and Subclinical Myocarditis in Competitive Athletes With Recent SARS-CoV-2 Infection: Results From the Big Ten COVID-19 Cardiac Registry | Cardiology | JAMA Cardiology | JAMA Network
05/27 Broad auto-reactive IgM responses are common in critically ill patients, including those with COVID-19: Cell Reports Medicine
05/27 BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans | Nature
05/27 SARS-CoV-2 variants of concern are emerging in India | Nature Medicine
05/27 Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents | NEJM
05/27 Same-day SARS-CoV-2 antigen test screening in an indoor mass-gathering live music event: a randomised controlled trial - The Lancet Infectious Diseases
05/27 Serum neutralising activity against SARS-CoV-2 variants elicited by CoronaVac - The Lancet Infectious Diseases
05/28 Assessment of SARS-CoV-2 Reinfection 1 Year After Primary Infection in a Population in Lombardy, Italy | Infectious Diseases | JAMA Internal Medicine | JAMA Network
05/28 Evaluation of Seropositivity Following BNT162b2 Messenger RNA Vaccination for SARS-CoV-2 in Patients Undergoing Treatment for Cancer | Oncology | JAMA Oncology | JAMA Network
05/29 Inferring SARS-CoV-2 variant within-host kinetics | medRxiv
05/29 The indirect effect of mRNA-based Covid-19 vaccination on unvaccinated household members | medRxiv
05/29 Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection | Nature Reviews Immunology
05/30 Small Airways Disease is a Post-Acute Sequelae of SARS-CoV-2 Infection | medRxiv
05/31 After COVID-19 successes, researchers push to develop mRNA vaccines for other diseases | Nature Medicine
05/31 AI for radiographic COVID-19 detection selects shortcuts over signal | Nature Machine Intelligence
June 2021
06/01 Vitamin D and COVID-19 susceptibility and severity in the COVID-19 Host Genetics Initiative: A Mendelian randomization study - PLOS
06/01 Symptomatic Acute Myocarditis in Seven Adolescents Following Pfizer-BioNTech COVID-19 Vaccination | American Academy of Pediatrics
06/01 SARS-CoV-2 cell-to-cell spread occurs rapidly and is insensitive to antibody neutralization | bioRxiv
06/01 SARS-CoV-2 variants, spike mutations and immune escape | Nature Reviews Microbiology
06/02 Proof of concept for real-time detection of SARS CoV-2 infection with an electronic nose - PLOS
06/02 A global analysis of the impact of COVID-19 stay-at-home restrictions on crime | Nature Human Behaviour
06/02 Thromboembolic Events in the South African Ad26.COV2.S Vaccine Study | NEJM
06/02 Can the USA return to pre-COVID-19 normal by July 4? - The Lancet Infectious Diseases
06/03 Estimating epidemiologic dynamics from cross-sectional viral load distributions | Science
06/03 Nasal delivery of an IgM offers broad protection from SARS-CoV-2 variants | Nature
06/03 Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination - The Lancet
06/04 A single dose of the SARS-CoV-2 vaccine BNT162b2 elicits Fc-mediated antibody effector functions and T-cell responses: Cell Host & Microbe
06/05 Neutralization against B.1.351 and B.1.617.2 with sera of COVID-19 recovered cases and vaccinees of BBV152 | bioRxiv
06/05 The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies: Cell
06/06 Evolution of enhanced innate immune evasion by the SARS-CoV-2 B.1.1.7 UK variant | bioRxiv
06/07 Dynamics of the SARS-CoV-2 antibody response up to 10 months after infection | Cellular & Molecular Immunology
06/07 SARS-CoV-2 RNAemia and proteomic trajectories inform prognostication in COVID-19 patients admitted to intensive care | Nature Communications
06/07 Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 | Nature
06/08 Senolytics reduce coronavirus-related mortality in old mice | Science
06/08 SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD and S2: Cell
06/08 Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional species: Immunity
06/08 Structural basis for SARS-CoV-2 envelope protein recognition of human cell junction protein PALS1 | Nature Communications
06/08 Collectivism predicts mask use during COVID-19 | PNAS
06/08 Analyzing the vast coronavirus literature with CoronaCentral | PNAS
06/08 Anti-SARS-CoV-2 mRNA vaccine in patients with rheumatoid arthritis - The Lancet Rheumatology
06/09 Associations of Vaccination and of Prior Infection With Positive PCR Test Results for SARS-CoV-2 in Airline Passengers Arriving in Qatar | Global Health | JAMA | JAMA Network
06/09 SARS-CoV-2 Variants of Interest and Concern naming scheme conducive for global discourse | Nature Microbiology
06/09 Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans | Nature
06/09 First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland | Nature Medicine
06/09 Impact of vaccination on new SARS-CoV-2 infections in the United Kingdom | Nature Medicine
06/09 Delayed Large Local Reactions to mRNA Covid-19 Vaccines in Blacks, Indigenous Persons, and People of Color | NEJM
06/09 Adjunct Immune Globulin for Vaccine-Induced Thrombotic Thrombocytopenia | NEJM
06/10 BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants | Nature
06/10 Community-level evidence for SARS-CoV-2 vaccine protection of unvaccinated individuals | Nature Medicine
06/11 Memory B cells targeting SARS-CoV-2 spike protein and their dependence on CD4+ T cell help: Cell Reports
06/11 Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum: Cell
06/11 In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies: Cell
06/11 Vaccination reduces need for emergency care in breakthrough COVID-19 infections: A multicenter cohort study | medRxiv
06/14 Effectiveness of COVID-19 vaccines against hospital admission with the Delta (B.1.617.2) variant - Public library - PHE national - Knowledge Hub
06/14 Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection | Nature
06/14 Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individuals | Nature Medicine
06/15 Serum neurofilament light protein correlates with unfavorable clinical outcomes in hospitalized patients with COVID-19 | Science Translational Medicine
06/15 Predicted domination of variant Delta of SARS-CoV-2 before Tokyo Olympic games, Japan | medRxiv
06/15 Divergent trajectories of antiviral memory after SARS-Cov-2 infection | Research Square
06/16 Antibody and B cell responses to SARS-CoV-2 infection and vaccination: Cell Host & Microbe
06/16 Reconstruction of a large-scale outbreak of SARS-CoV-2 infection in Iceland informs vaccination strategies | medRxiv
06/16 Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial | medRxiv
06/16 Immunotherapy for MIS-C — IVIG, Glucocorticoids, and Biologics | NEJM
06/16 Treatment of Multisystem Inflammatory Syndrome in Children | NEJM
06/17 Will we ever wash our hands of lubrication theory?: Physics of Fluids: Vol 33, No 8
06/17 Sperm Parameters Before and After COVID-19 mRNA Vaccination | Urology | JAMA | JAMA Network
06/17 SARS-CoV-2 spike P681R mutation enhances and accelerates viral fusion | bioRxiv
06/17 Cell-mimicking nanodecoys neutralize SARS-CoV-2 and mitigate lung injury in a non-human primate model of COVID-19 | Nature Nanotechnology
06/17 Causation or confounding: why controls are critical for characterizing long COVID | Nature Medicine
06/17 Spike D614G — A Candidate Vaccine Antigen Against Covid-19 | NEJM
06/18 Alarming COVID study indicates long-term loss of gray matter and other brain tissue - Medical News
06/20 Rapid spread of the SARS-CoV-2 δ variant in the area of Paris (France) in June 2021 | medRxiv
06/21 Assessing the Association Between Social Gatherings and COVID-19 Risk Using Birthdays | Public Health | JAMA Internal Medicine | JAMA Network
06/21 In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains - PubMed
06/22 Impaired humoral immunity to SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients and dialysis patients | Science Immunology
06/22 COVID-19 vaccine side effects: The positives about feeling bad | Science Immunology
06/22 Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice | Science
06/22 The total number and mass of SARS-CoV-2 virions | PNAS
06/22 SARS-CoV-2 B.1.617.2 Delta variant emergence and vaccine breakthrough | Research Square
06/22 Remote home monitoring (virtual wards) for confirmed or suspected COVID-19 patients: a rapid systematic review - EClinicalMedicine
06/22 Risk of hospitalisation associated with infection with SARS-CoV-2 lineage B.1.1.7 in Denmark: an observational cohort study - The Lancet Infectious Diseases
06/22 Mortality and critical care unit admission associated with the SARS-CoV-2 lineage B.1.1.7 in England: an observational cohort study - The Lancet Infectious Diseases
06/22 SARS-CoV-2 variants and considerations of inferring causality on disease severity - The Lancet Infectious Diseases
06/23 Effect of Vaccination on Household Transmission of SARS-CoV-2 in England - PubMed
06/23 Primary, Recall, and Decay Kinetics of SARS-CoV-2 Vaccine Antibody Responses | ACS Nano
06/23 Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicity | Science
06/23 Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants | Science
06/23 Increased lung cell entry of B.1.617.2 and evasion of antibodies induced by infection and BNT162b2 vaccination | bioRxiv
06/23 Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques | Nature
06/23 Long COVID in a prospective cohort of home-isolated patients | Nature Medicine
06/23 Acute and persistent symptoms in non-hospitalized PCR-confirmed COVID-19 patients | Scientific Reports
06/23 Effect of Vaccination on Household Transmission of SARS-CoV-2 in England | NEJM
06/23 Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients | NEJM
06/23 Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study - The Lancet Infectious Diseases
06/23 Effectiveness of BNT162b2 and ChAdOx1 nCoV-19 COVID-19 vaccination at preventing hospitalisations in people aged at least 80 years: a test-negative, case-control study - The Lancet Infectious Diseases
06/23 Invasive mould disease in fatal COVID-19: a systematic review of autopsies - The Lancet Microbe
06/24 Clinical Outcomes for Patients With Anosmia 1 Year After COVID-19 Diagnosis | Infectious Diseases | JAMA Network Open | JAMA Network
06/25 Multiplexed, quantitative serological profiling of COVID-19 from blood by a point-of-care test | Science Advances
06/25 Pfizer-BioNTech Vaccine Effectiveness Against SARS-CoV-2 Infection: Findings From a Large Observational Study in Israel by Yaki Saciuk, Jennifer Kertes, Micha Mandel, Beatriz Hemo, Naama Shamir Stein, Anat Ekka Zohar :: SSRN
06/25 Hybrid immunity | Science
06/25 Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial - The Lancet
06/25 Heterologous vaccine regimens against COVID-19 - The Lancet
06/28 Reduced neutralisation of the Delta (B.1.617.2) SARS-CoV-2 variant of concern following vaccination | medRxiv
06/28 SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses | Nature
06/28 Wearable materials with embedded synthetic biology sensors for biomolecule detection | Nature Biotechnology
06/28 AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC - The Lancet
06/28 Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial - The Lancet Infectious Diseases
06/28 The SARS-CoV-2 B.1.1.7 variant and increased clinical severity—the jury is out - The Lancet Infectious Diseases
06/28 COVID-19 vaccines for children younger than 12 years: are we ready? - The Lancet Infectious Diseases
06/29 Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military | Cardiology | JAMA Cardiology | JAMA Network
06/29 Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination | Cardiology | JAMA Cardiology | JAMA Network
06/29 Thrombosis With Thrombocytopenia After the Messenger RNA–1273 Vaccine | Annals of Internal Medicine
06/29 Thrombosis After Vaccination With Messenger RNA–1273: Is This Vaccine-Induced Thrombosis and Thrombocytopenia or Thrombosis With Thrombocytopenia Syndrome? | Annals of Internal Medicine
06/29 Structure-guided T cell vaccine design for SARS-CoV-2 variants and sarbecoviruses: Cell
06/29 Lessons from a local effort to screen for SARS-CoV-2 | PNAS
06/30 Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants | Science
06/30 SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern | Science
06/30 Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2 | Nature
06/30 Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines | NEJM
06/30 Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine | NEJM
06/30 Antibodies elicited by mRNA-1273 vaccination bind more broadly to the receptor binding domain than do those from SARS-CoV-2 infection - Science
July 2021
07/01 Impact of SARS-CoV-2 variants on the total CD4+ and CD8+ T cell reactivity in infected or vaccinated individuals: Cell Reports Medicine
07/01 Cerebral Venous Thrombosis | NEJM
07/02 Neutralization of Delta variant with sera of Covishield vaccinees and COVID-19 recovered vaccinated individuals | bioRxiv
07/02 Temporal Maturation of Neutralizing Antibodies in COVID-19 Convalescent Individuals Improves Potency and Breadth to Circulating SARS-CoV-2 Variants: Immunity
07/02 Efficacy, safety, and lot to lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): a, double-blind, randomised, controlled phase 3 trial | medRxiv
07/03 The Emergence of SARS-CoV-2 Variant Lambda (C.37) in South America | medRxiv
07/03 Prominent Spatiotemporal Waves of COVID-19 Incidence in the United States: Implications for Causality, Forecasting, and Control | medRxiv
07/05 Low dose mRNA-1273 COVID-19 vaccine generates durable T cell memory and antibodies enhanced by pre-existing crossreactive T cell memory | medRxiv
07/05 Fractionation of COVID-19 vaccine doses could extend limited supplies and reduce mortality | Nature Medicine
07/06 Meta-analysis of randomized trials of ivermectin to treat SARS-CoV-2 infection | Open Forum Infectious Diseases | Oxford Academic
07/06 Seroprevalence of and Risk Factors Associated With SARS-CoV-2 Infection in Health Care Workers During the Early COVID-19 Pandemic in Italy | Infectious Diseases | JAMA Network Open | JAMA Network
07/06 Prevalence of Symptoms More Than Seven Months After Diagnosis of Symptomatic COVID-19 in an Outpatient Setting | Annals of Internal Medicine
07/06 A selective sweep in the Spike gene has driven SARS-CoV-2 human adaptation: Cell
07/07 Assessment of Prolonged Physiological and Behavioral Changes Associated With COVID-19 Infection | Infectious Diseases | JAMA Network Open | JAMA Network
07/07 Long-Term Persistence of SARS-CoV-2 Neutralizing Antibody Responses After Infection and Estimates of the Duration of Protection by Eric H.Y. Lau, David S. C. Hui, Owen Tak-Yin Tsang, Wai-Hung Chan, Mike YE Kwan, Susan S. Chiu, Samuel MS Cheng, Ronald LW Ko, John KC Li, Sara Chaothai, Chi H. Tsang, Leo LM Poon, J.S. Malik Peiris :: SSRN
07/07 Undiagnosed SARS-CoV-2 seropositivity during the first 6 months of the COVID-19 pandemic in the United States | Science Translational Medicine
07/07 Viral infection and transmission in a large well-traced outbreak caused by the Delta SARS-CoV-2 variant - SARS-CoV-2 coronavirus / nCoV-2019 Genomic Epidemiology - Virological
07/07 Progressive Increase in Virulence of Novel SARS-CoV-2 Variants in Ontario, Canada, from December to July, 2021 | medRxiv
07/07 Antibody epitopes in vaccine-induced immune thrombotic thrombocytopenia | Nature
07/07 Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants | NEJM
07/07 Breakthrough SARS-CoV-2 Infections in Prison after Vaccination | NEJM
07/07 Therapeutic Plasma Exchange in Vaccine-Induced Immune Thrombotic Thrombocytopenia | NEJM
07/07 Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile | NEJM
07/07 The Origins of SARS-CoV-2: A Critical Review | Zenodo
07/08 Corneal confocal microscopy identifies corneal nerve fibre loss and increased dendritic cells in patients with long COVID | British Journal of Ophthalmology
07/08 SARS-CoV-2 targets MAVS for immune evasion | Nature Cell Biology
07/08 Mapping the human genetic architecture of COVID-19 | Nature
07/08 Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization | Nature
07/08 After the pandemic: perspectives on the future trajectory of COVID-19 | Nature
07/09 mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in Qatar | Nature Medicine
07/10 SARS-COV-2 spike binding to ACE2 in living cells monitored by TR-FRET: Cell Chemical Biology
07/12 Comparison of the Immunogenicity of BNT162b2 and CoronaVac COVID-19 Vaccines in Hong Kong: An Observational Cohort Study by Chris Ka Pun Mok, Carolyn A. Cohen, Samuel M.S. Cheng, Chunke Chen, Kin-On Kwok, Karen Yiu, Tat-On Chan, Maireid Bull, Kwun Cheung Ling, Zixi Dai, Susanna S. Ng, Grace C.Y. Lui, Chao Wu, Gaya K. Amarasinghe, Daisy W. Leung, Samuel Yeung Shan Wong, Sophie A. Valkenburg, J.S. Malik Peiris, David S. C. Hui :: SSRN
07/12 Systems vaccinology of the BNT162b2 mRNA vaccine in humans | Nature
07/13 Antibody response after second BNT162b2 dose in allogeneic HSCT recipients - The Lancet
07/14 SnapShot: SARS-CoV-2 antibodies: Cell Host & Microbe
07/14 SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape | Nature
07/14 Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination | Nature Medicine
07/14 Durable Humoral and Cellular Immune Responses 8 Months after Ad26.COV2.S Vaccination | NEJM
07/14 Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination | NEJM
07/14 Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19 | NEJM
07/14 Neurological manifestations of SARS-CoV-2 infection in hospitalised children and adolescents in the UK: a prospective national cohort study - The Lancet Child & Adolescent Health
07/15 Spike-antibody waning after second dose of BNT162b2 or ChAdOx1 - The Lancet
07/15 Comparative immunogenicity of mRNA and inactivated vaccines against COVID-19 - The Lancet Microbe
07/17 Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study - The Lancet
07/18 Impact of circulating SARS-CoV-2 variants on mRNA vaccine-induced immunity in uninfected and previously infected individuals | medRxiv
07/19 Comparison of Neutralizing Antibody Titers Elicited by mRNA and Adenoviral Vector Vaccine against SARS-CoV-2 Variants | bioRxiv
07/19 Cardiomyocytes Recruit Monocytes upon SARS-CoV-2 Infection by Secreting CCL2: Stem Cell Reports
07/19 SARS-CoV-2 antibody dynamics and transmission from community-wide serological testing in the Italian municipality of Vo’ | Nature Communications
07/19 Broad sarbecovirus neutralization by a human monoclonal antibody | Nature
07/20 Post-Vaccination Symptomatic SARS-CoV-2 Infections are Minimal and Non-Serious: An Observational Multicenter Indian Cohort Study of 28342 Healthcare Workers by Raju Vaishya, Anupam Sibal, Arpita Malani, Sujoy Kar, Hari Prasad K., Kiran SV, Sangita Reddy,
07/20 Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2 | Science
07/20 SARS-CoV-2 Vaccine Effectiveness in a High-Risk National Population in a Real-World Setting | Annals of Internal Medicine
07/20 Screening for SARS-CoV-2 Antigen Before a Live Indoor Music Concert: An Observational Study | Annals of Internal Medicine
07/20 Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells: Cell Reports Medicine
07/20 Transparent communication about negative features of COVID-19 vaccines decreases acceptance but increases trust | PNAS
07/20 Ongoing global and regional adaptive evolution of SARS-CoV-2 | PNAS
07/21 Household Transmission of SARS-CoV-2 from Children and Adolescents | NEJM
07/21 Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant | NEJM
07/22 Longitudinal assessment of COVID-19 vaccine acceptance and uptake among frontline medical workers in Los Angeles, California | Clinical Infectious Diseases | Oxford Academic
07/22 Optimizing testing for COVID-19 in India - PLOS
07/22 Safety and Cross-Variant Immunogenicity of a Three-Dose COVID-19 mRNA Vaccine Regimen in Kidney Transplant Recipients by Filippo Massa, Marion Cremoni, Alexandre Gerard, Hanen Grabsi, Lory Rogier, Mathilde Blois, Nadia Ben Hassen, Matthieu Rouleau, Susana
07/22 The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies - PubMed
07/22 Delta variants of SARS-CoV-2 cause significantly increased vaccine breakthrough COVID-19 cases in Houston, Texas | medRxiv
07/22 Covid-19 Vaccine Acceptance in California State Prisons | NEJM
07/22 Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines | NEJM
07/22 Evidence for antibody as a protective correlate for COVID-19 vaccines - ScienceDirect
07/23 Antibody Response After a Third Dose of the mRNA-1273 SARS-CoV-2 Vaccine in Kidney Transplant Recipients With Minimal Serologic Response to 2 Doses | Nephrology | JAMA | JAMA Network
07/23 SARS-CoV-2 Neutralization Resistance Mutations in Patient with HIV/AIDS, California, USA - Volume 27, Number 10—October 2021 - Emerging Infectious Diseases journal - CDC
07/26 Safety Evaluation of the Second Dose of Messenger RNA COVID-19 Vaccines in Patients With Immediate Reactions to the First Dose | Vaccination | JAMA Internal Medicine | JAMA Network
07/26 Long covid—mechanisms, risk factors, and management | The BMJ
07/26 Emergence of an early SARS-CoV-2 epidemic in the United States: Cell
07/26 Protection afforded by the BNT162b2 and mRNA-1273 COVID-19 vaccines in fully vaccinated cohorts with and without prior infection | medRxiv
07/26 Mucosal vaccines — fortifying the frontiers | Nature Reviews Immunology
07/26 A ‘mix and match’ approach to SARS-CoV-2 vaccination | Nature Medicine
07/26 Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19/mRNA vaccination | Nature Medicine
07/26 Comparative analysis of ChAdOx1 nCoV-19 and Ad26.COV2.S SARS-CoV-2 vector vaccines | Research Square
07/27 Recovery from Acute SARS-CoV-2 Infection and Development of Anamnestic Immune Responses in T Cell-Depleted Rhesus Macaques | mBio
07/27 Minute-scale detection of SARS-CoV-2 using a low-cost biosensor composed of pencil graphite electrodes | PNAS
07/27 Very rare thrombosis with thrombocytopenia after second AZD1222 dose: a global safety database analysis - The Lancet
07/28 Prior infection with SARS-CoV-2 boosts and broadens Ad26.COV2.S immunogenicity in a variant dependent manner | medRxiv
07/28 Six Month Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine | medRxiv
07/28 Six Month Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine | medRxiv
07/28 Rapid and stable mobilization of CD8+ T cells by SARS-CoV-2 mRNA vaccine | Nature
07/29 Presumed SARS-CoV-2 Viral Particles in the Human Retina of Patients With COVID-19 | Ophthalmology | JAMA Ophthalmology | JAMA Network
07/29 Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates | Science
07/29 SARS-CoV-2 specific T cell responses are lower in children and increase with age and time after infection | Nature Communications
07/29 Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden: a self-controlled case series and matched cohort study - The Lancet
07/30 Post-viral effects of COVID-19 in the olfactory system and their implications - The Lancet Neurology
07/30 The mechanisms of smell loss after SARS-CoV-2 infection - The Lancet Neurology
07/31 Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine-breakthrough infections: a multi-center cohort study | medRxiv
August 2021
08/02 Accelerated COVID-19 vaccine development: milestones, lessons, and prospects: Immunity
08/02 Studying SARS-CoV-2 infectivity and therapeutic responses with complex organoids | Nature Cell Biology
08/02 Behavioral Nudges Increase COVID-19 Vaccinations | Nature
08/02 Understanding why superspreading drives the COVID-19 pandemic but not the H1N1 pandemic - The Lancet Infectious Diseases
08/03 Broad betacoronavirus neutralization by a stem helix–specific human antibody | Science
08/03 Estimating SARS-CoV-2 infections from deaths, confirmed cases, tests, and random surveys | PNAS
08/03 Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2 - The Lancet Child & Adolescent Health
08/04 Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19 | NEJM
08/05 Elapsed time since BNT162b2 vaccine and risk of SARS-CoV-2 infection in a large cohort | medRxiv
08/05 SARS-CoV-2 Variants in Patients with Immunosuppression | NEJM
08/06 SARS-CoV-2 Antibody Responses in Infection-Naive or Previously Infected Individuals After 1 and 2 Doses of the BNT162b2 Vaccine | Infectious Diseases | JAMA Network Open | JAMA Network
08/06 Comparison of two highly-effective mRNA vaccines for COVID-19 during periods of Alpha and Delta variant prevalence | medRxiv
08/06 Seven-month kinetics of SARS-CoV-2 antibodies and role of pre-existing antibodies to human coronaviruses | Nature Communications
08/07 The unique evolutionary dynamics of the SARS-CoV-2 Delta variant | medRxiv
08/09 Comparison of two highly-effective mRNA vaccines for COVID-19 during periods of Alpha and Delta variant prevalence | medRxiv
08/09 Immunogenicity of BNT162b2 vaccine Against the Alpha and Delta Variants in Immunocompromised Patients | medRxiv
08/10 Transmission of SARS-CoV-2 Delta Variant Among Vaccinated Healthcare Workers, Vietnam by Nguyen Van Vinh Chau, Nghiem My Ngoc, Lam Anh Nguyet, Vo Minh Quang, Nguyen Thi Han Ny, Dao Bach Khoa, Nguyen Thanh Phong, Le Mau Toan, Nguyen Thi Thu Hong, Nguyen Th - The Lancet
08/10 Two doses of the SARS-CoV-2 BNT162b2 vaccine enhances antibody responses to variants in individuals with prior SARS-CoV-2 infection | Science Translational Medicine
08/10 Full vaccination suppresses SARS-CoV-2 delta variant mutation frequency | medRxiv
08/10 Immune Correlates Analysis of the mRNA-1273 COVID-19 Vaccine Efficacy Trial | medRxiv
08/10 Lipid nanoparticles for mRNA delivery | Nature Reviews Materials
08/10 Pairing facts with imagined consequences improves pandemic-related risk perception | PNAS
08/10 Elite party cues increase vaccination intentions among Republicans | PNAS
08/10 Empirical evidence to understand the human factor for effective rapid testing against SARS-CoV-2 | PNAS
08/11 Molecular basis of immune evasion by the delta and kappa SARS-CoV-2 variants | bioRxiv
08/11 Shedding of Infectious SARS-CoV-2 Despite Vaccination when the Delta Variant is Prevalent - Wisconsin, July 2021 | medRxiv
08/11 BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the Delta (B.1.617.2) variant in Qatar | medRxiv
08/11 Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients | NEJM
08/11 Evaluation of mRNA-1273 SARS-CoV-2 Vaccine in Adolescents | NEJM
08/12 Durability of mRNA-1273 vaccine–induced antibodies against SARS-CoV-2 variants | Science
08/12 Rapid induction of antigen-specific CD4+ T cells is associated with coordinated humoral and cellular immune responses to SARS-CoV-2 mRNA vaccination: Immunity
08/12 Transmission dynamics and epidemiological characteristics of Delta variant infections in China | medRxiv
08/12 Hospital-acquired SARS-CoV-2 infection in the UK's first COVID-19 pandemic wave - The Lancet
08/12 Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study - The Lancet Respiratory Medicine
08/13 Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants | Science
08/13 Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant | bioRxiv
08/13 Protective heterologous T cell immunity in COVID-19 induced by the trivalent Measles-Mumps-Rubella and Tetanus-Diptheria-Pertussis vaccine antigens: Med
08/13 Transmission dynamics and epidemiological characteristics of Delta variant infections in China | medRxiv
08/13 Rapid genome sequencing in hospitals to identify potential vaccine-escape SARS-CoV-2 variants - The Lancet Infectious Diseases
08/14 Delta variant and mRNA Covid-19 vaccines effectiveness: higher odds of vaccine infection breakthroughs | medRxiv
08/16 Association of Vaccine Type and Prior SARS-CoV-2 Infection With Symptoms and Antibody Measurements Following Vaccination Among Health Care Workers | Infectious Diseases | JAMA Internal Medicine | JAMA Network
08/16 Association of Age and Pediatric Household Transmission of SARS-CoV-2 Infection | Infectious Diseases | JAMA Pediatrics | JAMA Network
08/16 Vaccine nationalism and the dynamics and control of SARS-CoV-2 | Science
08/16 A vaccine-induced public antibody protects against SARS-CoV-2 and emerging variants: Immunity
08/17 Membrane fusion and immune evasion by the spike protein of SARS-CoV-2 Delta variant | bioRxiv
08/17 Live Imaging of SARS-CoV-2 Infection in Mice Reveals that Neutralizing Antibodies Require Fc Function for Optimal Efficacy: Immunity
08/17 SARS-CoV-2 aerosol transmission in schools: the effectiveness of different interventions | medRxiv
08/17 No evidence of human genome integration of SARS-CoV-2 found by long-read DNA sequencing - ScienceDirect
08/17 SARS-CoV-2 delta variant neutralisation after heterologous ChAdOx1-S/BNT162b2 vaccination - The Lancet
08/17 Early Release - Real-Time Genomics for Tracking Severe Acute Respiratory Syndrome Coronavirus 2 Border Incursions after Virus Elimination, New Zealand - Volume 27, Number 9—September 2021 - Emerging Infectious Diseases journal - CDC
08/18 The Origins of SARS-CoV-2: A Critical Review: Cell
08/18 A third COVID-19 vaccine shot markedly boosts neutralizing antibody potency and breadth | medRxiv
08/18 Pre-activated antiviral innate immunity in the upper airways controls early SARS-CoV-2 infection in children | Nature Biotechnology
08/18 Early Convalescent Plasma for High-Risk Outpatients with Covid-19 | NEJM
08/18 Pan-Sarbecovirus Neutralizing Antibodies in BNT162b2-Immunized SARS-CoV-1 Survivors | NEJM
08/19 Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths | Science Immunology
08/19 Large-scale study of antibody titer decay following BNT162b2 mRNA vaccine or SARS-CoV-2 infection | medRxiv
08/19 A glycan gate controls opening of the SARS-CoV-2 spike protein | Nature Chemistry
08/22 The SARS-CoV-2 Delta variant is poised to acquire complete resistance to wild-type spike vaccines | bioRxiv
08/22 The neutralization potency of anti-SARS-CoV-2 therapeutic human monoclonal antibodies is retained against viral variants: Cell Reports
08/23 COVID-19 Transmission Dynamics Among Close Contacts of Index Patients With COVID-19: A Population-Based Cohort Study in Zhejiang Province, China | Global Health | JAMA Internal Medicine | JAMA Network
08/23 Six-Month Effectiveness of BNT162B2 mRNA COVID-19 Vaccine in a Large US Integrated Health System: A Retrospective Cohort Study by Sara Y. Tartof, Jeff M. Slezak, Heidi Fischer, Vennis Hong, Bradley K. Ackerson, Omesh N. Ranasinghe, Timothy B. Frankland, O
08/23 Six-Month Effectiveness of BNT162B2 mRNA COVID-19 Vaccine in a Large US Integrated Health System: A Retrospective Cohort Study by Sara Y. Tartof, Jeff M. Slezak, Heidi Fischer, Vennis Hong, Bradley K. Ackerson, Omesh N. Ranasinghe, Timothy B. Frankland, Oluwaseye A. Ogun, Joann M. Zamparo, Sharon Gray, Srinivas R. Valluri, Kaijie Pan, Frederick J. Angulo, Luis Jodar, John M. McLaughlin :: SSRN
08/23 Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19 | Science Translational Medicine
08/23 mRNA Vaccination Induces Durable Immune Memory to SARS-CoV-2 with Continued Evolution to Variants of Concern | bioRxiv
08/24 Redox imbalance links COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome | PNAS
08/24 Asymptomatic SARS-CoV-2 infection: A systematic review and meta-analysis | PNAS
08/24 Morbidity and mortality from COVID-19 post-vaccination breakthrough infections in association with vaccines and the emergence of variants in Bahrain | Research Square
08/25 Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity: reinfections versus breakthrough infections | medRxiv
08/25 mRNA vaccines for infectious diseases: principles, delivery and clinical translation | Nature Reviews Drug Discovery
08/26 SARS-CoV-2 identified by transmission electron microscopy in lymphoproliferative and ischaemic intestinal lesions of COVID-19 patients with acute abdominal pain: two case reports | BMC Gastroenterology
08/26 The continuous evolution of SARS-CoV-2 in South Africa: a new lineage with rapid accumulation of mutations of concern and global detection | medRxiv
08/26 Durability of antibody responses elicited by a single dose of Ad26.COV2.S and substantial increase following late boosting | medRxiv
08/26 Long-term immunogenicity of BNT162b2 vaccination in the elderly and in younger health care workers | medRxiv
08/26 Burden and characteristics of COVID-19 in the United States during 2020 | Nature
08/26 CoronaVac induces lower neutralising activity against variants of concern than natural infection - The Lancet Infectious Diseases
08/27 Waning of BNT162b2 vaccine protection against SARS-CoV-2 infection in Qatar | medRxiv
08/27 Geometric deep learning of RNA structure - Science
08/27 Piercing the fog of the RNA structure-ome - Science
08/27 Importance of epidemiological factors in the evaluation of transmissibility and clinical severity of SARS-CoV-2 variants - The Lancet Infectious Diseases
08/27 Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study - The Lancet Infectious Diseases
08/27 COVID-19 and immune-mediated inflammatory diseases: effect of disease and treatment on COVID-19 outcomes and vaccine responses - The Lancet Rheumatology
08/28 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study - The Lancet
08/29 COVID-19-associated hospitalizations among vaccinated and unvaccinated adults ≥18 years – COVID-NET, 13 states, January 1 – July 24, 2021 | medRxiv
08/29 Effect of Salt Substitution on Cardiovascular Events and Death | NEJM
08/30 Comparison of SARS-CoV-2 Antibody Response Following Vaccination With BNT162b2 and mRNA-1273 | Vaccination | JAMA | JAMA Network
08/30 Durability of Spike Immunoglobin G Antibodies to SARS-CoV-2 Among Health Care Workers With Prior Infection | Infectious Diseases | JAMA Network Open | JAMA Network
08/30 Intramuscular SARS-CoV-2 vaccines elicit varying degrees of plasma and salivary antibody responses as compared to natural infection | medRxiv
08/30 Durability of antibody response to vaccination and surrogate neutralization of emerging variants based on SARS-CoV-2 exposure history | Scientific Reports
08/31 Prevalence of Allergic Reactions After Pfizer-BioNTech COVID-19 Vaccination Among Adults With High Allergy Risk | Allergy and Clinical Immunology | JAMA Network Open | JAMA Network
08/31 Epistasis at the SARS-CoV-2 RBD Interface and the Propitiously Boring Implications for Vaccine Escape | bioRxiv
08/31 Hybrid immunity versus vaccine-induced immunity against SARS CoV2 in Patients with Autoimmune Rheumatic Diseases | medRxiv
08/31 Short Term Reduction in the Odds of Testing Positive for SARS-CoV-2; a Comparison Between Two Doses and Three doses of the BNT162b2 Vaccine | medRxiv
08/31 Intensity and frequency of extreme novel epidemics | PNAS
08/31 Systemic COVID-19 vaccination also enhances the humoral immune response after SARS CoV-2 infection. An approach to criteria for COVID-19 re-immunization is needed. Do we need a third dose? | Research Square
08/31 Cross-reactive CD4+ T cells enhance SARS-CoV-2 immune responses upon infection and vaccination - Science
September 2021
09/01 Kidney Outcomes in Long COVID | American Society of Nephrology
09/01 Viral loads of Delta-variant SARS-CoV2 breakthrough infections following vaccination and booster with the BNT162b2 vaccine | medRxiv
09/01 Resurgence of SARS-CoV-2 Infection in a Highly Vaccinated Health System Workforce | NEJM
09/01 Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002) - The Lancet
09/01 Longer intervals and extra doses of ChAdOx1 nCoV-19 vaccine - The Lancet
09/01 Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study - The Lancet Infectious Diseases
09/01 Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial - The Lancet Respiratory Medicine
09/01 Baricitinib: the first immunomodulatory treatment to reduce COVID-19 mortality in a placebo-controlled trial - The Lancet Respiratory Medicine
09/02 Comparison of SARS-CoV-2 Antibody Response by Age Among Recipients of the BNT162b2 vs the mRNA-1273 Vaccine | Infectious Diseases | JAMA Network Open | JAMA Network
09/02 Real-World Effectiveness of the mRNA-1273 Vaccine Against COVID-19: Interim Results from a Prospective Observational Cohort Study by Katia Bruxvoort, Lina S. Sy, Lei Qian, Bradley K. Ackerson, Yi Luo, Gina S. Lee, Yun Tian, Ana Florea, Harpreet S. Takhar, Julia E. Tubert, Carla A. Talarico, Hung Fu Tseng :: SSRN
09/02 Use of artificial intelligence for image analysis in breast cancer screening programmes: systematic review of test accuracy | The BMJ
09/02 Longitudinal analysis of SARS-CoV-2 vaccine breakthrough infections reveal limited infectious virus shedding and restricted tissue distribution | medRxiv
09/02 Adaptive immune determinants of viral clearance and protection in mouse models of SARS-CoV-2 - Science
09/03 Emerging SARS-CoV-2 variants of concern evade humoral immune responses from infection and vaccination - Science
09/03 Hospitalisation associated with SARS-CoV-2 delta variant in Denmark - The Lancet Infectious Diseases
09/05 No difference in risk of hospitalisation between reported cases of the SARS-CoV-2 Delta variant and Alpha variant in Norway | medRxiv
09/06 The emergence and ongoing convergent evolution of the SARS-CoV-2 N501Y lineages: Cell
09/07 Ineffective neutralization of the SARS-CoV-2 Mu variant by convalescent and vaccine sera | bioRxiv
09/07 Effectiveness of the mRNA BNT162b2 vaccine six months after vaccination: findings from a large Israeli HMO | medRxiv
09/07 The prevalence of adaptive immunity to COVID-19 and reinfection after recovery – a comprehensive systematic review and meta-analysis of 12 011 447 individuals | medRxiv
09/07 Durability analysis of the highly effective BNT162b2 vaccine against COVID-19 | medRxiv
09/07 Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in pregnancy | Nature Medicine
09/07 Assessment of Aerosol Generating Events During the Nasopharyngeal Swabbing for SARS-CoV-2 Detection | Research Square
09/07 Hospitalisation among vaccine breakthrough COVID-19 infections - The Lancet Infectious Diseases
09/08 Effect of Vaccination on Transmission of SARS-CoV-2 | NEJM
09/09 Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial | Nature Medicine
09/09 Early cross-coronavirus reactive signatures of humoral immunity against COVID-19 - Science
09/09 Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study - The Lancet Infectious Diseases
09/10 Breathing more breadth into COVID-19 T cell responses: Med
09/13 Considerations in boosting COVID-19 vaccine immune responses - The Lancet
09/14 BNT162b2-Elicited Neutralization of Delta Plus, Lambda, and Other Variants | bioRxiv
09/14 A strategy to assess spillover risk of bat SARS-related coronaviruses in Southeast Asia | medRxiv
09/14 Antibody responses to BNT162b2 mRNA vaccine: infection-naïve individuals with abdominal obesity warrant attention | medRxiv
09/14 Short-range exposure to airborne virus transmission and current guidelines | PNAS
09/14 Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells - Science
09/14 Identification of resident memory CD8+ T cells with functional specificity for SARS-CoV-2 in unexposed oropharyngeal lymphoid tissue - Science
09/14 Daily testing for contacts of individuals with SARS-CoV-2 infection and attendance and SARS-CoV-2 transmission in English secondary schools and colleges: an open-label, cluster-randomised trial - The Lancet
09/14 Daily antigen testing to reduce disruption when schools return - The Lancet
09/14 Prevention of host-to-host transmission by SARS-CoV-2 vaccines - The Lancet Infectious Diseases
09/15 Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2: Cell Metabolism
09/15 Efficacy of vaccination against severe COVID-19 in relation to Delta variant and time since second dose: the REACT-SCOT case-control study | medRxiv
09/16 Association of Nursing Home Characteristics With Staff and Resident COVID-19 Vaccination Coverage | Geriatrics | JAMA Internal Medicine | JAMA Network
09/17 The biological and clinical significance of emerging SARS-CoV-2 variants | Nature Reviews Genetics
09/17 Coronaviruses with a SARS-CoV-2-like receptor-binding domain allowing ACE2-mediated entry into human cells isolated from bats of Indochinese peninsula | Research Square
09/17 Of bats and men: Immunomodulatory treatment options for COVID-19 guided by the immunopathology of SARS-CoV-2 infection - Science
09/20 mRNA vaccination of naive and COVID-19-recovered individuals elicits potent memory B cells that recognize SARS-CoV-2 variants: Immunity
09/20 Quantitative measurement of infectious virus in SARS-CoV-2 Alpha, Delta and Epsilon variants reveals higher infectivity (viral titer:RNA ratio) in clinical samples containing the Delta and Epsilon variants | medRxiv
09/20 EFFICACY OF THE MEASLES-MUMPS-RUBELLA (MMR) VACCINE IN THE REDUCING THE SEVERITY OF COVID-19: AN INTERIM ANALYSIS OF A RANDOMISED CONTROLLED CLINICAL TRIAL | medRxiv
09/21 Measuring the COVID-19 Mortality Burden in the United States: A Microsimulation Study: Annals of Internal Medicine: Vol 0, No 0
09/21 Strong humoral immune responses against SARS-CoV-2 Spike after BNT162b2 mRNA vaccination with a sixteen-week interval between doses | medRxiv
09/22 mRNA-1273 vaccine (Moderna): a better option than BNT162b2 (Pfizer) in kidney transplant recipients and dialysis patients? | medRxiv
09/22 The removal of airborne SARS-CoV-2 and other microbial bioaerosols by air filtration on COVID-19 surge units | medRxiv
09/22 Covid-19 in the Phase 3 Trial of mRNA-1273 During the Delta-variant Surge | medRxiv
09/22 Effectiveness of mRNA Covid-19 Vaccine among U.S. Health Care Personnel | NEJM
09/22 Infections, hospitalisations, and deaths averted via a nationwide vaccination campaign using the Pfizer–BioNTech BNT162b2 mRNA COVID-19 vaccine in Israel: a retrospective surveillance study - The Lancet Infectious Diseases
09/24 High-affinity memory B cells induced by SARS-CoV-2 infection produce more plasmablasts and atypical memory B cells than those primed by mRNA vaccines: Cell Reports
09/24 mRNA COVID-19 Vaccination and Development of CMR-confirmed Myopericarditis | medRxiv
09/26 Quantifying impacts of the COVID-19 pandemic through life-expectancy losses: a population-level study of 29 countries | International Journal of Epidemiology | Oxford Academic
09/26 COVID-19 Vaccine Breakthrough Infections in Veterans Health Administration | medRxiv
09/27 Determinants of SARS-CoV-2 entry and replication in airway mucosal tissue and susceptibility in smokers: Cell Reports Medicine
09/27 Effectiveness of BNT162b2 Vaccine in Adolescents during Outbreak of SARS-CoV-2 Delta Variant Infection, Israel, 2021 - Volume 27, Number 11—November 2021 - Emerging Infectious Diseases journal - CDC
09/28 Identifying and prioritizing potential human-infecting viruses from their genome sequences - PLoS
09/28 Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19 - PLoS
09/28 Four SARS-CoV-2 vaccines induce quantitatively different antibody responses against SARS-CoV-2 variants | medRxiv
09/28 A prenylated dsRNA sensor protects against severe COVID-19 - Science
09/29 Efficacy of COVID-19 Vaccination on the Symptoms of Patients With Long COVID: A Target Trial Emulation Using Data From the ComPaRe e-Cohort in France by Viet-Thi Tran, Elodie Perrodeau, Julia Saldanha, Isabelle Pane, Philippe Ravaud :: SSRN
09/29 No Significant Difference in Viral Load Between Vaccinated and Unvaccinated, Asymptomatic and Symptomatic Groups Infected with SARS-CoV-2 Delta Variant | medRxiv
09/29 Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine | NEJM
09/30 Durability of immune responses to the BNT162b2 mRNA vaccine | bioRxiv
09/30 Eurosurveillance | Nosocomial outbreak caused by the SARS-CoV-2 Delta variant in a highly vaccinated population, Israel, July 2021
09/30 The origins of viruses: discovery takes time, international resources, and cooperation - The Lancet
October 2021
10/01 SARS-CoV-2 infections elicit higher levels of original antigenic sin antibodies compared to SARS-CoV-2 mRNA vaccinations | medRxiv
10/01 The durability of immunity against reinfection by SARS-CoV-2: a comparative evolutionary study - The Lancet Microbe
10/02 What data can reveal and conceal - The Lancet
10/03 Recombinant adjuvanted zoster vaccine and reduced risk of COVID-19 diagnosis and hospitalization in older adults | medRxiv
10/04 Acute Myocarditis Following COVID-19 mRNA Vaccination in Adults Aged 18 Years or Older | Cardiology | JAMA Internal Medicine | JAMA Network
10/04 Frequency of surveillance testing necessary to reduce transmission of SARS-CoV-2 | medRxiv
10/04 Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study - The Lancet
10/04 COVID-19 and metabolic disease: mechanisms and clinical management - The Lancet Diabetes & Endocrinology
10/05 Type I interferon response and vascular alteration in chilblain‐like lesions during the COVID‐19 outbreak - Frumholtz - - British Journal of Dermatology - Wiley Online Library
10/05 Association of Vaccination With the Persistence of Post-COVID Symptoms by Juan P. Wisnivesky, Usha Govindarajulu, Emilia Bagiella, Ruchir Goswami, Minal Kale, Kirk N. Campbell, Kristin Meliambro, Zijian Chen, Judith A. Aberg, Jenny J. Lin :: SSRN
10/05 Racial and Ethnic Disparities in Excess Deaths During the COVID-19 Pandemic, March to December 2020 | Annals of Internal Medicine
10/05 One-year Risks and Burdens of Incident Cardiovascular Disease in COVID-19: Cardiovascular Manifestations of Long COVID | Research Square
10/06 Coverage and Estimated Effectiveness of mRNA COVID-19 Vaccines Among US Veterans | Infectious Diseases | JAMA Network Open | JAMA Network
10/06 Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar | NEJM
10/06 Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months | NEJM
10/07 genetic link between risk for Alzheimer's disease and severe COVID-19 outcomes via the OAS1 gene | Brain | Oxford Academic
10/07 Protection Across Age Groups of BNT162b2 Vaccine Booster against Covid-19 | medRxiv
10/07 Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings | NEJM
10/07 Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel | NEJM
10/07 Can high SARS-CoV-2 adult vaccination rates help protect unvaccinated children? Evidence from a unique rapid mass vaccination campaign | Research Square
10/07 Implications of suboptimal COVID-19 vaccination coverage in Florida and Texas - The Lancet Infectious Diseases
10/08 Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic - The Lancet
10/09 COVID-19 Vaccine Effectiveness by Product and Timing in New York State | medRxiv
10/10 Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico | medRxiv
10/11 Association Between Risk of COVID-19 Infection in Nonimmune Individuals and COVID-19 Immunity in Their Family Members | Infectious Diseases | JAMA Internal Medicine | JAMA Network
10/11 Transmission of SARS-CoV-2 Delta Variant Among Vaccinated Healthcare Workers, Vietnam by Nguyen Van Vinh Chau, Nghiem My Ngoc, Lam Anh Nguyet, Vo Minh Quang, Nguyen Thi Han Ny, Dao Bach Khoa, Nguyen Thanh Phong, Le Mau Toan, Nguyen Thi Thu Hong, Nguyen Thi Kim Tuyen, Voong Vinh Phat, Le Nguyen Truc Nhu, Nguyen Huynh Thanh Truc, Bui Thi Ton That, Huynh Phuong Thao, Tran Nguyen Phuong Thao, Vo Trong Vuong, Tran Thi Thanh Tam, Ngo Tan Tai, Ho The Bao, Huynh Thi Kim Nhung, Nguyen Thi Ngoc Minh, Nguyen Thi My Tien, Nguy Cam Huy, Marc Choisy, Dinh Nguyen Huy Man, Dinh Thi Bich Ty, Nguyen To Anh, Le Thi Tam Uyen, Tran Nguyen Hoang Tu, Lam Minh Yen, Nguyen Thanh Dung, Le Manh Hung, Nguyen Thanh Truong, Tran Tan Thanh, Guy Thwaites, Le Van Tan, OUCRU COVID-19 Research Group :: SSRN
10/11 Putative host origins of RNA insertions in SARS-CoV-2 genomes - SARS-CoV-2 coronavirus - Virological
10/11 Immunity to SARS-CoV-2 up to 15 months after infection | bioRxiv
10/11 Direct Comparison of Antibody Responses to Four SARS-CoV-2 Vaccines in Mongolia: Cell Host & Microbe
10/11 Immunogenicity of a BNT162b2 vaccine booster in health-care workers - The Lancet Microbe
10/12 Prior infection with SARS-CoV-2 boosts and broadens Ad26.COV2.S immunogenicity in a variant-dependent manner: Cell Host & Microbe
10/13 Short-term and Long-term Rates of Postacute Sequelae of SARS-CoV-2 Infection: A Systematic Review | Infectious Diseases | JAMA Network Open | JAMA Network
10/13 Heterologous SARS-CoV-2 Booster Vaccinations – Preliminary Report | medRxiv
10/14 HMG-CoA reductase inhibitors and COVID-19 mortality in Stockholm, Sweden: A registry-based cohort study - PLoS
10/14 One-shot immunization with Sputnik Light (the first component of Sputnik V vaccine) is effective against SARS-CoV-2 Delta variant: efficacy data on the use of the vaccine in civil circulation in Moscow | medRxiv
10/14 Breakthrough SARS-CoV-2 infections in 620,000 U.S. Veterans, February 1, 2021 to August 13, 2021 | medRxiv
10/14 Vaccine effectiveness against SARS-CoV-2 transmission to household contacts during dominance of Delta variant (B.1.617.2), August-September 2021, the Netherlands | medRxiv
10/14 Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK | Nature Medicine
10/14 Genomic characterization and epidemiology of an emerging SARS-CoV-2 variant in Delhi, India - Science
10/14 mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern - Science
10/15 COVID-19 mRNA Based Vaccine Immune-Response Assessment for Public Health Decision by David San Segundo, Alejandra Comins, Patricia Lamadrid, Juan Irure, José María Castillo, Reinhard Wallmann, Jorge Calvo, Carmela Baamonde, Isabel Sanchez Molina, Marina Lecue, Silvia Ventisca, Marcos Lopez-Hoyos :: SSRN
10/15 Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine: Cell
10/15 SARS-CoV-2 vaccine breakthrough infections with the alpha variant are asymptomatic or mildly symptomatic among health care workers | Nature Communications
10/17 Effectiveness of heterologous ChAdOx1 nCoV-19 and mRNA prime-boost vaccination against symptomatic Covid-19 infection in Sweden: A nationwide cohort study - The Lancet Regional Health – Europe
10/18 Comparative effectiveness of ChAdOx1 versus BNT162b2 COVID-19 vaccines in Health and Social Care workers in England: a cohort study using OpenSAFELY | medRxiv
10/18 Time-varying effectiveness of the mRNA-1273, BNT162b2 and Ad26.COV2.S vaccines against SARS-CoV-2 infections and COVID-19 hospitalizations and deaths: an analysis based on observational data from Puerto Rico | medRxiv
10/18 Long-term consequences of the misuse of ivermectin data - The Lancet Infectious Diseases
10/18 Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial - The Lancet Respiratory Medicine
10/19 Asymptomatic SARS-CoV-2 Vaccine Breakthrough Infections in Health Care Workers Identified Through Routine Universal Surveillance Testing | Annals of Internal Medicine
10/19 Asymptomatic SARS-CoV-2 Vaccine Breakthrough Infections in Health Care Workers Identified Through Routine Universal Surveillance Testing | Annals of Internal Medicine
10/19 Impact of SARS-CoV-2 infection on longitudinal vaccine immune responses | medRxiv
10/19 The association of opening K–12 schools with the spread of COVID-19 in the United States: County-level panel data analysis | PNAS
10/19 Computational prediction of the effect of amino acid changes on the binding affinity between SARS-CoV-2 spike RBD and human ACE2 | PNAS
10/19 Pregnancy influences immune responses to SARS-CoV-2 - Science
10/20 Airborne transmission of SARS-CoV-2 over distances greater than two metres: a rapid systematic review | medRxiv
10/20 Evidence of transmission from fully vaccinated individuals in a large outbreak of the SARS-CoV-2 Delta variant in Provincetown, Massachusetts | medRxiv
10/21 Environmental contamination with SARS‐CoV‐2 in nursing homes - Mody - - Journal of the American Geriatrics Society - Wiley Online Library
10/21 The SARS-CoV-2 main protease Mpro causes microvascular brain pathology by cleaving NEMO in brain endothelial cells | Nature Neuroscience
10/21 Does infection with or vaccination against SARS-CoV-2 lead to lasting immunity? - The Lancet Respiratory Medicine
10/22 Incidence of SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential Workers During a Prevaccination COVID-19 Surge in Arizona | JAMA Health Forum | JAMA Network
10/22 Assessment of Cognitive Function in Patients After COVID-19 Infection | Dementia and Cognitive Impairment | JAMA Network Open | JAMA Network
10/22 Post COVID-19 in children, adolescents, and adults: results of a matched cohort study including more than 150,000 individuals with COVID-19 | medRxiv
10/23 Virology, transmission, and pathogenesis of SARS-CoV-2 | The BMJ
10/24 Protection from SARS-CoV-2 Delta one year after mRNA-1273 vaccination in nonhuman primates is coincident with an anamnestic antibody response in the lower airway | bioRxiv
10/25 Anti–SARS-CoV-2 and Autoantibody Profiles in the Cerebrospinal Fluid of 3 Teenaged Patients With COVID-19 and Subacute Neuropsychiatric Symptoms | Neurology | JAMA Neurology | JAMA Network
10/25 Evaluation of the relative virulence of novel SARS-CoV-2 variants: a retrospective cohort study in Ontario, Canada | CMAJ
10/25 Ivermectin for COVID-19: addressing potential bias and medical fraud | Research Square
10/26 Effectiveness of BNT162b2 mRNA COVID-19 vaccine against acquisitions of SARS-CoV-2 among health care workers in long-term care facilities: a prospective cohort study | Clinical Infectious Diseases | Oxford Academic
10/26 Weekly SARS-CoV-2 screening of asymptomatic kindergarten to grade 12 students and staff helps inform strategies for safer in-person learning: Cell Reports Medicine
10/26 Third doses of COVID-19 vaccines reduce infection and transmission of SARS-CoV-2 and could prevent future surges in some populations | medRxiv
10/26 Six-month sequelae of post-vaccination SARS-CoV-2 infection: a retrospective cohort study of 10,024 breakthrough infections | medRxiv
10/26 Membrane fusion and immune evasion by the spike protein of SARS-CoV-2 Delta variant - Science
10/26 Identification of driver genes for critical forms of COVID-19 in a deeply phenotyped young patient cohort - Science
10/27 Invincibility threatens vaccination intentions during a pandemic - PLoS
10/27 COVCOG 1: Factors predicting Cognitive Symptoms in Long COVID. A First Publication from the COVID and Cognition Study | medRxiv
10/27 The impact of school opening model on SARS-CoV-2 community incidence and mortality | Nature Medicine
10/27 No causal effect of school closures in Japan on the spread of COVID-19 in spring 2020 | Nature Medicine
10/27 Functional antibody and T cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study | Nature Cancer
10/27 Adverse Effects after BNT162b2 Vaccine and SARS-CoV-2 Infection, According to Age and Sex | NEJM
10/27 Waning Immunity after the BNT162b2 Vaccine in Israel | NEJM
10/27 Comment on “Genomic epidemiology of superspreading events in Austria reveals mutational dynamics and transmission properties of SARS-CoV-2” - Science
10/27 Household transmission of COVID-19 cases associated with SARS-CoV-2 delta variant (B.1.617.2): national case-control study - The Lancet Regional Health – Europe
10/27 Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial - The Lancet Global Health
10/28 Age-Varying Susceptibility to the Delta Variant (B.1.617.2) of SARS-CoV-2 by June Young Chun, Hwichang Jeong, Yongdai Kim :: SSRN
10/28 Differential dynamics of peripheral immune responses to acute SARS-CoV-2 infection in older adults | Nature Aging
10/28 Characteristics and risk of COVID-19-related death in fully vaccinated people in Scotland - The Lancet
10/28 COVID-19 vaccination in patients with multiple myeloma: a consensus of the European Myeloma Network - The Lancet Haematology
10/29 Anti-spike antibody response to natural SARS-CoV-2 infection in the general population | Nature Communications
10/29 Evaluating and Deploying Covid-19 Vaccines — The Importance of Transparency, Scientific Integrity, and Public Trust | NEJM
10/29 Complete protection by a single-dose skin patch–delivered SARS-CoV-2 spike vaccine - Science
10/29 Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study - ScienceDirect
10/29 Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study - The Lancet
10/29 Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study - The Lancet Infectious Diseases
November 2021
11/01 Association of Prior SARS-CoV-2 Infection With Risk of Breakthrough Infection Following mRNA Vaccination in Qatar | Infectious Diseases | JAMA | JAMA Network
11/01 Durability of Antibody Levels After Vaccination With mRNA SARS-CoV-2 Vaccine in Individuals With or Without Prior Infection | Infectious Diseases | JAMA | JAMA Network
11/01 High anti-SARS-CoV-2 antibody seroconversion rates before the second wave in Manaus, Brazil, and the protective effect of social behaviour measures: results from the prospective DETECTCoV-19 cohort - The Lancet Global Health
11/02 Visualizing in deceased COVID-19 patients how SARS-CoV-2 attacks the respiratory and olfactory mucosae but spares the olfactory bulb: Cell
11/02 An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19 - Science
11/02 Exponential growth, high prevalence of SARS-CoV-2, and vaccine effectiveness associated with the Delta variant - Science
11/02 BNT162b2 vaccination induces durable SARS-CoV-2 specific T cells with a stem cell memory phenotype - Science
11/02 A broadly cross-reactive antibody neutralizes and protects against sarbecovirus challenge in mice - Science
11/02 Has Spain reached herd immunity? - The Lancet Respiratory Medicine
11/03 Effects of covid-19 pandemic on life expectancy and premature mortality in 2020: time series analysis in 37 countries | The BMJ
11/03 Phase 3 Trial of mRNA-1273 during the Delta-Variant Surge | NEJM
11/04 Identification of LZTFL1 as a candidate effector gene at a COVID-19 risk locus | Nature Genetics
11/04 Prevention of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines | NEJM
11/04 Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months | NEJM
11/04 Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase | NEJM
11/04 Rapid assessment of SARS-CoV-2 evolved variants using virus-like particles - Science
11/04 SARS-CoV-2 vaccine protection and deaths among US veterans during 2021 - Science
11/08 A need of COVID19 vaccination for children aged < 12 years: Comparative evidence from the clinical characteristics in patients during a recent Delta surge (B.1.617.2)| medRxiv
11/09 Current Insights Into Respiratory Virus Transmission and Potential Implications for Infection Control Programs: A Narrative Review: Annals of Internal Medicine: Vol 0, No 0
11/09 Identification of a therapeutic interfering particle—A single-dose SARS-CoV-2 antiviral intervention with a high barrier to resistance: Cell
11/09 IJMS | Free Full-Text | SARS-CoV-2 Variants, RBD Mutations, Binding Affinity, and Antibody Escape - IJMS
11/09 Waning of SARS-CoV-2 antibodies targeting the Spike protein in individuals post second dose of ChAdOx1 and BNT162b2 COVID-19 vaccines and risk of breakthrough infections: analysis of the Virus Watch community cohort | medRxiv
11/09 A novel SARS-CoV-2 related coronavirus in bats from Cambodia | Nature Communications
11/09 Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age | NEJM
11/09 SARS-CoV-2 indoor air transmission is a threat that can be addressed with science | PNAS
11/09 Molecular basis of immune evasion by the Delta and Kappa SARS-CoV-2 variants - Science
11/09 T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort study - The Lancet Microbe
11/10 Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant | NEJM
11/11 COVID-19 convalescents exhibit deficient humoral and T cell responses to variant of concern Spike antigens at 12 month post-infection | medRxiv
11/11 Deaths in children and young people in England after SARS-CoV-2 infection during the first pandemic year | Nature Medicine
11/11 100,000 Genomes Pilot on Rare-Disease Diagnosis in Health Care — Preliminary Report | NEJM
11/11 Inactivated SARS-CoV-2 vaccine (BBV152)-induced protection against symptomatic COVID-19 - The Lancet
11/12 An outbreak of SARS-CoV-2 with high mortality in mink (Neovison vison) on multiple Utah farms - PLoS
11/12 Total virome characterizations of game animals in China reveals a spectrum of emerging viral pathogens | bioRxiv
11/14 Using high-resolution contact networks to evaluate SARS-CoV-2 transmission and control in large-scale multi-day events | medRxiv
11/15 Infection, recovery and re-infection of farmed mink with SARS-CoV-2 - PLoS
11/15 From Online Data Collection to Identification of Disease Mechanisms: The IL-1ß, IL-6 and TNF-α Cytokine Triad Is Associated With Post-Acute Sequelae of COVID-19 in a Digital Research Cohort by Christoph Schultheiß, Edith Willscher, Lisa Paschold, Cornelia Gottschick, Bianca Klee, Saskia Glasauer, Svenja-Sibylla Henkes, Lidia Bosurgi, Jochen Dutzmann, Daniel G. Sedding, Thomas Frese, Matthias Girndt, Jessica I. Höll, Michael Gekle, Rafael Mikolajczyk, Mascha Binder :: SSRN
11/15 Long Covid after Breakthrough COVID-19: the post-acute sequelae of breakthrough COVID-19 | Research Square
11/15 Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis - The Lancet Microbe
11/16 Global Prevalence of Post-Acute Sequelae of COVID-19 (PASC) or Long COVID: A Meta-Analysis and Systematic Review | medRxiv
11/17 Evaluating the potential for respiratory metagenomics to improve treatment of secondary infection and detection of nosocomial transmission on expanded COVID-19 intensive care units | Genome Medicine | Full Text
11/17 SARS-CoV-2 Antibodies in Children: A One-Year Seroprevalence Study From June 2020 to May 2021 in Germany by Anna-Lisa Sorg, Leon Bergfeld, Marietta Jank, Victor M. Corman, Ilia Semmler, Anna Görtz, Andreas Beyerlein, Eva Verjans, Norbert Wagner, Horst von Bernuth, Fabian Lander, Katharina Weil, Markus Hufnagel, Ute Spiekerkoetter, Chao Cho-Ming, Lutz Nährlich, Ania C. Muntau, Ulf Schulze-Sturm, Gesine Hansen, Martin Wetzke, Anna-Maria Jung, Tim Niehues, Susanne Fricke-Otto, Ulrich von Both, Johannes Hübner, Uta Behrends, Johannes G. Liese, Christian Schwerk, Christian Drosten, Rüdiger von Kries, Horst Schroten :: SSRN
11/17 Impact of SARS-CoV-2 Vaccines on Covid-19 Incidence and Mortality in the United States | medRxiv
11/17 Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trial - The Lancet Respiratory Medicine
11/18 Growing Public Health Concern of COVID-19 Chronic Olfactory Dysfunction | Public Health | JAMA Otolaryngology–Head & Neck Surgery | JAMA Network
11/18 Duration of Effectiveness of Vaccines Against SARS-CoV-2 Infection and COVID-19 Disease: Results of a Systematic Review and Meta-Regression by Daniel Feikin, Melissa M. Higdon, Laith J. Abu-Raddad, Nick Andrews, Rafael Araos, Yair Goldberg, Michelle Groome, Amit Huppert, Katherine O'Brien, Peter G. Smith, Annelies Wilder-Smith, Scott L Zeger, Maria D. Knoll, Minal Patel :: SSRN
11/18 Effectiveness of public health measures in reducing the incidence of covid-19, SARS-CoV-2 transmission, and covid-19 mortality: systematic review and meta-analysis | The BMJ
11/18 Covid-19 Vaccination during Pregnancy and First-Trimester Miscarriage | NEJM
11/18 Differential Kinetics of Immune Responses Elicited by Covid-19 Vaccines | NEJM
11/18 COVID-19 targets human adrenal glands - The Lancet Diabetes & Endocrinology
11/19 Changes in SARS-CoV-2 viral load and mortality during the initial wave of the pandemic in New York City - PLoS
11/19 Transmission potential of vaccinated and unvaccinated persons infected with the SARS-CoV-2 Delta variant in a federal prison, July—August 2021 | medRxiv
11/21 Antibody titers before and after booster doses of SARS-CoV-2 mRNA vaccines in healthy adults | medRxiv
11/22 Understanding and tracking the impact of long COVID in the United Kingdom | Nature Medicine
11/23 Estimates of the stochasticity of droplet dispersion by a cough: Physics of Fluids: Vol 33, No 11
11/23 Risks of SARS-CoV-2 Breakthrough Infection and Hospitalization in Fully Vaccinated Patients With Multiple Myeloma | Hematology | JAMA Network Open | JAMA Network
11/23 Prevalence and determinants of healthcare avoidance during the COVID-19 pandemic: A population-based cross-sectional study - PLOS
11/23 Adaptation, spread and transmission of SARS-CoV-2 in farmed minks and associated humans in the Netherlands | Nature Communications
11/23 Plastic waste release caused by COVID-19 and its fate in the global ocean | PNAS
11/23 Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial - Science
11/23 Effectiveness of an inactivated virus-based SARS-CoV-2 vaccine, BBV152, in India: a test-negative, case-control study - The Lancet Infectious Diseases
11/24 Severity of SARS-CoV-2 Reinfections as Compared with Primary Infections | NEJM
11/25 Elapsed time since BNT162b2 vaccine and risk of SARS-CoV-2 infection: test negative design study | The BMJ
11/25 Effectiveness of BNT162b2 Vaccine against Delta Variant in Adolescents | NEJM
11/26 Germany’s current COVID-19 crisis is mainly driven by the unvaccinated | medRxiv
11/29 COVID-19 in Africa: Catalyzing change for sustainable development - PLOS
11/29 Real-time alerting system for COVID-19 and other stress events using wearable data | Nature Medicine
11/30 Report on Omicron Spike mutations on epitopes and immunological/epidemiological/kinetics effects from literature - nCoV-2019 Genomic Epidemiology - Virological
11/30 Main protease mutants of SARS-CoV-2 variants remain susceptible to PF-07321332 | bioRxiv
11/30 Nanometer-resolution in situ structure of the SARS-CoV-2 postfusion spike protein | PNAS
11/30 Risk of COVID-19 hospital admission among children aged 5–17 years with asthma in Scotland: a national incident cohort study - The Lancet Respiratory Medicine
December 2021
12/01 Diminished amplification of SARS-CoV-2 ORF1ab in a commercial dual-target qRT-PCR diagnostic assay - PubMed
12/01 The dual function monoclonal antibodies VIR-7831 and VIR-7832 demonstrate potent in vitro and in vivo activity against SARS-CoV-2 | bioRxiv
12/01 Effectiveness and durability of protection against future SARS-CoV-2 infection conferred by COVID-19 vaccination and previous infection; findings from the UK SIREN prospective cohort study of healthcare workers March 2020 to September 2021 | medRxiv
12/01 Viral Dynamics of SARS-CoV-2 Variants in Vaccinated and Unvaccinated Persons | NEJM
12/01 Comparative Effectiveness of BNT162b2 and mRNA-1273 Vaccines in U.S. Veterans | NEJM
12/01 Covid-19 Vaccine Effectiveness in New York State | NEJM
12/01 COVID-19 vaccination in pregnancy—number needed to vaccinate to avoid harm - The Lancet Infectious Diseases
12/02 Protection from SARS-CoV-2 Delta one year after mRNA-1273 vaccination in rhesus macaques is coincident with anamnestic antibody response in the lung: Cell
12/02 Third COVID-19 Vaccine Dose Boosts Neutralising Antibodies in Poor Responders | medRxiv
12/02 BNT162b2 and ChAdOx1 nCoV-19 Vaccine Effectiveness against Death from the Delta Variant | NEJM
12/02 Toxic Effects from Ivermectin Use Associated with Prevention and Treatment of Covid-19 | NEJM
12/02 REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19 | NEJM
12/02 Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel | NEJM
12/02 Myocarditis after Covid-19 Vaccination in a Large Health Care Organization | NEJM
12/02 Impact of community masking on COVID-19: A cluster-randomized trial in Bangladesh
12/02 Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial - The Lancet
12/03 Omicron and Delta Variant of SARS-CoV-2: A Comparative Computational Study of Spike protein | bioRxiv
12/03 Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic - The Lancet
12/03 Severe breakthrough COVID-19 cases in the SARS-CoV-2 delta (B.1.617.2) variant era - The Lancet Microbe
12/04 Willingness to vaccinate against SARS-CoV-2: The role of reasoning biases and conspiracist ideation - ScienceDirect
12/05 Ad26.COV2.S or BNT162b2 Boosting of BNT162b2 Vaccinated Individuals | medRxiv
12/05 Brain Injury in COVID-19 is Associated with Autoinflammation and Autoimmunity | medRxiv
12/06 Predictions of the SARS-CoV-2 Omicron Variant (B.1.1.529) Spike Protein Receptor-Binding Domain Structure and Neutralizing Antibody Interactions | bioRxiv
12/06 Pre-existing humoral immunity to human common cold coronaviruses negatively impacts the protective SARS-CoV-2 antibody response: Cell Host & Microbe
12/06 Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial - The Lancet
12/07 Previous Infection Combined with Vaccination Produces Neutralizing Antibodies with Potency against SARS-CoV-2 Variants | mBio
12/07 Pre-existing humoral immunity to human common cold coronaviruses negatively impacts the protective SARS-CoV-2 antibody response - PubMed
12/07 An upper bound on one-to-one exposure to infectious human respiratory particles | PNAS
12/07 In vivo kinetics of SARS-CoV-2 infection and its relationship with a person’s infectiousness | PNAS
12/07 Robust immune responses are observed after one dose of BNT162b2 mRNA vaccine dose in SARS-CoV-2 experienced individuals - Science
12/08 Reduced Neutralization of SARS-CoV-2 Omicron Variant by Vaccine Sera and monoclonal antibodies | medRxiv
12/08 BNT162b2 Vaccine Booster and Mortality Due to Covid-19 | NEJM
12/08 Protection against Covid-19 by BNT162b2 Booster across Age Groups | NEJM
12/09 Minimal cross-over between mutations associated with Omicron variant of SARS-CoV-2 and CD8+ T cell epitopes identified in COVID-19 convalescent individuals | bioRxiv
12/09 B.1.1.529 escapes the majority of SARS-CoV-2 neutralizing antibodies of diverse epitopes | bioRxiv
12/10 Breakthrough Infections with SARS-CoV-2 Omicron Variant Despite Booster Dose of mRNA Vaccine by Constanze Kuhlmann, Carla Konstanze Mayer, Mathilda Claassen, Tongai G. Maponga, Andrew D. Sutherland, Tasnim Suliman, Megan Shaw, Wolfgang Preiser :: SSRN
12/10 Comparative effectiveness of mRNA-1273 and BNT162b2 against symptomatic SARS-CoV-2 infection: Med
12/11 SARS-CoV-2 B.1.1.529 variant (Omicron) evades neutralization by sera from vaccinated and convalescent individuals | medRxiv
12/13 Efficacy and Safety of COVID-19 Convalescent Plasma in Hospitalized Patients: A Randomized Clinical Trial | Critical Care Medicine | JAMA Internal Medicine | JAMA Network
12/14 SARS-CoV-2 Omicron: evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern | medRxiv
12/14 Global Percentage of Asymptomatic SARS-CoV-2 Infections Among the Tested Population and Individuals With Confirmed COVID-19 Diagnosis: A Systematic Review and Meta-analysis | Global Health | JAMA Network Open | JAMA Network
12/14 Third BNT162b2 vaccination neutralization of SARS-CoV-2 Omicron infection | medRxiv
12/14 mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant | medRxiv
12/14 mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant | medRxiv
12/14 mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant | medRxiv
12/14 Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection | Nature Medicine
12/15 Estimated Effectiveness of COVID-19 Messenger RNA Vaccination Against SARS-CoV-2 Infection Among Older Male Veterans Health Administration Enrollees, January to September 2021 | Infectious Diseases | JAMA Network Open | JAMA Network
12/15 Genomic determinants of Furin cleavage in diverse European SARS-related bat coronaviruses | bioRxiv
12/15 HKUMed finds Omicron SARS-CoV-2 can infect faster and better than Delta in human bronchus but with less severe infection in lung - News | HKUMed
12/15 Booster of mRNA-1273 Vaccine Reduces SARS-CoV-2 Omicron Escape from Neutralizing Antibodies | medRxiv
12/15 Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico | NEJM
12/16 Waning of mRNA-1273 vaccine effectiveness against SARS-CoV-2 infection in Qatar | medRxiv
12/16 Capturing adaptive immunity against SARS-CoV-2 in patients with cancer | Nature Cancer
12/16 Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients | NEJM
12/16 A SARS-CoV-2 ferritin nanoparticle vaccine elicits protective immune responses in nonhuman primates - Science
12/17 Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers: Cell Host & Microbe
12/20 Neutralization and Stability of SARS-CoV-2 Omicron Variant | bioRxiv
12/20 Diagnostics for COVID-19: moving from pandemic response to control - The Lancet
12/20 Two-dose ChAdOx1 nCoV-19 vaccine protection against COVID-19 hospital admissions and deaths over time: a retrospective, population-based cohort study in Scotland and Brazil - The Lancet
12/21 Effectiveness of a Third Dose of BNT162b2 mRNA COVID-19 Vaccine in a Large US Health System: A Retrospective Cohort Study by Sara Y. Tartof, Jeff M. Slezak, Laura Puzniak, Vennis Hong, Timothy B. Frankland, Bradley K. Ackerson, Harpreet S. Takhar, Oluwaseye A. Ogun, Sarah Simmons, Joann M. Zamparo, Sharon Gray, Srinivas R. Valluri, Kaijie Pan, Luis Jodar, John M. McLaughlin :: SSRN
12/21 COVID-19 Vaccination Effectiveness Against Infection or Death in a National U.S. Health Care System: A Target Trial Emulation Study: Annals of Internal Medicine
12/21 Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent Plasma | medRxiv
12/21 Omicron-specific cytotoxic T-cell responses are boosted following a third dose of mRNA COVID-19 vaccine in anti-CD20-treated multiple sclerosis patients | medRxiv
12/21 Early assessment of the clinical severity of the SARS-CoV-2 Omicron variant in South Africa | medRxiv
12/21 Escape from recognition of SARS-CoV-2 Beta variant spike epitopes but overall preservation of T cell immunity
12/22 Incidence and Estimated Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Among Persons Tested in US Retail Locations, May 1 to August 7, 2021 | Infectious Diseases | JAMA Network Open | JAMA Network
12/22 SARS-CoV-2 Omicron spike mediated immune escape, infectivity and cell-cell fusion | bioRxiv
12/22 Neutralization against Omicron SARS-CoV-2 from previous non-Omicron infection | bioRxiv
12/22 SARS-CoV-2 mRNA vaccination elicits a robust and persistent T follicular helper cell response in humans: Cell
12/22 Analytical sensitivity of seven SARS-CoV-2 antigen-detecting rapid tests for Omicron variant | medRxiv
12/22 Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift - Nature
12/22 Enhanced fitness of SARS-CoV-2 variant of concern Alpha but not Beta | Nature
12/22 Local and systemic responses to SARS-CoV-2 infection in children and adults | Nature
12/22 Cross-reactive adaptive immunity against coronaviruses in young children | Nature Immunology
12/22 Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection | Nature Immunology
12/22 Boosted immunity to the common cold might protect children from COVID-19 | Nature Immunology
12/22 Effects of BNT162b2 Covid-19 Vaccine Booster in Long-Term Care Facilities in Israel | NEJM
12/22 Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients | NEJM
12/23 mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant: Cell
12/23 Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2 - Nature
12/23 Considerable escape of SARS-CoV-2 Omicron to antibody neutralization - Nature
12/23 BNT162b2 Vaccine Booster and Mortality Due to Covid-19 | NEJM
12/23 A Phase 2a clinical trial of Molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus - Science
12/23 Transmission of Omicron (B.1.1.529) - SARS-CoV-2 Variant of Concern in a designated quarantine hotel for travelers: a challenge of elimination strategy of COVID-19 - The Lancet Regional Health – Western Pacific
12/24 COVID-19 Vaccination and Breakthrough Infections in Patients with Cancer - Annals of Oncology
12/24 Evidence for a mouse origin of the SARS-CoV-2 Omicron variant - ScienceDirect
12/26 A subset of Memory B-derived antibody repertoire from 3-dose vaccinees is ultrapotent against diverse and highly transmissible SARS-CoV-2 variants, including Omicron | bioRxiv
12/26 The omicron (B.1.1.529) SARS-CoV-2 variant of concern does not readily infect Syrian hamsters | bioRxiv
12/27 Early Computational Detection of Potential High Risk SARS-CoV-2 Variants | bioRxiv
12/27 High Rate of Asymptomatic Carriage Associated with Variant Strain Omicron | medRxiv
12/27 SARS-CoV-2 Omicron VOC Transmission in Danish Households | medRxiv
12/28 Association Between Immune Dysfunction and COVID-19 Breakthrough Infection After SARS-CoV-2 Vaccination in the US | HIV | JAMA Internal Medicine | JAMA Network
12/28 SARS-CoV-2 Omicron-B.1.1.529 Variant leads to less severe disease than Pango B and Delta variants strains in a mouse model of severe COVID-19 | bioRxiv
12/28 Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern. | bioRxiv
12/28 SARS-CoV-2 vaccination induces immunological memory able to cross-recognize variants from Alpha to Omicron | bioRxiv
12/28 SARS-CoV-2 spike T cell responses induced upon vaccination or infection remain robust against Omicron | medRxiv
12/28 Intranasal inhibitor blocks omicron and other variants of SARS-CoV-2 | Research Square
12/29 Clinical Severity of COVID-19 Patients Admitted to Hospitals in Gauteng, South Africa During the Omicron-Dominant Fourth Wave by Waasila Jassat, Salim Abdool Karim, Caroline Mudara, Richard Welch, Lovelyn Ozougwu, Michelle Groome, Nevashan Govender, Anne von Gottberg, Nicole Wolter, DATCOV Author Group, Lucille Blumberg, Cheryl Cohen :: SSRN
12/29 Vaccine effectiveness against hospital admission in South African health care workers who received a homologous booster of Ad26.COV2 during an Omicron COVID19 wave: Preliminary Results of the Sisonke 2 Study. | medRxiv
12/29 Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa | NEJM
12/29 Attenuated replication and pathogenesis of SARS-CoV-2 B.1.1.529 Omicron | Research Square
12/29 The SARS-CoV-2 B.1.1.529 Omicron virus causes attenuated infection and disease in mice and hamsters | Research Square
12/30 Characteristics and Outcomes of Hospitalized Patients in South Africa During the COVID-19 Omicron Wave Compared With Previous Waves | Global Health | JAMA | JAMA Network
12/31 Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron - Nature
January 2022
01/01 Vaccination-infection interval determines cross-neutralization potency to SARS-CoV-2 Omicron after breakthrough infection by other variants | medRxiv
01/01 Preferential expansion upon boosting of cross-reactive “pre-existing” switched memory B cells that recognize the SARS-CoV-2 Omicron variant Spike protein | medRxiv
01/02 Executive dysfunction following SARS-CoV-2 infection: A cross-sectional examination in a population-representative sample | medRxiv
01/03 Reduced Pathogenicity of the SARS-CoV-2 Omicron Variant in Hamsters | bioRxiv
01/03 SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses: Cell
01/03 Vaccines Elicit Highly Cross-Reactive Cellular Immunity to the SARS-CoV-2 Omicron Variant | medRxiv
01/03 The hyper-transmissible SARS-CoV-2 Omicron variant exhibits significant antigenic change, vaccine escape and a switch in cell entry mechanism | medRxiv
01/03 Mapping the antigenic diversification of SARS-CoV-2 | medRxiv
01/04 Association of Birth During the COVID-19 Pandemic With Neurodevelopmental Status at 6 Months in Infants With and Without In Utero Exposure to Maternal SARS-CoV-2 Infection | Child Development | JAMA Pediatrics | JAMA Network
01/04 Comparison of infectious SARS-CoV-2 from the nasopharynx of vaccinated and unvaccinated individuals | medRxiv
01/04 Vaccines Elicit Highly Cross-Reactive Cellular Immunity to the SARS-CoV-2 Omicron Variant | medRxiv
01/05 Test to release from isolation after testing positive for SARS-CoV-2 | medRxiv
01/05 T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all prior infected and vaccinated individuals | medRxiv
01/06 Protection afforded by prior infection against SARS-CoV-2 reinfection with the Omicron variant | medRxiv
01/06 Association between vaccination status and reported incidence of post-acute COVID-19 symptoms in Israel: a cross-sectional study of patients infected between March 2020 and November 2021 | medRxiv
01/06 Superior immunity that allows neutralization of all SARS-CoV-2 variants of concern develops in COVID-19 convalescents and naïve individuals after three vaccinations | Research Square
01/06 COVID mortality in India: National survey data and health facility deaths - Science
01/06 Using correlates to accelerate vaccinology - Science
01/06 COVID mortality in India: National survey data and health facility deaths - Science
01/07 Comparison of Moderna Versus Pfizer-Biontech COVID-19 Vaccine Outcomes: A Target Trial Emulation Study In the U.S. Veterans Affairs Healthcare System by George Ioannou, Emily Locke, Pamela Green, Kristin Berry :: SSRN
01/07 Rapid Diagnostic Testing for SARS-CoV-2 | NEJM
01/07 Innate immunological pathways in COVID-19 pathogenesis - Science
01/08 Effectiveness of mRNA-1273 against SARS-CoV-2 omicron and delta variants | medRxiv
01/10 Mild respiratory SARS-CoV-2 infection can cause multi-lineage cellular dysregulation and myelin loss in the brain | bioRxiv
01/10 The Dynamics of SARS-CoV-2 Infectivity with Changes in Aerosol Microenvironment | medRxiv
01/11 Infectious viral load in unvaccinated and vaccinated patients infected with SARS-CoV-2 WT, Delta and Omicron | medRxiv
01/11 Clinical outcomes among patients infected with Omicron (B.1.1.529) SARS-CoV-2 variant in southern California | medRxiv
01/11 Predicting the mutational drivers of future SARS-CoV-2 variants of concern - Science
01/12 Assessment of Functional Mobility After COVID-19 in Adults Aged 50 Years or Older in the Canadian Longitudinal Study on Aging | Geriatrics | JAMA Network Open | JAMA Network
01/12 SARS-CoV-2 variants with reduced infectivity and varied sensitivity to the BNT162b2 vaccine are developed during the course of infection
01/12 Screening for SARS-CoV-2 persistence in Long COVID patients using sniffer dogs and scents from axillary sweats samples | medRxiv
01/12 Outcomes of laboratory-confirmed SARS-CoV-2 infection in the Omicron-driven fourth wave compared with previous waves in the Western Cape Province, South Africa | medRxiv
01/12 Ultrarapid Nanopore Genome Sequencing in a Critical Care Setting | NEJM
01/12 Effectiveness of BNT162b2 Vaccine against Critical Covid-19 in Adolescents | NEJM
01/13 US Insurer Spending on Ivermectin Prescriptions for COVID-19 | Health Care Economics, Insurance, Payment | JAMA | JAMA Network
01/13 SARS-CoV-2 prolonged infection during advanced HIV disease evolves extensive immune escape: Cell Host & Microbe
01/13 Omicron’s Message on Vaccines: Boosting Begets Breadth: Cell
01/13 COVID infection severity in children under 5 years old before and after Omicron emergence in the US | medRxiv
01/13 Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection | Nature Immunology
01/13 SARS-CoV-2 infection and COVID-19 vaccination rates in pregnant women in Scotland | Nature Medicine
01/14 Β-Amyloid Deposits in Young COVID Patients by C. Harker Rhodes, David S. Priemer, Esma Karlovich, Daniel P. Perl, James Goldman :: SSRN
01/14 Ancestral SARS-CoV-2-specific T cells cross-recognize Omicron - Nature
01/15 Generation of novel SARS-CoV-2 variants on B.1.1.7 lineage in three patients with advanced HIV disease | medRxiv
01/16 Resilient T cell responses to B.1.1.529 (Omicron) SARS-CoV-2 variant | medRxiv
01/17 Association between vaccination status and reported incidence of post-acute COVID-19 symptoms in Israel: a cross-sectional study of patients tested between March 2020 and November 2021 | medRxiv
01/17 Limited cross-variant immunity after infection with the SARS-CoV-2 Omicron variant without vaccination | medRxiv
01/17 The UGT2A1/UGT2A2 locus is associated with COVID-19-related loss of smell or taste | Nature Genetics
01/17 Post-acute neurological consequences of COVID-19: an unequal burden | Nature Medicine
01/17 SARS-CoV-2 Omicron spike mediated immune escape and tropism shift | Research Square
01/17 Detection of the Omicron (B.1.1.529) variant of SARS-CoV-2 in aircraft wastewater - ScienceDirect
01/18 BNT162b2 (Pfizer–Biontech) mRNA COVID-19 Vaccine Against Omicron-Related Hospital and Emergency Department Admission in a Large US Health System: A Test-Negative Design by Sara Y. Tartof, Jeff M. Slezak, Laura Puzniak, Vennis Hong, Fagen Xie, Bradley K. Ackerson, Srinivas R. Valluri, Luis Jodar, John M. McLaughlin :: SSRN
01/18 Neutralization of SARS-CoV-2 Omicron by BNT162b2 mRNA vaccine–elicited human sera - Science
01/18 Neutralization of SARS-CoV-2 Omicron by BNT162b2 mRNA vaccine–elicited human sera - Science
01/18 Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose - The Lancet
01/19 Evaluation of SARS‐COV‐2 transmission and infection in airliner cabins - Wang - 2022 - Indoor Air - Wiley Online Library
01/19 Structural basis for Nirmatrelvir in vitro efficacy against the Omicron variant of SARS-CoV-2 | bioRxiv
01/19 SARS-CoV-2 breakthrough infections elicit potent, broad and durable neutralizing antibody responses: Cell
01/19 SARS-CoV-2 infections in children: Understanding diverse outcomes: Immunity
01/19 Differential immunogenicity of homologous versus heterologous boost in Ad26.COV2.S vaccine recipients: Med
01/19 Milder disease with Omicron: is it the virus or the pre-existing immunity? | Nature Reviews Immunology
01/19 Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar | NEJM
01/19 Immunogenicity and Reactogenicity of Vaccine Boosters after Ad26.COV2.S Priming | NEJM
01/19 Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis - The Lancet
01/19 Three-dose vaccination elicits neutralising antibodies against omicron - The Lancet
01/20 SARS-CoV-2 Omicron efficiently infects human airway, but not alveolar epithelium | bioRxiv
01/20 Omicron variant of SARS-CoV-2 exhibits an increased resilience to the antiviral type I interferon response | bioRxiv
01/20 Mutations in SARS-CoV-2 variants of concern link to increased spike cleavage and virus transmission: Cell Host & Microbe
01/20 A blood atlas of COVID-19 defines hallmarks of disease severity and specificity: Cell
01/20 Cannabidiol inhibits SARS-CoV-2 replication through induction of the host ER stress and innate immune responses - Science
01/20 Nervous system consequences of COVID-19 - Science
01/20 SARS-CoV-2 Omicron variant: Antibody evasion and cryo-EM structure of spike protein–ACE2 complex - Science
01/21 Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants | Vaccination | JAMA | JAMA Network
01/21 How the Supreme Court’s COVID-19 Vaccine Mandate Rulings Could Shape the Pandemic’s Next Phase | Law and Medicine | JAMA | JAMA Network
01/21 Outbreak.info: A standardized, searchable platform to discover and explore COVID-19 resources and data | bioRxiv
01/21 Effectiveness of BNT162b2 and mRNA-1273 COVID-19 boosters against SARS-CoV-2 Omicron (B.1.1.529) infection in Qatar | medRxiv
01/21 SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters | Nature
01/21 Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron | Nature
01/22 Neutralization of Omicron SARS-CoV-2 by 2 or 3 doses of BNT162b2 vaccine | bioRxiv
01/23 SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron: Cell
01/23 Omicron (BA.1) SARS-CoV-2 variant is associated with reduced risk of hospitalization and length of stay compared with Delta (B.1.617.2) | medRxiv
01/24 Clinical Outcomes Among Patients With 1-Year Survival Following Intensive Care Unit Treatment for COVID-19 | Critical Care Medicine | JAMA | JAMA Network
01/24 Multiple Early Factors Anticipate Post-Acute COVID-19 Sequelae: Cell
01/24 Immune imprinting, breadth of variant recognition and germinal center response in human SARS-CoV-2 infection and vaccination: Cell
01/24 SARS-CoV-2 infection and vaccine effectiveness in England (REACT-1): a series of cross-sectional random community surveys - The Lancet Respiratory Medicine
01/25 Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021 | Cardiology | JAMA | JAMA Network
01/25 Carditis After COVID-19 Vaccination With a Messenger RNA Vaccine and an Inactivated Virus Vaccine: A Case–Control Study: Annals of Internal Medicine: Vol 0, No 0
01/25 Immuno-proteomic profiling reveals aberrant immune cell regulation in the airways of individuals with ongoing post-COVD-19 respiratory disease: Immunity
01/25 Rapid emergence of SARS-CoV-2 Omicron variant is associated with an infection advantage over Delta in vaccinated persons | medRxiv
01/25 Immunoglobulin signature predicts risk of post-acute COVID-19 syndrome | Nature Communications
01/25 SARS-CoV-2 infection triggers paracrine senescence and leads to a sustained senescence-associated inflammatory response | Nature Aging
01/25 Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement - Science
01/25 Vaccination before or after SARS-CoV-2 infection leads to robust humoral response and antibodies that effectively neutralize variants - Science
01/26 Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome | Gut
01/26 Unadjuvanted intranasal spike vaccine booster elicits robust protective mucosal immunity against sarbecoviruses | bioRxiv
01/26 Lung Transplantation for Covid-19–Related Respiratory Failure in the United States | NEJM
01/26 Efficacy of Antibodies and Antiviral Drugs against Covid-19 Omicron Variant | NEJM
01/26 SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination | NEJM
01/27 Vaccination with BNT162b2 reduces transmission of SARS-CoV-2 to household contacts in Israel - Science
01/27 Indirect protection of children from SARS-CoV-2 infection through parental vaccination - Science
01/27 Persistence of protection against SARS-CoV-2 clinical outcomes up to 9 months since vaccine completion: a retrospective observational analysis in Lombardy, Italy - The Lancet Infectious Diseases
01/28 Transmission of SARS-CoV-2 (Variant Delta) from Pet Hamsters to Humans and Onward Human Propagation of the Adapted Strain: A Case Study by Hui-Ling Yen, Thomas HC Sit, Christopher J. Brackman, Shirley SY Chuk, Samuel M.S. Cheng, Haogao Gu, Lydia DJ Chang, Pavithra Krishnan, Daisy YM Ng, Gigi YZ Liu, Mani MY Hui, Sin Ying Ho, Karina WS Tam, Pierra YT Law, Wen Su, Sin Fun Sia, Ka-Tim Choy, Sammi SY Cheuk, Sylvia PN Lau, Amy WY Tang, Joe CT Koo, Louise Yung, Gabriel Leung, J.S. Malik Peiris, Leo LM Poon :: SSRN
01/28 Early introduction and rise of the Omicron SARS-CoV-2 variant in highly vaccinated university populations | medRxiv
01/28 Human genetic and immunological determinants of critical COVID-19 pneumonia | Nature
01/28 Memory B cell repertoire from triple vaccinees against diverse SARS-CoV-2 variants | Nature
01/28 Three exposures to the spike protein of SARS-CoV-2 by either infection or vaccination elicit superior neutralizing immunity to all variants of concern | Nature Medicine
01/30 Acute upper airway disease in children with the omicron (B.1.1.529) variant of SARS-CoV-2: a report from the National COVID Cohort Collaborative (N3C) | medRxiv
01/30 Transmission of SARS-CoV-2 Omicron VOC subvariants BA.1 and BA.2: Evidence from Danish Households | medRxiv
01/31 Omicron Neutralizing and Anti-SARS-CoV-2 S-RBD Antibodies in Naïve and Convalescent Populations After Homologous and Heterologous Boosting With an mRNA Vaccine by Matteo Pagliari, Eva Mazzetto, Michele Gastaldelli, Alessio Bortolami, Daniele Donà, Andrea Padoan, Costanza Di Chiara, Maria Diletta Pezzani, Chiara Cosma, Alessandra Napolitan, Erika Giorgia Quaranta, Edoardo Giussani, Alice Fusaro, Michela Pascarella, Ada Aita, Cecilia Liberati, Alessio Lorusso, Isabella Monne, Anita De Rossi, Daniela Basso, Stefano Porru, Antonia Ricci, Calogero Terregino, Mario Plebani, Evelina Tacconelli, Carlo Giaquinto, Francesco Bonfante :: SSRN
01/31 Equitable access to COVID-19 vaccines makes a life-saving difference to all countries | Nature Human Behaviour
01/31 T cell responses to SARS-CoV-2 spike cross-recognize Omicron | Nature
01/31 Vaccines Elicit Highly Conserved Cellular Immunity to SARS-CoV-2 Omicron | Nature
01/31 Recognition and inhibition of SARS-CoV-2 by humoral innate immunity pattern recognition molecules | Nature Immunology
01/31 Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 vaccine in adults aged ≥65 years: a phase 2, randomised, open-label study - The Lancet Respiratory Medicine
February 2022
02/01 Historically High Excess Mortality During the COVID-19 Pandemic in Switzerland, Sweden, and Spain | Annals of Internal Medicine
02/01 SARS-CoV-2 invades cognitive centers of the brain and induces Alzheimer's-like neuropathology | bioRxiv
02/01 Non-cell autonomous disruption of nuclear architecture as a potential cause of COVID-19 induced anosmia: Cell
02/01 Protection by 4th dose of BNT162b2 against Omicron in Israel | medRxiv
02/01 Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant | Nature
02/01 Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts tropism and fusogenicity | Nature
02/01 SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo | Nature
02/01 Innate immunity: the first line of defense against SARS-CoV-2 | Nature Immunology
02/01 The T cell immune response against SARS-CoV-2 | Nature Immunology
02/01 Immunology of SARS-CoV-2 infection in children | Nature Immunology
02/01 Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge | Research Square
02/02 Face mask fit hacks: Improving the fit of KN95 masks and surgical masks with fit alteration techniques
02/02 Utility of SARS-CoV-2 Rapid Antigen Testing for Patient Triage in the Emergency Department: A Clinical Implementation Study in Melbourne, Australia by Katherine Bond, Ben Smith, Emma Gardiner, Kwee Chin Liew, Eloise Williams, Nicola Walsham, Mark Putland, Deborah Williamson :: SSRN
02/02 T-cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals: Cell
02/02 High Rates of Rapid Antigen Test Positivity After 5 days of Isolation for COVID-19 | medRxiv
02/02 Neutralization profile of Omicron variant convalescent individuals | medRxiv
02/02 Durability of Omicron-neutralizing serum activity following mRNA booster immunization in elderly individuals | medRxiv
02/02 Challenges in Inferring Intrinsic Severity of the SARS-CoV-2 Omicron Variant | NEJM
02/03 Prevalence and Durability of SARS-CoV-2 Antibodies Among Unvaccinated US Adults by History of COVID-19 | Coronavirus (COVID-19) | JAMA | JAMA Network
02/03 Complications Following SARS-CoV-2 Infection in Victoria, Australia: A Record Linkage Study by Stacey L. Rowe, Karin Leder, Kylie Dyson, Lalitha Sundaresan, Dennis Wollersheim, Brigid M. Lynch, Ifrah Abdullahi, Benjamin C. Cowie, Nicola Stephens, Terry Nolan, Sheena Sullivan, Brett Sutton, Cheng AC :: SSRN
02/03 Tracking cryptic SARS-CoV-2 lineages detected in NYC wastewater | Nature Communications
02/03 Delayed-interval BNT162b2 mRNA COVID-19 vaccination enhances humoral immunity and induces robust T cell responses | Nature Immunology
02/03 Lethal mutagenesis as an antiviral strategy - Science
02/03 When viruses become more virulent - Science
02/03 Divergent SARS CoV-2 Omicron-reactive T- and B cell responses in COVID-19 vaccine recipients - Science
02/04 Comparative Analysis of the Risks of Hospitalisation and Death Associated with SARS-CoV-2 Omicron (B.1.1.529) and Delta (B.1.617.2) Variants in England by Tommy Nyberg, Neil M. Ferguson, Sophie G. Nash, Harriet H. Webster, Seth Flaxman, Nick Andrews, Wes Hinsley, Jamie Lopez Bernal, Meaghan Kall, Samir Bhatt, Paula Bianca Blomquist, Asad Zaidi, Erik Volz, Nurin Abdul Aziz, Katie Harman, Russell Hope, Andre Charlett, Meera A. Chand, Azra Ghani, Shaun Seaman, Gavin Dabrera, Daniela DeAngelis, Anne M. Presanis, Simon Thelwall :: SSRN
02/04 mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits comparable B cell expansion, neutralizing antibodies and protection against Omicron | bioRxiv
02/04 Pediatric Croup during the COVID-19 Omicron Variant Surge | medRxiv
02/04 The costs and benefits of primary prevention of zoonotic pandemics - Science
02/07 Long-Term Mortality Following COVID-19 Infection: A National Cohort Study From Estonia by Anneli Uuskula, Tuuli Jürgenson, Heti Pisarev, Raivo Kolde, Tatjana Meister, Anna Tisler, Kadri Suija, Ruth Kalda, Marko Piirsoo, Krista Fischer :: SSRN
02/07 Vaccine Protection Against the SARS-CoV-2 Omicron Variant in Macaques | bioRxiv
02/07 Development of a T cell-based immunodiagnostic system to effectively distinguish SARS-CoV-2 infection and COVID-19 vaccination status: Cell Host & Microbe
02/07 Protection of COVID-19 vaccination and previous infection against Omicron BA.1 and Delta SARS-CoV-2 infections, the Netherlands, 22 November 2021- 19 January 2022 | medRxiv
02/07 Clinical Severity and mRNA Vaccine Effectiveness for Omicron, Delta, and Alpha SARS-CoV-2 Variants in the United States: A Prospective Observational Study | medRxiv
02/07 Rapid and ultrasensitive electromechanical detection of ions, biomolecules and SARS-CoV-2 RNA in unamplified samples | Nature Biomedical Engineering
02/07 Longitudinal analysis of antibody dynamics in COVID-19 convalescents reveals neutralizing responses up to 16 months after infection | Nature Microbiology
02/07 Long-term cardiovascular outcomes of COVID-19 | Nature Medicine
02/07 Long COVID symptoms in SARS-CoV-2-positive adolescents and matched controls (LongCOVIDKidsDK): a national, cross-sectional study - The Lancet Child & Adolescent Health
02/07 Physical and mental health 3 months after SARS-CoV-2 infection (long COVID) among adolescents in England (CLoCk): a national matched cohort study - The Lancet Child & Adolescent Health
02/07 Assessing the impact of the pandemic in children and adolescents: SARS-CoV-2 infection and beyond - The Lancet Child & Adolescent Health
02/08 OSF Preprints | The role of schools in driving SARS-CoV-2 transmission: not just an open-and-shut case
02/08 Boosting of Serum Neutralizing Activity Against the Omicron Variant Among Recovered COVID-19 Patients by BNT162b2 and Coronavac Vaccines by Lu Lu, Lin-Lei Chen, Ricky Rui-Qi Zhang, Owen Tak-Yin Tsang, Jacky Man-Chun Chan, Anthony Raymond Tam, Wai-Shing Leung, Thomas Shiu-Hong Chik, Daphne Pui-Ling Lau, Chris Yau-Chung Choi, Carol Ho-Yan Fong, Jian-Piao Cai, Hoi-Wah Tsoi, Charlotte Yee-Ki Choi, Xiaojuan Zhang, Syed Muhammad Umer Abdullah, Brian Pui-Chun Chan, Kwok-Hung Chan, Kwok-Yung Yuen, Ivan Fan-Ngai Hung, Kelvin Kai-Wang To :: SSRN
02/08 Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2: Cell
02/08 SARS-CoV-2 infects, replicates, elevates angiotensin II and activates immune cells in human testes | medRxiv
02/08 Post-marketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12-39 years in Italy: a multi-database, self-controlled case series study | medRxiv
02/08 Duration of protection of BNT162b2 and mRNA-1273 COVID-19 vaccines against symptomatic SARS-CoV-2 Omicron infection in Qatar | medRxiv
02/08 Multiple spillovers from humans and onward transmission of SARS-CoV-2 in white-tailed deer | PNAS
02/08 Rapid increase in Omicron infections in England during December 2021: REACT-1 study - Science
02/08 A human antibody reveals a conserved site on beta-coronavirus spike proteins and confers protection against SARS-CoV-2 infection - Science
02/09 An anchor in troubled times: Trust in science before and within the COVID-19 pandemic - PLOS
02/09 Boosting with Omicron-matched or historical mRNA vaccines increases neutralizing antibody responses and protection against B.1.1.529 infection in mice | bioRxiv
02/09 The mechanism of RNA capping by SARS-CoV-2 | bioRxiv
02/09 Risk of persistent and new clinical sequelae among adults aged 65 years and older during the post-acute phase of SARS-CoV-2 infection: retrospective cohort study | The BMJ
02/09 Early prediction of preeclampsia in pregnancy with cell-free RNA | Nature
02/09 Protection against the Omicron Variant from Previous SARS-CoV-2 Infection | NEJM
02/09 Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S | NEJM
02/10 Antiviral agents for the treatment of COVID-19: progress and challenges: Cell Reports Medicine
02/10 Initial analysis of viral dynamics and circulating viral variants during the mRNA-1273 Phase 3 COVE trial | Nature Medicine
02/13 Coronavirus Disease 2019 (COVID-19) Vaccine Boosting in Persons Already Protected by Natural or Vaccine-Induced Immunity | medRxiv
02/13 Excess COVID-19 associated deaths among the unvaccinated population ≥18 years old in the US, May 30 – December 4, 2021 | medRxiv
02/14 Effectiveness of a third dose of BNT162b2 mRNA COVID-19 vaccine in a large US health system: A retrospective cohort study - The Lancet Regional Health – Americas
02/15 The Human Nose Organoid Respiratory Virus Model: an Ex Vivo Human Challenge Model To Study Respiratory Syncytial Virus (RSV) and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pathogenesis and Evaluate Therapeutics | mBio
02/15 The Effectiveness of mRNA Vaccine Boosters for Laboratory-Confirmed COVID-19 During a Period of Predominance of the Omicron Variant of SARS-CoV-2 by Susana Monge, Ayelén Rojas-Benedicto, Carmen Olmedo, Clara Mazagatos, María José Sierra, Aurora Limia, Elisa Martín-Merino, Amparo Larrauri, Miguel A. Hernán :: SSRN
02/15 Virological characteristics of SARS-CoV-2 BA.2 variant | bioRxiv
02/15 Increased Potency and Breadth of SARS-CoV-2 Neutralizing Antibodies After a Third mRNA Vaccine Dose | bioRxiv
02/15 Distinguishing Admissions Specifically for COVID-19 from Incidental SARS-CoV-2 Admissions: A National EHR Research Consortium Study | medRxiv
02/15 Co-infection with SARS-COV-2 Omicron and Delta Variants Revealed by Genomic Surveillance | medRxiv
02/15 4th Dose COVID mRNA Vaccines’ Immunogenicity & Efficacy Against Omicron VOC | medRxiv
02/15 The oral protease inhibitor (PF-07321332) protects Syrian hamsters against infection with SARS-CoV-2 variants of concern | Nature Communications
02/15 Germinal centre-driven maturation of B cell response to mRNA vaccination | Nature
02/15 Neutralizing antibody responses elicited by SARS-CoV-2 mRNA vaccination wane over time and are boosted by breakthrough infection - Science
02/16 SARS-CoV-2 Omicron BA.2 Variant Evades Neutralization by Therapeutic Monoclonal Antibodies | bioRxiv
02/16 Risks of mental health outcomes in people with covid-19: cohort study | The BMJ
02/16 The Effectiveness Of Government Masking Mandates On COVID-19 County-Level Case Incidence Across The United States, 2020 | Health Affairs
02/16 Bat coronaviruses related to SARS-CoV-2 and infectious for human cells | Nature
02/16 mRNA vaccine-induced antibodies more effective than natural immunity in neutralizing SARS-CoV-2 and its high affinity variants | Scientific Reports
02/16 Effectiveness of the BNT162b2 Vaccine after Recovery from Covid-19 | NEJM
02/16 Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19 | NEJM
02/16 Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection | NEJM
02/16 Effectiveness of the BNT162b2 Vaccine after Recovery from Covid-19 | NEJM
02/17 Immunogenicity of a BNT162b2 Vaccine Booster Against SARS-CoV-2 Delta and Omicron Variants in Older People by Enagnon Kazali Alidjinou, Julie Demaret, Bénédicte Corroyer-Simovic, Julien Labreuche, Anne Goffard, Jacques Trauet, Daniela Lupau, Sophie Miczek, Fanny Vuotto, Arnaud Dendooven, Dominique Huvent-Grelle, Juliette Podvin, Daniel Dreuil, Karine Faure, Dominique Deplanque, Laurence Bocket, Alain Duhamel, Annie Sobaszek, Didier Hober, Michael Hisbergues, François Puisieux, Brigitte Autran, Yazdan Yazdanpanah, Myriam Labalette, Guillaume Lefèvre :: SSRN
02/17 Neutralization and durability of 2 or 3 doses of the BNT162b2 vaccine against Omicron SARS-CoV-2: Cell Host & Microbe
02/17 Viruses | Free Full-Text | SARS-CoV-2 Delta Variant (AY.3) in the Feces of a Domestic Cat - MDPI
02/18 Efficacy of Ivermectin Treatment on Disease Progression Among Adults With Mild to Moderate COVID-19 and Comorbidities: The I-TECH Randomized Clinical Trial | Complementary and Alternative Medicine | JAMA Internal Medicine | JAMA Network
02/18 Paediatric hospitalisations due to COVID-19 during the first SARS-CoV-2 omicron (B.1.1.529) variant wave in South Africa: a multicentre observational study - The Lancet Child & Adolescent Health
02/19 Clinical severity of Omicron sub-lineage BA.2 compared to BA.1 in South Africa | medRxiv
02/19 Risk of SARS-CoV-2 reinfection 18 months after primary infection: population-level observational study | medRxiv
02/21 Risk of Second Allergic Reaction to SARS-CoV-2 Vaccines: A Systematic Review and Meta-analysis | Allergy and Clinical Immunology | JAMA Internal Medicine | JAMA Network
02/21 Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants | Nature Medicine
02/22 Symptoms After COVID-19 Vaccination in Patients with Post-Acute Sequelae of SARS-CoV-2 | SpringerLink
02/22 Efficient recall of Omicron-reactive B cell memory after a third dose of SARS-CoV-2 mRNA vaccine | bioRxiv
02/22 A neural population selective for song in human auditory cortex: Current Biology
02/22 Occurrence and significance of Omicron BA.1 infection followed by BA.2 reinfection | medRxiv
02/22 The major genetic risk factor for severe COVID-19 is associated with protection against HIV | PNAS
02/23 Population Immunity and Covid-19 Severity with Omicron Variant in South Africa | NEJM
02/24 Multiple early factors anticipate post-acute COVID-19 sequelae: Cell
02/24 Risk of Long Covid in people infected with SARS-CoV-2 after two doses of a COVID-19 vaccine: community-based, matched cohort study | medRxiv
02/24 Fighting the SARS-CoV-2 pandemic requires a global approach to understanding the heterogeneity of vaccine responses | Nature Immunology
02/25 Protection of Omicron sub-lineage infection against reinfection with another Omicron sub-lineage | medRxiv
02/25 Risk of COVID-19 related deaths for SARS-CoV-2 Omicron (B.1.1.529) compared with Delta (B.1.617.2) | medRxiv
02/28 An immunoPET probe to SARS-CoV-2 reveals early infection of the male genital tract in rhesus macaques | bioRxiv
02/28 Effectiveness of the BNT162b2 vaccine among children 5-11 and 12-17 years in New York after the Emergence of the Omicron Variant | medRxiv
02/28 Post-acute symptoms, new onset diagnoses and health problems 6 to 12 months after SARS-CoV-2 infection: a nationwide questionnaire study in the adult Danish population | medRxiv
02/28 Multiscale PHATE identifies multimodal signatures of COVID-19 | Nature Biotechnology
02/28 Durability of omicron-neutralising serum activity after mRNA booster immunisation in older adults - The Lancet Infectious Diseases
March 2022
03/01 Modeling the filtration efficiency of a woven fabric: The role of multiple lengthscales: Physics of Fluids: Vol 34, No 3
03/01 Peripheral Neuropathy Evaluations of Patients With Prolonged Long COVID | Neurology Neuroimmunology & Neuroinflammation
03/01 Prescribing Nirmatrelvir–Ritonavir: How to Recognize and Manage Drug–Drug Interactions | Annals of Internal Medicine
03/01 Response to additional COVID-19 vaccine doses in people who are immunocompromised: a rapid review - The Lancet Global Health
03/02 Severe Neuro-COVID is associated with peripheral immune signatures, autoimmunity and signs of neurodegeneration: a prospective cross-sectional study | medRxiv
03/02 Recurrent SARS-CoV-2 Mutations in Immunodeficient Patients | medRxiv
03/02 Detection of COVID-19 using multimodal data from a wearable device: results from the first TemPredict Study | Scientific Reports
03/02 Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant | NEJM
03/03 Assessment of Clinical Effectiveness of BNT162b2 COVID-19 Vaccine in US Adolescents | Adolescent Medicine | JAMA Network Open | JAMA Network
03/03 Evidence of co-infection during Delta and Omicron variants of concern co-circulation, weeks 49-2021 to 02-2022, France | medRxiv
03/03 Genome-wide analysis provides genetic evidence that ACE2 influences COVID-19 risk and yields risk scores associated with severe disease | Nature Genetics
03/03 Waning immune responses against SARS-CoV-2 variants of concern among vaccinees in Hong Kong - eBioMedicine
03/07 The mutational steps of SARS-CoV-2 to become like Omicron within seven months: the story of immune escape in an immunocompromised patient | medRxiv
03/07 SARS-CoV-2 is associated with changes in brain structure in UK Biobank | Nature
03/08 Toward Unbiased Evaluation of Postacute Sequelae of SARS-CoV-2 Infection: Challenges and Solutions for the Long Haul Ahead | Annals of Internal Medicine
03/08 SARS-CoV-2 Infection Induces Ferroptosis of Sinoatrial Node Pacemaker Cells | Circulation Research
03/08 Maintaining face mask use before and after achieving different COVID-19 vaccination coverage levels: a modelling study - The Lancet Public Health
03/09 Social Determinants of Health Factors for Gene–Environment COVID‐19 Research: Challenges and Opportunities - Phuong - - Advanced Genetics - Wiley Online Library
03/09 School Masking Policies and Secondary SARS-CoV-2 Transmission | Pediatrics | American Academy of Pediatrics
03/09 Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study | The BMJ
03/09 Broad neutralization of SARS-CoV-2 variants by an inhalable bispecific single-domain antibody: Cell
03/09 Boosters protect against SARS-CoV-2 infections in young adults during an Omicron-predominant period | medRxiv
03/09 Resistance Mutations in SARS-CoV-2 Delta Variant after Sotrovimab Use | NEJM
03/09 Efficacy of Antiviral Agents against the SARS-CoV-2 Omicron Subvariant BA.2 | NEJM
03/09 Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar | NEJM
03/10 Observed Protection Against SARS-CoV-2 Reinfection Following a Primary Infection: A Danish Cohort Study Using Two Years of Nationwide PCR-Test Data by Daniela Michlmayr, Christian Holm Hansen, Sophie Madeleine Gubbels, Palle Valentiner-Branth, Peter Michael Bager, Niels Obel, Birgitte Drewes, Camilla Holten Møller, Frederik Trier Møller, Rebecca Legarth, Kåre Mølbak, Steen Ethelberg :: SSRN
03/10 Trends, regional variation and clinical characteristics of recipients of antivirals and neutralising monoclonal antibodies for non-hospitalised COVID-19: a descriptive cohort study of 23.4 million people in OpenSAFELY | medRxiv
03/10 The changing epidemiology of SARS-CoV-2 - Science
03/10 The immunology and immunopathology of COVID-19 - Science
03/10 COVID-19 vaccination: The road ahead - Science
03/10 COVID-19 - lessons for zoonotic disease - Science
03/10 Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020–21 - The Lancet
03/12 Transmission of SARS-CoV-2 delta variant (AY.127) from pet hamsters to humans, leading to onward human-to-human transmission: a case study - The Lancet
03/13 High vaccine effectiveness against severe Covid-19 in the elderly in Finland before and after the emergence of Omicron | medRxiv
03/13 Vaccination against SARS-CoV-2 in UK school-aged children and young people decreases infection rates and reduces COVID-19 symptoms | medRxiv
03/14 SARS-CoV-2 incidence, transmission, and reinfection in a rural and an urban setting: results of the PHIRST-C cohort study, South Africa, 2020–21 - The Lancet Infectious Diseases
03/15 Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa - Science
03/15 Duration of Infectious Virus Shedding by SARS-CoV-2 Omicron Variant–Infected Vaccinees - Volume 28, Number 5—May 2022 - Emerging Infectious Diseases journal - CDC
03/16 Imprinted SARS-CoV-2-specific memory lymphocytes define hybrid immunity: Cell
03/16 Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 Variants | NEJM
03/16 Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron | NEJM
03/17 Getting to the (germinal) center of humoral immune responses to SARS-CoV-2: Cell
03/18 Protection of prior natural infection compared to mRNA vaccination against SARS-CoV-2 infection and severe COVID-19 in Qatar | medRxiv
03/21 Intrinsic Severity of SARS-CoV-2 Omicron BA.2 in Uninfected, Unvaccinated Children: A Population-Based, Case-Control Study on Hospital Complications by Winnie Wan Yee Tso, Mike Kwan, Yu Liang Wang, Lok Kan Leung, Daniel Leung, Gilbert T. Chua, Patrick Ip, Wilfred Hing Sang Wong, Sophelia Hoi Shan Chan, Jasper Fuk-Woo Chan, J.S. Malik Peiris, Yu Lung Lau, Jaime Sou Rosa Duque :: SSRN
03/21 Identification of a Novel SARS-CoV-2 Delta-Omicron Recombinant Virus in the United States | bioRxiv
03/21 Bacterial and Fungal Isolation from Face Masks: Newly Emerged Hygiene Issues Under COVID-19 Pandemic | Research Square
03/21 Risks and burdens of incident diabetes in long COVID: a cohort study - The Lancet Diabetes & Endocrinology
03/21 Rising diabetes diagnosis in long COVID - The Lancet Diabetes & Endocrinology
03/22 Effect of prior infection, vaccination, and hybrid immunity against symptomatic BA.1 and BA.2 Omicron infections and severe COVID-19 in Qatar | medRxiv
03/22 Vaccine effectiveness of two and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong | medRxiv
03/22 An evolutionary insight into Severe Acute Respiratory Syndrome Coronavirus 2 Omicron variant of concern. - ScienceDirect
03/23 Post-acute sequelae of COVID-19: A metabolic perspective | eLife
03/23 Omicron: What Makes the Latest SARS-CoV-2 Variant of Concern So Concerning? | Journal of Virology
03/23 Neutralization Profile after Recovery from SARS-CoV-2 Omicron Infection | NEJM
03/23 Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 Vaccine | NEJM
03/23 SARS-CoV-2-specific antibody and T-cell responses 1 year after infection in people recovered from COVID-19: a longitudinal cohort study - The Lancet Microbe
03/24 Neutralization of Omicron BA.1, BA.2, and BA.3 SARS-CoV-2 by 3 doses of BNT162b2 vaccine | bioRxiv
03/24 SARS-CoV-2 Omicron triggers cross-reactive neutralization and Fc effector functions in previously vaccinated, but not unvaccinated individuals: Cell Host & Microbe
03/24 SARS-CoV-2 Omicron triggers cross-reactive neutralization and Fc effector functions in previously vaccinated, but not unvaccinated, individuals: Cell Host & Microbe
03/24 mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits similar B cell expansion, neutralizing responses, and protection from Omicron: Cell
03/24 Relative Effectiveness of Four Doses Compared to Three Dose of the BNT162b2 Vaccine in Israel | medRxiv
03/24 Inconsistent directions of change in case severity across successive SARS-CoV-2 variant waves suggests an unpredictable future | medRxiv
03/24 Second Booster Vaccine and Covid-19 Mortality in Adults 60 to 100 Years Old | Research Square
03/24 Structural basis for potent antibody neutralization of SARS-CoV-2 variants including B.1.1.529 - Science
03/24 Understanding T-cell responses to COVID-19 is essential for informing public health strategies - Science
03/25 Levels of SARS-CoV-2 Antibodies Among Fully-Vaccinated Individuals With Delta or Omicron Variant Breakthrough Infections: A Prospective Cohort Study by Nina Breinholt Stærke, Joanne Reekie, Henrik Nielsen, Thomas Benfield, Lothar Wiese, Lene Surland Knudsen, Mette Brouw Iversen, Kasper Karmark Iversen, Kamille Fogh, Jacob Bodilsen, Maria Ruwald Juhl, Susan Olaf Lindvig, Anne Øvrehus, Lone Wulff Madsen, Vibeke Klastrup, Sidsel Dahl Andersen, Anna Karina Juhl, Signe Rode Andreasen, Sisse Rye Ostrowski, Christian Erikstrup, Thea K. Fischer, Martin Tolstrup, Lars Jørgen Østergaard, Isik S. Johansen, Jens Lundgren, Ole S. Søgaard :: SSRN
03/25 SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses - The Lancet
03/26 Monitoring of the SARS-CoV-2 Omicron BA.1/BA.2 variant transition in the Swedish population reveals higher viral quantity in BA.2 cases | medRxiv
03/27 Neutralizing immunity in vaccine breakthrough infections from the SARS-CoV-2 Omicron and Delta variants: Cell
03/27 Boosting with variant-matched or historical mRNA vaccines protects against Omicron infection in mice: Cell
03/27 Global Reports of Myocarditis Following COVID-19 Vaccination: A Systematic Review and Meta-Analysis | medRxiv
03/28 Intrinsic Generation Time of the SARS-CoV-2 Omicron Variant: An Observational Study of Household Transmission by Mattia Manica, Alfredo De Bellis, Giorgio Guzzetta, Pamela Mancuso, Massimo Vicentini, Francesco Venturelli, Eufemia Bisaccia, Maria Litvinova, Piero Poletti, Valentina Marziano, Agnese Zardini, Valeria d'Andrea, Filippo Trentini, Antonino Bella, Flavia Riccardo, Patrizio Pezzotti, Marco Ajelli, Paolo Giorgi Rossi, Stefano Merler :: SSRN
03/28 Pre-existing SARS-CoV-2 immunity influences potency, breadth, and durability of the humoral response to SARS-CoV-2 vaccination: Cell Reports Medicine
03/28 Detection of a BA.1/BA.2 recombinant in travelers arriving in Hong Kong, February 2022 | medRxiv
03/28 A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeutic | Nature
03/28 Serum neutralisation of the SARS-CoV-2 omicron sublineage BA.2 - The Lancet Microbe
03/29 mRNA-1273 and BNT162b2 COVID-19 vaccines elicit antibodies with differences in Fc-mediated effector functions - Science
03/29 Estimating Relative Abundance of 2 SARS-CoV-2 Variants through Wastewater Surveillance at 2 Large Metropolitan Sites, United States - Volume 28, Number 5—May 2022 - Emerging Infectious Diseases journal - CDC
03/30 Cross-neutralization of Omicron BA.1 against BA.2 and BA.3 SARS-CoV-2 | bioRxiv
03/30 Smart toilets for monitoring COVID-19 surges: passive diagnostics and public health | npj Digital Medicine
03/30 Effect of Early Treatment with Ivermectin among Patients with Covid-19 | NEJM
03/30 BNT162b2 Protection against the Omicron Variant in Children and Adolescents | NEJM
03/30 SARS-CoV-2 infection of airway cells causes intense viral and cell shedding, two spreading mechanisms affected by IL-13 | PNAS
03/30 Vaccine effectiveness against infection and COVID-19-associated hospitalisation with the Omicron (B.1.1.529) variant after vaccination with the BNT162b2 or mRNA-1273 vaccine: A nationwide Danish cohort study | Research Square
03/31 Defining the risk of SARS-CoV-2 variants on immune protection | Nature
03/31 Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults | Nature Medicine
03/31 Effectiveness of CoronaVac, ChAdOx1 nCoV-19, BNT162b2, and Ad26.COV2.S among individuals with previous SARS-CoV-2 infection in Brazil: a test-negative, case-control study - The Lancet Infectious Diseases
03/31 Risk of SARS-CoV-2 reinfection and COVID-19 hospitalisation in individuals with natural and hybrid immunity: a retrospective, total population cohort study in Sweden - The Lancet Infectious Diseases
03/31 Interplay of infection and vaccination in long-term protection from COVID-19 - The Lancet Infectious Diseases
April 2022
04/01 Projecting COVID-19 Mortality as States Relax Nonpharmacologic Interventions - JAMA Health Forum
04/01 Incidence Rates and Clinical Outcomes of SARS-CoV-2 Infection With the Omicron and Delta Variants in Children Younger Than 5 Years in the US | Infectious Diseases | JAMA Pediatrics | JAMA Network
04/01 Safety of COVID-19 Vaccines During Pregnancy: A Systematic Review and Meta-Analysis by Agustin Ciapponi, Mabel Berrueta, Ariel Bardach, Agustina Mazzoni, Steven A. Anderson, Fernando J. Argento, Jamile Ballivian, Karin Bok, Daniel Comandé, Erin Goucher, Beate Kampmann, Edward Parker, Federico Rodriguez Cairoli, María Victoria Santa María, Andy Stergachis, Gerald Voss, Xu Xiong, Natalia Zamora, Pierre M. Buekens, Sabra Zaraa :: SSRN
04/01 Omicron breakthrough infection drives cross-variant neutralization and memory B cell formation | bioRxiv
04/02 The Evolution and Biology of SARS-CoV-2 Variants - Perspectives in Medicine
04/03 Humanized mice reveal a macrophage-enriched gene signature defining human lung tissue protection during SARS-CoV-2 infection: Cell Reports
04/03 Cardiac impairment in Long Covid 1-year post-SARS-CoV-2 infection | medRxiv
04/04 Rapid characterization of a Delta-Omicron SARS-CoV-2 recombinant detected in Europe | Research Square
04/05 Studying severe long COVID to understand post-infectious disorders beyond COVID-19 | Nature Medicine
04/05 Protection by a Fourth Dose of BNT162b2 against Omicron in Israel | NEJM
04/05 SARS-CoV-2 BA.1 variant is neutralized by vaccine booster-elicited serum, but evades most convalescent serum and therapeutic antibodies - Science
04/06 Spiral: Twin peaks: the Omicron SARS-CoV-2 BA.1 and BA.2 epidemics in England - Imperial College London
04/06 Risks of deep vein thrombosis, pulmonary embolism, and bleeding after covid-19: nationwide self-controlled cases series and matched cohort study | The BMJ
04/06 Pulse Oximetry for Monitoring Patients with Covid-19 at Home — A Pragmatic, Randomized Trial | NEJM
04/06 Protection with a Third Dose of mRNA Vaccine against SARS-CoV-2 Variants in Frontline Workers | NEJM
04/06 COVID-19 therapeutics: Challenges and directions for the future | PNAS
04/07 Cryo-EM structures of SARS-CoV-2 Omicron BA.2 spike | bioRxiv
04/07 Efficient recall of Omicron-reactive B cell memory after a third dose of SARS-CoV-2 mRNA vaccine: Cell
04/07 Epidemiology of infections with SARS-CoV-2 Omicron BA.2 variant in Hong Kong, January-March 2022 | medRxiv
04/07 Applying lessons learned from nanomedicines to understand rare hypersensitivity reactions to mRNA-based SARS-CoV-2 vaccines | Nature Nanotechnology
04/07 Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron | NEJM
04/08 Three-dose mRNA-1273 vaccination schedule: sufficient antibody response in majority of immunocompromised hematology patients | medRxiv
04/08 Infectious viral load in unvaccinated and vaccinated individuals infected with ancestral, Delta or Omicron SARS-CoV-2 | Nature Medicine
04/08 An immunoPET probe to SARS-CoV-2 reveals early infection of the male genital tract in rhesus macaques | Research Square
04/08 Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis - The Lancet
04/11 Postmortem Assessment of Olfactory Tissue Degeneration and Microvasculopathy in Patients With COVID-19 | Infectious Diseases | JAMA Neurology | JAMA Network
04/11 SARS-CoV-2 Infection and Associated Cardiovascular Manifestations and Complications in Children and Young Adults: A Scientific Statement From the American Heart Association | Circulation
04/11 Prevalence, Characteristics, and Outcomes of COVID-19–Associated Acute Myocarditis | Circulation
04/11 Omicron neutralizing antibody response following booster vaccination compared with breakthrough infection | medRxiv
04/11 Understanding COVID-19 through genome-wide association studies | Nature Genetics
04/11 Myopericarditis following COVID-19 vaccination and non-COVID-19 vaccination: a systematic review and meta-analysis - The Lancet Respiratory Medicine
04/12 Evolution of nasal and olfactory infection characteristics of SARS-CoV-2 variants | bioRxiv
04/12 Gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA suggest prolonged gastrointestinal infection: Med
04/12 Admissions to a large tertiary care hospital and Omicron BA.1 and BA.2 SARS-CoV-2 PCR positivity: primary, contributing, or incidental COVID-19 | medRxiv
04/12 SARS-CoV-2 spike protein–induced cell fusion activates the cGAS-STING pathway and the interferon response - Science
04/12 Population-level implications of the Israeli booster campaign to curtail COVID-19 resurgence - Science
04/12 Comparable neutralisation evasion of SARS-CoV-2 omicron subvariants BA.1, BA.2, and BA.3 - The Lancet Infectious Diseases
04/13 Immunogenicity of convalescent and vaccinated sera against clinical isolates of ancestral SARS-CoV-2, beta, delta, and omicron variants: Med
04/14 To mask, or not to mask, Alice and Bob’s dating dilemma | medRxiv
04/14 High vaccine effectiveness against severe Covid-19 in the elderly in Finland before and after the emergence of Omicron | Research Square
04/14 A SARS-CoV-2 omicron (B.1.1.529) variant outbreak in a primary school in Geneva, Switzerland - The Lancet Infectious Diseases
04/15 Acute Upper Airway Disease in Children With the Omicron (B.1.1.529) Variant of SARS-CoV-2—A Report From the US National COVID Cohort Collaborative | Pediatrics | JAMA Pediatrics | JAMA Network
04/19 Inter-individual variation in objective measure of reactogenicity following COVID-19 vaccination via smartwatches and fitness bands | npj Digital Medicine
04/20 Vaccine effectiveness against SARS-CoV-2 infection and COVID-19-related hospitalization with the Alpha, Delta and Omicron SARS-CoV-2 variants: a nationwide Danish cohort study | medRxiv
04/20 Intramuscular AZD7442 (Tixagevimab–Cilgavimab) for Prevention of Covid-19 | NEJM
04/21 Impact of the additional/booster dose of COVID-19 vaccine against severe disease during the epidemic phase characterized by the predominance of the Omicron variant in Italy, November 2021 - March 2022 | medRxiv
04/21 Brain changes after COVID-19 — how concerned should we be? | Nature Reviews Neurology
04/21 Increased Memory B Cell Potency and Breadth After a SARS-CoV-2 mRNA Boost | Nature
04/21 Policy stringency and mental health during the COVID-19 pandemic: a longitudinal analysis of data from 15 countries - The Lancet Public Health
04/22 Tixagevimab/Cilgavimab for Treatment of Hospitalised COVID-19 Patients: A Randomised, Double-Blind, Phase 3 Trial by Thomas L. Holland, Adit A. Ginde, Roger Paredes, Thomas A. Murray, Nicole Engen, Greg Grandits, Andrew Vekstein, Noel Ivey, Ahmad Mourad, Uriel Sandkovsky, Robert L. Gottlieb, Mezgebe Berhe, Mamta Jain, Rubria Marines-Price, Barbine Tchamba Agbor Agbor, Lourdes Mateu, Sergio Espana-Cueto, Gemma Llados, Eleftherios Mylonakis, Ralph Rogers, Fadi Shehadeh, Michael R. Filbin, Kathryn A. Hibbert, Kami Kim, Thanh Tran, Peter E. Morris, Evan P. Cassity, Barbara Trautner, Lavannya M. Pandit, Kirk U. Knowlton, Lindsay Leither, Michael A. Matthay, Angela J. Rogers, Wonder Drake, Beatrice Jones, Garyfallia Poulakou, Konstantinos N. Syrigos, Eduardo Fernandez-Cruz, Marisa Di Natale, Eyad Almasri, Leire Balerdi-Sarasola, Sanjay R. Bhagani, Katherine L. Boyle, Jonathan D. Casey, Peter Chen, David J. Douin, D. Clark Files, Huldrych F. Günthard, R. Duncan Hite, Robert C. Hyzy, Akram Khan, Moses Kibirige, Robert Kidega, Ivan Kimuli, Francis Kiweewa, Jens Ulrik Stæhr Jensen, Bradley G. Leshnower, Joseph K. Lutaakome, Prasad Manian, Vidya Menon, Jose Luis Morales-Rull, Darragh O'Mahony, J. Scott Overcash, Srikant Ramachandruni, Jay S. Steingrub, Hassan S. Taha, Michael Waters, Barnaby E. Young, Andrew N. Phillips, Daniel D. Murray, Tomas O. Jensen, Maria L. Padilla, David Sahner, Katy Shaw-Saliba, Robin L. Dewar, Marc Teitelbaum, Ven Natarajan, M. Tauseef Rehman, Sarah Pett, Fleur Hudson, Giota Touloumi, Samuel M. Brown, Wesley H. Self, Christina C. Chang, Adriana Sanchez, Amy C. Weintrob, Timothy Hatlen, Birgit Grund, Shweta Sharma, Cavan S. Reilly, Pedro Garbes, Mark T. Esser, Alison Templeton, Abdel G. Babiker, Victoria J. Davey, Annetine C. Gelijns, Elizabeth S. Higgs, Virginia Kan, Gail Matthews, B. Taylor Thompson, James D. Neaton, H. Clifford Lane, Jens Lundgren :: SSRN
04/22 Durability of BNT162b2 vaccine against hospital and emergency department admissions due to the omicron and delta variants in a large health system in the USA: a test-negative case–control study - The Lancet Respiratory Medicine
04/23 Excess all-cause mortality across counties in the United States, March 2020 to December 2021 | medRxiv
04/23 Effectiveness of homologous and heterologous booster doses for an inactivated SARS-CoV-2 vaccine: a large-scale prospective cohort study - The Lancet Global Health
04/23 Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study - The Lancet Respiratory Medicine
04/25 A living WHO guideline on drugs for covid-19 | The BMJ
04/25 Safety and immunogenicity of the Pfizer/BioNTech SARS-CoV-2 mRNA third booster vaccine dose against the SARS-CoV-2 BA.1 and BA.2 Omicron variants: Med
04/25 Impact of population mixing between vaccinated and unvaccinated subpopulations on infectious disease dynamics: implications for SARS-CoV-2 transmission | CMAJ
04/25 Effectiveness of a second BNT162b2 booster vaccine against hospitalization and death from COVID-19 in adults aged over 60 years | Nature Medicine
04/27 An orally available Mpro inhibitor is effective against wild-type SARS-CoV-2 and variants including Omicron | Nature Microbiology
04/28 Fourth Dose of BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting | NEJM
May 2022
05/01 The performance of wearable sensors in the detection of SARS-CoV-2 infection: a systematic review - The Lancet Digital Health
|
Main |
News |
Articles |
Papers|
About
|